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This thesis considers the design of paediatric allergy services in the West Midlands (WM) 
region. It is presented in 3 parts: the first discusses a systematic review of allergy service 
delivery pathways across the UK and the rest of the world; The second quantifies the burden 
of paediatric allergy across the WM and compares it with the rest of the country using data 
from the health information network (THIN) database for primary care and the hospital 
episodes statistics (HES) database for secondary care. The final part ascertains the 
experiences of parents in the WM region who have accessed these services through a 
qualitative study and elicits parental preferences for these services using a discrete choice 
experiment. 
The main argument put forth in this thesis is that services in a financially constrained 
environment should be planned efficiently and be responsive to the needs and preferences of 
the local population. A systematic way method to achieve this is presented along with 
recommendations for improving the efficacy and efficiency of paediatric allergy pathways in 
the WM region.    
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1 INTRODUCTION 
This thesis will evaluate paediatric allergy services in the WM region with a view to 
understanding the current pathways of service delivery, the challenges faced by clinicians and 
patients and proposing changes that can improve these services.
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1.1 BACKGROUND 
The NHS in the UK is a tax payer funded health care system which is free for all at the 
point of contact. The service embodies the notion of equity of health care- be it in terms of 
access, treatment availability or quality of services. The reality, is however, quite different. 
Services are often patchy, heterogeneous and, in the case of allergy, frequently non-existent. 
Terms such as ‘allergy epidemic’[1], ‘unmet need’[2], ‘post code lottery’ have all been used 
to describe the perceived urgency and inequity in the provision of these services in the UK.  
There has been much interest in allergy services over the last two decades: eight reports by 
UK governmental institutions discussing the current state of allergy services between 2003 
and 2013 [3-8], two reports from the World Allergy Organization (WAO) [9, 10], a further 
white book on allergy from the WAO recommending concerted action for improved patient 
care worldwide [11], and a report on allergy management in primary care across Europe [12] 
have all been published. Two prospective studies aimed at improving allergy service 
pathways have been initiated in the UK over the last two decades- one was a pilot scheme 
carried out in the Northwest of England [13] and another is a large NIHR funded project 
based in North west London [14]. The first project encountered many barriers and was unable 
to meet its target [13] and the second is yet to publish its final report. 
The conclusion of most of these publications is the same: allergy services are not meeting 
the increasing demand placed on them. Specialist services are patchy, inadequate and are 
'letting the patients down' [7]. More funding is needed to improve the number of available 
specialist allergists, specialist centres, trainee doctors in allergy and to improve primary care 
training for allergy. 
Whilst these investments are important for service improvement, in the current reality of 
serious funding cuts to the NHS it is important to look at innovative and evidence based ways 
of improving efficiency of available services. This thesis explores the idea that improved 
service delivery can be achieved by planning services regionally through understanding the 
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demand placed on primary and secondary care services, learning from end user experiences of 
existing services and incorporating their preferences into future planning of services. 
1.2 PAEDIATRIC ALLERGY SERVICES IN THE UK 
Specialist allergy service provision in the UK is mainly provided by clinical allergists [15] 
and immunologists [16]. Given that there are very few centres across the UK with specialist 
availability, other medical specialists (such as respiratory physicians, dermatologists, ENT 
surgeons and general paediatricians) are often required to provide an allergy service to meet 
the growing demand. An assessment of NHS allergy service availability carried out in 2002 
estimated the consultant availability for allergy in the whole of the WM region as being half 
of a full time equivalent consultant [15]. While this study grossly underestimated the 
contributions of immunologists [16] and specialists from other fields, it did highlight the 
severe shortage of allergy services in the UK. Many formal reports have since focused 
attention on the state of UK allergy services and the need for improvement [6-8, 17, 18], but 
concrete action has been lacking so far. 
A questionnaire survey was carried out to examine the provision of paediatric allergy 
services in the WM in 2012 by Dr Martyn Rees, a consultant respiratory physician at the 
Royal Shrewsbury Hospital. Of the 16 trusts that were surveyed, 11 responded. All the 
responding hospitals provided paediatric allergy services, although only 63% of these were 
manned by personnel formally trained in allergy. 6 centres (55%) had access to nurse support, 
whereas only 3 of these were allergy specialist nurses. A third of the centres offered 
desensitisation or immunotherapy services for children. Only 2 centres had access to dietician 
support on the same day [personal communication with Dr.Rees; data included with 
permission]. Figure 1.A in the appendix shows a map of the WM highlighting NHS hospitals 
that provide paediatric allergy services. 
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1.3 AIM AND OBJECTIVES 
The aim of this study is to evaluate paediatric allergy services in the WM region. 
The study objectives are: 
1. To understand the modes of delivery of allergy services worldwide; to explore the 
challenges, success stories and the future directions for service delivery 
2. To understand the current demands placed on NHS services due to paediatric 
allergy in a) the UK or England and b) the West Midlands (WM) 
3. To understand end user experiences in relation to paediatric allergy services in the 
WM 
4. To ascertain end user preferences for these services in the WM 
The implications of the research findings on pathways for paediatric allergy service 
delivery in the WM will be considered.  
1.4 OVERVIEW OF THE THESIS 
Chapter 2 addresses objective 1 by presenting a systematic literature review of pathways 
for the delivery of allergy services worldwide [19].Very few prospective studies were 
identified in this review, none of which included a control group. Most of the publications 
included in the study were from the UK, confirming an intense interest in allergy service re-
organisation within the country. A copy of the publication related to this work is included in 
the appendix (7.A). 
  1.Introduction 
5 
Chapters 3 and 4 address objective 2 of the thesis.  
Chapter 3 is dedicated to the analysis of the health information network (THIN) database, 
a primary care database for the UK NHS. Trends in the UK incidence and prevalence of 
common childhood allergies and related conditions are presented. Data from the WM are 
specifically explored to understand whether or not there are regional differences in allergy 
epidemiology which can be used to inform service provision. 
Chapter 4 reports the analysis of a secondary care database, the Hospital Episodes 
Statistics (HES), which includes data on all admissions into NHS hospitals in England. Data 
relating to emergency admissions and to elective admissions (specifically those related to 
immunotherapy treatments) are presented.  
Chapter 5 describes a qualitative study carried out to understand experiences of parents 
who have accessed primary and secondary care paediatric allergy services for their children 
within the WM region, thus addressing objective 3 of the thesis. 18 parents recruited from two 
different secondary care paediatric allergy centres were interviewed. 
Using the themes identified from Chapter 5, a discrete choice experiment (DCE) was 
planned to ascertain parent preferences for paediatric allergy services in the WM. This is 
discussed in Chapter 6. Around 280 parents from the region completed a carefully designed 
questionnaire aimed at understanding the magnitude of preference for the choices provided in 
the study. This chapter addresses objective 4 of the thesis. 
Finally, Chapter 7 discusses the overall conclusions from the thesis. Findings from the 
various elements of the work are viewed together to provide a coherent view of paediatric 
allergy services in the UK and the WM. Recommendations are made for the improved 
delivery of these services in the WM and areas for future research are highlighted.
   
 




In the previous chapter, the issues relating to allergy service provision in the UK and the 
WM were touched upon. Given that an increase in allergy prevalence is not likely to be UK 
specific issue, a review of published literature was carried out to understand delivery of 
services elsewhere in the world. This chapter describes the scope, methods and results of this 
literature review. The aim of this systematic review is to assess published approaches to 
allergy service delivery. The objective is to identify and appraise these publications to gain an 
understanding of the advantages as well as challenges associated with these service pathways; 
and also to explore current ideas regarding the future direction for these services. 
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2.1 INTRODUCTION  
The United Kingdom (UK) has amongst  the highest rates of allergy and related diseases in 
the western hemisphere [20] and there has been a steady increase in the prevalence, severity 
and complexity of allergic disease in the last 2-3 decades [21-24]. It is estimated that 30% of 
all adults and 40% of children in the UK will be affected by allergy related conditions during 
their lifetime [18]. Nevertheless, allergy services have remained ‘woefully poor’ [18] with 
very limited and patchy specialist service availability.  This shortfall in service availability 
and the inherent heterogeneity of limited available services has been the focus of multiple 
expert body reviews in the UK, which have called for increased investment in allergy 
management and for re-organisation of allergy services [6-8, 17, 18].  
One of the major barriers to service planning in allergy is the lack of political engagement 
and reluctance to allocate funds from the local budget for improving allergy services [13, 25]. 
Allergy is not generally perceived as a serious condition with major implications for health 
and quality of life. There is a growing body of evidence to the contrary, however. It is now 
established that children with food allergies are more anxious than those with insulin 
dependent diabetes, and tend to have overprotective and very anxious parents [26]. This is 
also true of adolescents with a history of anaphylaxis [27]. Allergy and related conditions are 
estimated to cost the UK NHS about £1 billion per year  [28]. Productivity losses associated 
with allergic rhinitis in the USA were higher than those due to stress, migraine and depression 
[29]. Studies have shown that effective allergy services can not only improve quality of life, 
but can also be cost-saving [30, 31]. Hence there is an urgent need to impress upon policy 
makers the importance and wisdom of investing in the improvement of allergy services. 
There is currently no agreement on how allergy services should be structured. In the UK 
and Europe, primary care practitioners diagnose and manage the majority of individuals with 
allergies [25] whereas in Australia and the USA, specialist services face the bulk of allergy 
care [32]. Allergy service delivery by non-physician practitioners such as pharmacists and 
dieticians, whilst possible, is not optimally utilised [8]. Various pathways have been 
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suggested and are being tested [13, 14, 33]. However, it is not yet clear whether any particular 
model of service delivery may be preferable to the others.  
The aim of this systematic review is to assess published approaches to allergy service 
delivery. The objective is to identify and appraise these publications to gain an understanding 
of the advantages as well as challenges associated with these service pathways; and also to 
explore current ideas regarding the future direction for these services.  
2.2 METHODS 
The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 
guidelines were followed in conducting this systematic scoping review. The PRISMA 
checklist is included in appendix Table 2.A 
2.2.1 Data sources and search strategy 
A systematic search of the literature was carried out to identify articles related to allergy 
service pathways in humans. Search terms included allergy, eczema, care, service and 
pathway (See Appendix Table 2.B). MEDLINE, EMBASE, HMIC, CINAHL, Cochrane, 
DARE, NHS EED, INAHTA databases were searched for the purposes of this review. An 
explanation regarding these databases and their scope is shown in Appendix Table 2.C.  
Searches included publications indexed until the 4th of October 2016. In order for the 
Medline® searches to be relevant, we stipulated that two papers selected a priori [9, 15] 
should be identified in the search. References within the publications identified as relevant 
were individually examined to identify more articles of interest. Publications citing the chosen 
articles were also carefully examined for relevance. 
2.2.2 Selection of literature 
After discarding duplicates, the title and abstract of the articles were examined for 
relevance. Where these were not informative, the full text of the publication was reviewed. 
Articles were included for review if they discussed pathways for the delivery of allergy or 
eczema services. Publications which reported opinions, conference abstracts, case reports or 
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case series were excluded. Non-English language articles were not included in the review. 
Asthma service pathways were also not considered. One of the researchers (LD) carried out 
the searches with help and advice from an information specialist from the University of 
Birmingham. LD screened all the articles as per the pre-determined criteria. A total of 50% of 
the unselected articles (25% each) were reviewed independently by the thesis supervisors (TR 
and CC).  Disagreements, if any, were resolved through discussion and consensus. 
The PRISMA flow chart for selection of articles is shown in Fig.2.1 
2.2.3 Data extraction and analysis 
The data extraction form was initially piloted using a few publications. Appropriate 
modifications were made after discussion with supervisors and colleagues before the full 
extraction was started.  
Data was extracted by LD using the finalised extraction table (Appendix Table 2.D). For 
each publication, the author, year of publication, geographical region of interest, type of study 
(report, discussion, consensus etc), study design (prospective, retrospective, cross section), 
treatment pathway (primary, secondary or both), principal findings and key recommendations 
were extracted. 
Most of the articles were descriptive and hence the analysis followed a narrative synthesis. 
This is a common approach in reviews of very heterogeneous studies which aim to describe 
and scope an area of interest [34]. Since the objective of the report was to explore options for 
service delivery, the review was designed to be inclusive. Publications were, therefore, not 
excluded based on quality criteria but were described and critiqued briefly as appropriate. 
Given the nature of the publications, the review aimed at mapping the current literature and 
understanding the type of evidence available in this area (i.e. delivery of allergy services). 
2.3 RESULTS 
The database search identified 351 articles of which 158 were duplicates. An additional 12 
articles were included following reference and citation searches. After consideration of the 
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title and abstract, a further 142 articles were excluded and a total of 63 publications were 
screened thoroughly for their relevance to the review. Figure 2-1 shows a flow diagram of the 
papers screened, identified, retained or excluded at each stage, and the reasons for exclusion 

















Figure 2-1: PRISMA flow diagram for the systematic review 
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Twenty seven publications were included in the final review and these are summarised in 
Appendix Table 2.D. Only three publications describe prospective data collection alongside 
service re-organisation [13, 33, 36]. There were no eligible prospective, randomised 
controlled trials identified.  
Seven of the publications discussed allergy services in other parts of the world [9, 12, 25, 
33, 37], whereas the rest are focused specifically on services in the UK. Of the 20 UK papers, 
eight are reports published by governmental organisations discussing the state of allergy 
services in the UK [3-8, 17, 18]. One of these reports provides a brief overview on aspects of 
allergy services in other European countries (Germany and Denmark) [18]. Another 
summarises experiences following the establishment of a pilot allergy service in the North 
West of England [13]. 
Re-organisation of primary care was addressed by seven publications, secondary care 
services were the focus of six articles, while four discussed both levels of care.  All eight 
government reports (Appendix Table 2.D) discuss all aspects of service delivery. Three 
studies discussed the use of digital technology based interventions for allergy [38-40]; one of 
these retrospectively evaluated such a service [40].  Findings, statements and 
recommendations about allergy service pathways from the included papers are reported in 
Appendix Table 2.D and are synthesised thematically below. 
2.3.1 Primary care services 
Primary Care Practitioners (PCPs) in allergy service delivery 
PCPs are the first line providers of health care in most countries around Europe [12]. They 
are well placed to provide diagnosis, to manage mild and most of the moderate allergic 
conditions, as well as to refer individuals with complex and severe allergies to specialist 
services [12]. Many publications have identified that the training offered to PCPs in allergy 
currently is inadequate [6-8, 13, 17, 18, 41, 42]. The current inadequacies in training and the 
need for better information provision as well as structured training programmes for PCPs in 
allergy were reinforced in studies from Scotland, Italy and Spain [25].  
  2. Systematic review 
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 It was argued in two European publications that a model of care which is centred on 
specialists or consultants is untenable in allergy [12, 25]. In public funded health systems such 
as the UK where PCPs assess and manage the majority of patients, the burden placed by 
allergy and related conditions on primary care could be significant.  For example, it was 
estimated that allergy accounts for 8% of all general practice consultations in the UK and that 
up to 11% of the total drugs budget is spent on allergy related medication (including asthma 
and eczema) [18]. 
 One article considered the lack of access to secondary services as allergy’s ‘greatest 
unmet need’ [25]. Referral times to specialists vary considerably across Europe from over 3 
months in some tax funded health systems [6, 8, 25, 37] to as little as one week when 
specialists can be accessed privately [25].  Across Europe organ specialists are generally more 
readily accessible to PCPs than allergists [25]. In a UK based survey of over 480 PCPs, 81.5% 
of the 240 PCPs who responded felt that the NHS allergy services were poor and 80% felt that 
secondary care provision was inadequate [41]. These practitioners were reported as being 
especially anxious about treating children with food allergies, although most felt quite 
confident about managing common allergic conditions such as anaphylaxis, urticaria, allergic 
rhinitis and drug allergy [41].   
PCPs with an interest in allergy 
Two publications specifically discussed a second tier service for allergy within primary 
care [25, 43]. Such an arrangement was also proposed by the House of Lords report [18].  In 
the UK, a prospective evaluation of a General Practitioner with Special Interest (GPwSI) 
facility in allergy revealed that the service was well received,  reduced the levels of secondary 
care referral and had a potential for cost savings [36]. Further, in this study, PCPs appeared to 
refer patients more readily to the GPwSI than to secondary care [36].  However, establishing 
these services would need a well-defined process of accreditation and specialist mentorship 
[12] which is difficult to achieve in most countries given the current severe shortage in the 
availability of specialists across Europe [9, 12]. 
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Non-physician services in Primary care 
 Non –physician services for allergy were specifically discussed by 6 publications in this 
review [4, 6, 8, 18, 42, 44]. Most of the articles discuss the under-utilisation of these 
professionals in allergy and suggest that there is a scope for better training of nurses, 
pharmacists and dieticians in allergy. Depending upon the extent of training and the 
competencies achieved, nurses can be involved with testing, diagnosis and management of 
patients with allergy [42]. 
Some authors felt that pharmacists could, if adequately trained and sufficiently supervised,  
provide information to patients regarding techniques for using devices such as nasal sprays, 
eye drops, adrenaline auto-injectors as well as inhalers for allergy and related conditions [18, 
42]. They can help patients choose over the counter medication for allergy judiciously. They 
can also be trained to advice individuals on the need for consultation with their PCP, where 
appropriate [8]. The House of Lords committee suggested that all pharmacists be formally 
trained in allergy to ensure that high quality advice is provided to all patients [18]. This 
committee also reported concerns from clinicians regarding availability of unvalidated tests 
over the counter for allergies in some establishments [18]. There are, however, no 
publications to-date formally assessing the role of pharmacists in the diagnosis and 
management of allergy. 
Barriers to providing optimal allergy care in the Primary care sector 
In most countries, the lack of leadership and support offered by a stable, well-staffed 
specialist service was identified as one of the main barriers to improvement of primary care 
services [4, 6, 7, 17, 25].   
Several authors were also concerned that PCPs do not receive structured instruction in 
allergy during their training and very few are familiar with guidelines for management of 
allergic disease [6-8, 15, 25].  The House of Commons health committee highlighted the lack 
of allergy knowledge in primary care as “…..one of the principal causes of distress to 
patients” [17]. Some articles have specifically highlighted the significant gaps in allergy 
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training at the undergraduate and postgraduate levels, as well as inadequate continuing 
medical education programmes for PCPs in allergy [6, 7, 12]. This was identified as leading 
to  inappropriate referrals to a range of specialists [13], lack of engagement with secondary 
care services for allergy, delays in diagnosis and starting appropriate management [6] and, 
sometimes, to inappropriate management [15]. All these issues resulted in poor patient 
experience but also cause a significant wastage of scarce health care resources [6, 7]. A 
retrospective review of the patients at a secondary care allergy clinic in Sussex showed that at 
least 42% of patients were referred for conditions that could have easily been managed in 
primary care, had the PCPs been appropriately trained [45]. An Irish study also suggested that 
increasing awareness of common allergic conditions amongst PCPs can significantly reduce 
referrals to specialists [46].This suggestion was reinforced in UK government reports [6-8, 
17] and other studies [13]. 
2.3.2 Secondary care services 
Availability of specialist services 
 A publication by the World Allergy Organisation (WAO) has suggested that there is a 
great degree of heterogeneity in access to specialist allergy services across the world [9, 37]. 
For example, the  number of certified allergy specialists per head of population range from 
1:25 million (in Malaysia) to about 1:2 million  (in the UK) and 1:16,000 (in Germany) [9].  
Heterogeneity in specialist training has also been highlighted [9, 15] with only a few 
countries providing certified courses to practitioners in allergy. Experts point out that whilst 
there has been very little increase in availability over the last few years, the demand for 
specialist allergy services has been steadily increasing [7].  A worldwide study by the WAO 
showed that  paediatric allergy services are particularly underserved and children with allergic 
problems are generally managed by general paediatricians with or without formal allergy 
training [9]. This study also found that  in many countries children may be managed by 
specialist adult physicians without appropriate paediatric training [9]. Specialist training 
pathways for allergy vary markedly worldwide. In countries such as the UK, formal 
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certification procedures in either allergy alone or in a combination of allergy and immunology 
exist. Similarly, in the United States, allergists/ immunologists should have passed a 
professional examination taken after 2 years of structured speciality training. In other 
countries, allergy may be included as a sub-speciality in general internal medicine or 
paediatrics training  [9]. In Germany, for example, allergology is considered a subspecialty of 
dermatology [18].  In the UK, the British Society for Allergy and Clinical Immunology 
(BSACI) has estimated that 90% of secondary care in the UK is provided by allergists and 
immunologists [5]. A study carried out in the UK has shown that immunologists, who have 
formal training in allergy, provide allergy care to 32 million individuals in the UK [16]. Some 
authors have pointed out that immunologists are indeed the sole providers of allergy services 
in parts of the UK [4, 16]. Other specialists such as those with primary qualifications in ENT, 
respiratory medicine or dermatology also contribute to the delivery of allergy services in 
many countries [9] including about 10% of the total secondary care for allergy in the UK [5]. 
Even if this broad definition of allergy specialists were to be accepted, many experts feel that 
allergy services remain inadequate in most countries in the face of increasing demand for 
these services [9, 17, 37]. 
Specialist centres for allergy 
Some authors propose the ‘hub and spoke’ model  [6, 17, 18, 37] which involves the 
establishment of supra- regional tertiary allergy centres (or hubs) which can support regional 
secondary and primary care centres (the so-called spokes) for delivery of specialist services. 
A few suggested that these centres should be manned by consultant adult and paediatric 
allergists, nurse specialists as well as adult and paediatric dieticians while providing facilities 
for training at least two specialist registrars in allergy [6]. Others felt that these should be 
multi-specialist centres (e.g. chest physician, dermatologist, ENT specialist, paediatrician in 
addition to an allergist or clinical immunologist) that are built on existing expertise of the 
local area and serve as ‘clusters of expertise’ [18]. In some countries, these centres would 
typically be University Hospitals which would receive referrals only from specialists [18]. 
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Whatever their composition, most agree that these centres could serve to educate and 
support primary and secondary care physicians in the region [6, 17, 18]. It was suggested that 
they had a potential to serve as centres of excellence for adults and children with complex and 
severe allergies; establish a good, working network between organ-based specialists, 
generalists and allergists and serve to improve the overall provision of allergy services in the 
region [18].  
Some experts point out that the existing shortage of specialists in allergy would be a 
barrier to the development of such centres [7, 47]. A pilot study carried out in the North West 
region of England found that  developing large tertiary centres would not be practical in 
regions with large cities in close proximity to one another [13]. They may not be cost-
effective for many regions within the UK [7].  
The House of Commons Health Committee has pointed out that there are no clear data to 
suggest that specialist centres improve clinical outcomes in allergy management [17, 48]. 
Indeed, even in countries like Germany with a relatively high proportion of  allergy specialists 
per 100,000 population, the numbers of emergency admissions for allergy remain high [9].  
The North East England pilot study found that the lack of confidence amongst primary care 
physicians while dealing with patients with allergy led to poor referral practices [13]. As a 
consequence,  management of simple conditions took up a disproportionate amount of 
specialist time and resources while individuals with complex allergies faced long waiting lists 
as well as inappropriate referrals to other specialists [13].   
2.3.3 Future direction for services 
Whilst efforts are being made to improve allergy education at the undergraduate and post 
graduate levels, there has been a focus also on the improvement of training of current 
practitioners. The Royal College of Paediatrics and Child health has developed care pathways 
for children which define core competencies for all those involved in managing allergies and 
related conditions; these are freely accessible online [49]. These are UK focused but 
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potentially can be modified to suit other countries. Such pathways embrace the current 
heterogeneity in service delivery whilst attempting to raise standards.  
The ‘Hub and spokes’ model was trialled in the UK with mixed results [13]. The authors 
suggested that new services should be tagged onto existing pathways and also stated that a 
model of visiting specialists in secondary centres would be more welcome in some areas than 
the establishment of large tertiary centres [13].  It was also suggested that models of good care 
can vary from one region to another [7, 13]. 
There have been recent publications regarding the use of digital technology in the 
provision of allergy services [38-40]. One addresses the use of telemedicine in improving 
communications between primary and secondary care in order to improve adult allergy 
pathways within the NHS [38]; whereas another makes a case for clinical trials using 
information communication and technology (ICT) in management of allergic rhinitis in 
Europe [39]. A publication from Ireland reported on the use of an email communication 
system, which received an average of only 4 enquiries per month over a 12 month period. 
Although it was rated useful by 100% of the non-specialists who responded to the survey 
carried out by the researchers (response rate of 35%), this communication system did not 
reduce referrals to the specialist allergy services [40].  
 There has been a lot of interest lately in the “Finnish model” of service re-organisation. 
This re-structuring exercise takes inspiration from the successful interventions for asthma in 
Finland [50]. Whilst acknowledging the differences between asthma and allergy as well as 
emphasising the need to understand and improve tolerance to allergens, the architects of this 
model hope to use the existing asthma infrastructure to improve services for allergy sufferers. 
They suggest that increased initial outlay aimed at preventing allergies and changing attitudes 
towards health alongside improving service delivery can reduce the cost and burden of 
allergic disease in the future [33]. The results of this experiment are currently awaited.  
 




2.4.1 Principal findings of the review 
This systematic review aimed to identify and discuss various pathways that are relevant to 
the delivery of allergy services. There were large gaps in literature pertaining to services in 
countries with high rates of allergy (such as Australia, New Zealand, United States) [20, 51] 
as well as very populous regions of the world including China, India, Brazil and the whole of 
Africa. There were virtually no publications from low and middle income countries. In 
addition, there was a lack of well-designed studies in this area with only three prospective 
studies identified [13, 36, 50]. None of the studies included a control group. Two of these 
publications [13, 33] describe service re-organisation on a large scale with direct involvement 
of the relevant health ministries.  
There is clear evidence from literature that allergy services across the world have not kept 
up with rising demand. The ‘allergy epidemic’ [1] has surprised unprepared health systems 
globally. There has been failure on the part of governments and fund holders to acknowledge 
the rapid rise in allergies. Given that there are no signs of abatement in the observed increase 
in allergies worldwide [23], it is conceivable that the demand on services is set to increase 
even higher over the next few years.  
The psychosocial impact of these conditions is often overlooked. For example, atopic 
individuals experience significantly worse memory and cognitive ability during allergy season 
[52]. Children with eczema report higher levels of anxiety and depression [53]. In addition, 
these conditions currently place an inordinate financial burden on healthcare services [30, 54, 
55]. Urgent and effective measures are therefore needed to cope with the problem. 
About three-quarters of the eligible publications (20/27) are from the UK which suggests 
that there has been a lot of interest here in investigating the extent of the supply gap in allergy 
services over the last 15 years. It is striking, however, that whilst most of these reports 
describe the problems with service delivery and suggest some solutions, none seem to have 
addressed the problem in a structured manner. There has been no response to the UK 
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Department of Health’s request for reliable baseline data on needs of the population, costs 
involved in service re-organisation and the details of  skills and competencies of the existing 
workforce in order that future services can be planned [3-5].  
Primary care services are key to optimal management of allergy. Appropriate management 
after good history taking and specific testing can easily be achieved in primary care for a 
majority of patients. Referral to specialist centres can be limited to only complex patients 
needing multi-disciplinary input or those that need desensitisation therapy. However, a UK 
survey has shown that PCP confidence in managing allergies in children [41] and initiating 
referrals appropriately is limited. Although  PCPs in this particular survey felt confident about 
managing adults, studies have shown that most individuals referred to secondary care could 
have been managed effectively in primary care [13, 46, 56]. This serves to highlight the 
inadequate training received by PCPs in allergy at both undergraduate and postgraduate 
levels. This leads to not only poor patient experience and outcomes but is also more expensive 
for the health service providers.    
A paucity of specialists in allergy encourages PCPs to refer patients to specialists who are 
only able to deal with individual manifestations of the condition (e.g. respiratory physicians 
for allergic asthma; ophthalmologists for allergic eye disease). Organ based specialists play a 
very important role in the management of allergic disease. Indeed, in some instances (e.g. 
children with very severe disease), their input is essential. However, specialists trained 
specifically in allergy management can provide clinically effective and potentially cost 
effective services by intervening across several of these conditions for most patients[6].   
Scarcity and inequity of specialist allergy services was a recurring theme in many articles 
worldwide. Although numerous publications have made a compelling case for more specialist 
centres [6, 7, 9, 15, 17, 18], these have not been forthcoming. Many factors appear to 
contribute to this apparent inertia [7]- the important ones being lack of adequate central 
funding to increase training numbers for specialists, lack of interest in allergy services 
amongst fund holders [13],  lack of clarity regarding the role of various specialists involved 
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[7]. Another important issue is the lack of formal training programmes in allergy in many 
countries [9]. This not only blights the care of individuals with allergy in these countries, but 
also prevents the speciality being taken seriously by decision makers. In the case of the UK, 
lack of clinical codes to measure allergy activity and disagreements between the two main 
specialist groups that provide allergy services (allergists and immunologists)  are also 
important issues [3].  Further, in the UK, the lack of specialist services and poor referral 
practices within primary care have resulted in unreliable waiting list data, which are often 
used as a surrogate marker for need within the NHS [4]. This has proved to be a barrier for 
further investment in services [3]. 
It should be noted that there are no published data that support the success of large, tertiary 
centres. Nevertheless, it is conceivable that centres which treat large volumes of individuals 
will provide better outcomes for complicated patients [57].  However, the lack of confidence 
amongst primary care physicians while dealing with patients with allergy leads to poor 
referral practices leading to long waiting lists as well as inappropriate referrals to other 
specialists [13].   
There have been many encouraging advances in allergy service re-organisation in the UK 
and beyond.  New multi-consultant allergy centres were created in the North West of England 
as per the recommendations of the House of Lords report into allergy services [18].  This 
service development encountered many barriers including non-engagement of local 
commissioners, non-availability of appropriately trained staff, and poor coding practices [13]. 
Nevertheless, the project was successful in improving networking amongst specialists across 
the region, improved clinical governance including audit, better regional education 
programmes for clinical staff and patients in allergy [13].  There was an opportunity during 
the course of this project to prospectively collect data on patient experiences and outcomes, 
which was unfortunately missed. 
The heterogeneity in specialist training across Europe is also being addressed with the 
introduction of the European Examination in Allergology and Clinical Immunology since 
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2008 by the European Academy of Allergy and Clinical Immunology (EAACI). The aim of 
this examination is to “raise standard of allergology and clinical immunology in Europe” and 
to “facilitate the exchange of young people trained in Allergology and Clinical Immunology” 
in Europe  [58].  
The Finnish allergy model is based on the very successful restructuring of asthma care in 
Finland [59] and is now being adapted to the management of other chronic conditions [60]. In 
Finland, the model has been altered to incorporate the complex and heterogeneous nature of 
allergy but it essentially builds on the existing infrastructure developed for the asthma 
programme [50]. The Finnish allergy plan is an ambitious project that aims to reduce the 
burden of allergic disease by improving tolerance and reducing the emphasis on allergen 
avoidance in affected individuals. The objective is to help alleviate the psychosocial aspects 
of allergy whilst improving services provided to these persons [33]. Aspects of this plan have 
also been adopted by Norway [61] and by health authorities in North West London as well as 
Sheffield [62]. Preliminary results from the London project are very encouraging [14, 63, 64]. 
More data are awaited to ascertain whether the project has been successful and also if this 
success can be emulated in other regions. 
2.4.2 Strengths and limitations of the review 
The strength of this review is that it provides a systematic and comprehensive look at the 
reported current provision of allergy services across the world. There are some limitations 
mainly due to paucity of information from most countries, including some with relatively high 
allergy incidence and prevalence, regarding available services. Most of the literature is UK 
based and hence generalisability of data to other countries, especially those without publicly 
funded health systems may be limited. In addition, there were very few well planned 
prospective studies and no controlled studies in this area.  Most of the included studies had 
little empirical data and therefore a formal quality assessment of the publications was not 
carried out. Studies not reported in the English language were excluded. 
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2.4.3 Strengths and limitations in relation to other studies 
This review is the first to comprehensively review all the published reports and journal 
articles on allergy services. This review, in concurrence a previous UK review [65],  found 
that prospective studies in the area were lacking and that there were no data objectively 
comparing different levels of service delivery (e.g. primary care versus secondary care).  
2.4.4 Future research 
 There is a need for data on service pathways from across the world, especially from 
countries with a high burden of allergic disease so that the extent of the problem can be 
identified and lessons may be learnt from successful models. Prospective data aimed at 
estimating the costs and outcomes of service pathways are especially important. To ensure 
that a service is successfully re-organised, it is important to understand the needs of the local 
population, their preferences for services and to estimate costs and benefits of the possible 
service pathways.  
2.5 CONCLUSIONS 
There is a consensus that allergy services across the world are inadequate to meet the 
rising demand. There is a high degree of heterogeneity and inequity in the availability of 
services across the world. Untreated or poorly treated allergic conditions can have a high 
psychosocial impact on individuals and can place a substantial economic burden on healthcare 
services. Allergy training does not feature adequately in the current undergraduate and 
postgraduate medical curricula, which is adversely affecting patient care at all levels, 
especially in primary care.  Primary care services are affected by poor training of practitioners 
and by poor access to specialists. Specialist services are hampered by the non-availability of 
appropriately trained personnel and poor referral practices from primary care (where 
applicable) which lead to long waiting lists and poor overall patient care. There is currently no 
clear consensus on how services should be structured, although the Finnish model of service 
re-organisation has shown significant promise. Political engagement and patient 
empowerment are important to the success of these projects. 




Having carried out a review to look at the allergy pathways globally, the next step was to 
look at the performance of NHS allergy services in the UK and the WM. In order to assess the 
demands placed on the NHS due to allergies, an analysis of routinely collected NHS primary 
and secondary care data was planned. The next chapter describes and discusses the results 
from analysis of the health improvement network (THIN) database, whereas Chapter 4 
discusses the findings from analysis of the hospital episodes statistics (HES) database.




3 ANALYSIS OF HEALTHCARE DATABASES- THE HEALTH 
IMPROVEMENT NETWORK (THIN) DATABASE 
 
In the previous chapter, pathways for delivery of allergy services around the world were 
reviewed. It is important to estimate the demands placed on available services and to 
understand the incidence and prevalence trends of allergies in order to effectively plan future 
services. An analysis of primary and secondary care databases was therefore planned for this 
thesis. This chapter will discuss findings from the analysis of primary care data using the 
health information network (THIN) database.




One of the findings of the literature review was that there is considerable heterogeneity in 
the availability of paediatric allergy services across the UK. Various reports commissioned in 
the UK proposed solutions to improve these services nationwide [6, 7]. Important as these 
improvements may be, health services in the UK are now commissioned by Clinical 
Commissioning Groups in order to best serve the needs of the local population [66]. In 
addition, the distribution of expertise is quite unequal across the UK [47], suggesting that 
there needs to be some flexibility in adapting these solutions regionally. The Department of 
Health has suggested that regional allergy services could be structured based on the needs of 
the local population and availability of regional expertise [3].  
There are no published data exploring the regional differences in the epidemiology of 
allergy and related conditions across the UK. Indeed, it is not clear if and how the allergy 
needs of children in the WM differ from those in the UK as a whole. Therefore, an estimation 
of the demand placed on primary and secondary NHS services in the West Midlands (WM) 
and more broadly in the UK (or England) due to paediatric allergy and related problems was 
planned for this thesis. Contrasting the estimates for WM with those obtained from the entire 
nation would help provide an understanding about the issues unique to the region, if any, 
which may help in planning regional services.  This would serve as a good starting point for 
planning effective and efficient care pathways for the region. 
In this chapter, data from the Health Information network (THIN) database is used to 
estimate the burden placed by paediatric allergy and related conditions on primary care 
practitioners in the UK. The burden of disease on WM primary care will also be discussed.  
3.2 BACKGROUND 
It has been shown that the incidence and prevalence of allergies worldwide is increasing 
[20]. Indeed, data from the International Study of Allergies and Asthma in Childhood 
(ISAAC) suggests that there has been a rise in the prevalence of parent-reported asthma, 
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rhinitis and eczema amongst 6-7 year old and 13-14 year old children globally over an 
average of 7 years (range: 5-10 years; SD:1.2 years). The ISAAC study used standardized 
diagnostic questionnaires [67] delivered to participants at certain time points. Whilst the 
trends in the various ISAAC respondent countries (between 37-56 countries overall in ISAAC 
I,II and III studies) varied markedly, the overall trend has shown an increase in the prevalence 
of these conditions, especially in the 6-7 year old age group [68]. However, data from 
individual countries present a more mixed picture [69-72].  
The incidence and prevalence trends in allergies have been studied intensively in the UK 
in the last decade [22, 73-75]. An important factor driving this interest is the relatively easy 
access to large datasets that can provide a wealth of information regarding these (and other) 
conditions while maintaining patient confidentiality [76]. The advantage of investigating 
national health datasets is that they are representative of the population of the country as a 
whole and the results obtained can be applicable to all regions of the country. The data can be 
used to assess the scale of the problem, and to identify areas where investments can be 
targeted to obtain maximal improvement in patient care. Various databases providing health 
related information are available in the UK [76]. Some of these are outlined in Appendix 
Table 3.A.  
Allergy related epidemiological data have been reported from other sources such as 
population surveys in selected geographical areas [77] or from evaluation of at-risk patients 
(e.g. scrutinising medical records of patients attending allergy clinics [78] or assessing atopy 
in children with eczema [79]) . Whilst such information is useful in understanding the health 
needs of a selected population, the data are not generalisable. In addition, direct comparisons 
between such data from different regions are often not possible since there may be differences 
in definition of disease condition, mode of data collection and also demographic differences 
in the populations studied  [77, 80]. More recently a large scale, multi-country, Europe wide 
study has been initiated to better understand the prevalence of childhood food allergies [81]. 
Children are being followed up from birth (in some cases, antenatally) to prospectively 
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evaluate the prevalence of specific food allergies using validated questionnaires and double 
blind placebo controlled food challenges [81]. While this study boasts the most robust 
protocol for evaluation of food allergy prevalence to date, the generalisability of these data to 
all regions of Europe is debatable.  
We set out to understand the burden placed by paediatric allergy on the NHS in the UK 
and also in the WM by interrogating two large databases comprising of routinely collected 
health data - The Health Information Network database or THIN (which is a primary care 
database) and the Hospital Episodes Statistics or HES database (a secondary care database). 
These datasets are large, fairly uniform across the entire user-base and reflect everyday care 
provided within the NHS. THIN and HES databases differ from each other in many aspects. 
The main differences are outlined in Appendix Table 3.B. This Chapter will be dedicated to 
the discussion of THIN data analysis. Analysis of the HES database will be discussed in 
Chapter 4. 
3.3 THE HEALTH IMPROVEMENT NETWORK DATABASE (THIN) 
3.3.1 Introduction 
The Health Improvement Network (THIN) database is a large anonymised primary care 
dataset containing information from UK general practices. It was launched in 1995 and was 
designed to enable record keeping for the benefit of patients and clinicians. The database 
reflects everyday care provided to individuals within the participating general practices [82]. 
These practices use Vision® computer software and data collected are anonymised  and made 
accessible for research via the company IMS health. 
The database currently includes information from 587 GP practices across the UK, 
covering a total of over 12 million patients (about 3.6 million active patients), who represent 
5.67% of the whole UK population [83]. These patients are representative of the UK 
population by age, gender, medical conditions and death rates adjusted for demographics and 
social deprivation [82].  
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3.3.2 Data captured within the THIN Database 
At each appointment, the primary care practitioner records reason for consultation, 
diagnosis, main symptoms and signs and, where applicable, details of prescription, laboratory 
tests, demographic details (such as height, weight, blood pressure). The data are anonymised 
by removing identifiers such as name, address, post code, date of birth of the patient and the 
name, address and post code of the practice. Free text is also removed as this often contains 
patient identifiers. Data are cleaned by removing duplicates and made available for research. 
In the THIN database, medical conditions are identified using Read codes [84] (so called 
since they were developed by Dr. James Read- a UK primary care physician). These codes are 
dynamic i.e. are regularly updated based on user feedback and experience [84]. The codes 
mainly consist of alpha numeric identification of the condition in 4 character codes (or the 4-
byte version of code) or, more recently, in 5 character codes (5-byte code or Version 2) [85]. 
The earlier versions have now been merged into a unified Version 2, which is currently in use 
within the UK.  
Read codes have a broader remit than other diagnostic codes (such as ICD codes) and can 
be applied for recording symptoms and signs, ethnicity, socio-economic status, administrative 
items (such as invitation for screening tests), laboratory tests and results. Over 100,000 codes 
are currently available and are used by all practices using the Vision software. 
It is important to note that the health data obtained from the THIN database are physician 
identified and demand driven (i.e., only include individuals who choose to see their GP for the 
given ailment).  
3.3.3 Organisation of data within the THIN Database 
The THIN database is continually updated (usually once every 3 months) and the 
consultations are linked to individual patients.  
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The data collected are organised into different records linked to every individual patient 
namely patient records, medical records, therapy data and additional health records as shown 
in Figure 3-1. 
In addition to these data, THIN includes Townsend score, which is a socio-economic 
indicator derived from the patient’s post code [86]. The population is divided into quintiles 
with the least deprived 20% receiving a score of 1 and so on. Thus, higher scores represent 
greater levels of deprivation. Individual level socio-economic indicators are not available 











































Figure 3-1 Data included within the THIN database 
MEDICAL RECORDS 
 
DETAILS OF MEDICAL 
DIAGNOSIS/SYMPTOMS/ 
INTERVENTIONS. THESE ARE CODED 
USING READ CODES. 
THERAPY RECORDS 
 
PRESCRIPTIONS ISSUED EITHER BY 
GP OR THE PRACTICE NURSE. DATA 
AVAILABLE INCLUDE NAME OF DRUG, 
DOSAGE AND QUANTITY PRESCRIBED. 
ALL OTHER DATA FROM THE 
CONSULTATIONS INCLUDING LIFESTYLE 
DATA, IMMUNISATIONS, AND TEST 
RESULTS. ANONYMISED FREE TEXT 






PATIENT CHARACTERISTICS AND 
REGISTRATION DETAILS (E.G. DATE OF 
BIRTH, SEX, DATE OF REGISTRATION, 
REGISTRATION STATUS, DATE OF 
TRANSFER, DATE OF DEATH, MARITAL 
STATUS) 
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All practices contributing to THIN are checked to ensure that they meet set quality criteria 
namely the acceptable mortality reporting (AMR) and the acceptable computer usage (ACU) 
standards. AMR refers to the date after which the practice is deemed to have a mortality rate 
that is in line with the expected rate derived from the Office for National Statistics, after 
correcting for differences in demographic data [87]. ACU date, on the other hand, is the date 
after which the practice is confirmed to have contributed at least one medical record, one 
additional health record and two prescriptions per patient per year to the database [88]. 
3.4 AIMS AND OBJECTIVES  
The aim of this analysis is to quantify the burden placed on NHS primary care in the UK 
and the WM due to paediatric allergy and related illnesses.  
The objectives are  
1. to estimate the GP diagnosed incidence, prevalence and diagnostic frequency rates 
amongst children aged 0-17 for the following conditions (see also Appendix Table 
3.C):  
 allergic rhinoconjunctivitis 
 food allergy 




2. to compare the rates mentioned above for WM with those for the UK  
3.5 METHODS 
3.5.1 Study design 
A retrospective analysis was carried out using data from practices contributing to the 
THIN database.  
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3.5.2 Inclusion criteria 
Data from individual practices were considered only after the AMR and ACU dates. All 
children aged 0 to 17 years who registered for a minimum of one year between 1st January 
2000 and 31st December 2015 in primary care practices contributing to the THIN database 
were included in the analysis. The children contributed to the dataset from the time of their 
registration with the practice until the earliest of their 18th birthday, transfer to another 
surgery, death or last data collection from the practice.  
3.5.3 Outcomes of interest 
The outcomes of interest were the annual incidence, prevalence and diagnosis frequency 
(as defined in section 3.5.3) of common allergic conditions in children encountered in clinical 
practice namely allergic rhinoconjuncitivitis, food allergy, drug allergy, urticaria, eczema and 
asthma between 2000 and 2015. These measures were used as indicators of disease burden 
and demand placed on primary care services. Comparisons were made between the rates for 
WM and those for the UK as a whole. 
All entries into the THIN database are made by General Practitioners (GPs) and are driven 
by patient demand. The conditions that were considered in this analysis are described in the 
appendix (Appendix table 3.C). The Read codes used to identify these conditions are listed in 
Appendix table 3.D. Additional codes were used to identify prevalent conditions (also listed 
in Appendix table 3.D) 
Children who were registered in with a GP practice within one month of birth were 
included in a "birth" cohort, whereas the rest (i.e., those who were registered at a surgery later 
in life) were included in a "transferred-in" cohort.  
3.5.4 Ethical approval 
The NHS South-East Research Ethics Committee approved the use of THIN for scientific 
research in 2003. Permission to access the THIN database for this study was obtained from a 
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Scientific Research Committee (SRC) which is linked to IMS Health (SRC approval number 
13-021). The relevant permissions are shown in the Appendix (3.E).  
3.6 ANALYSIS 
Analysis was carried out using Stata 12® and Microsoft Excel 2010®. Using an open cohort 
of children aged between 0-17 years registered within the THIN practices, annual incidence 
and prevalence rates as well as  age specific rates were determined within the chosen study 
period. 
 Rates and trends for specific allergies in the UK were compared with those for the WM. 
3.6.1 Initial exploration of the database 
The dataset was explored to understand the year on year variations in the numbers of 
registered patients in the UK and WM practices (Figure 3-2, Figure 3-3 and Appendix Table 
3.F).  
3.6.2 Outcome definitions 
UK incidence rates (by calendar year as well as by age of child), period prevalence and 
diagnosis frequency of allergies were estimated for children aged 0-17 years between the 
years 2000-2015. Proportionate increase in these rates between the years 2000 and 2015 was 
also estimated, where appropriate. 
Incidence 
An incident case was defined as “the first ever presentation of an individual within the 
study with the condition of interest”. In order to ensure that only new diagnoses were declared 
as incident in this study, we omitted transferred-in patients who were diagnosed within 6 
months of their registration date with their primary care practitioner. This is in keeping with 
previously published literature using GP databases [89]. For eczema, a condition that is 
commonly diagnosed in early infancy [90], children who received the diagnosis within 3 
months of their transfer to a new GP surgery were omitted from the analysis. All children in 
the birth cohort were included in the analysis irrespective of their time of diagnosis. 
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Incidence rate was defined as the number of incident cases for the given group divided by 
the total number of children in the group. 
 Prevalence 
Prevalence is defined as the proportion of the population known to have a given condition. 
Annual prevalence rates were estimated as the total number of individuals with the condition 
divided by the total number of individuals in the dataset for a particular year. 
Diagnosis frequency 
The diagnosis frequency for a particular condition in this analysis refers to the likelihood 
of being diagnosed with the condition at any time since birth for the duration of inclusion 
within the dataset. Only children within the birth cohort were considered for this analysis. 
Proportionate increase 
This referred to the increase in the incidence, prevalence, consultation or prescription rate 
between the year 2000 and the year 2015 calculated as [(Rate(2015)-Rate 
(2000))/Rate(2000)]*100. 
3.7 RESULTS 
3.7.1 Initial exploration of the database 
  The uptake of Vision software amongst primary care practices varies from 
year to year. There was a rapid increase in uptake of the software by GP practices between 
2000-2010, after which period the uptake reached a plateau followed by a slight decline. The 
dataset used for this study was obtained in May 2017. The entries in the dataset, therefore, 
ranged between August 1995 and May 2017. As shown in Figure 3-2 and Figure 3-3 , there 
were fewer than 100,000 entries for UK children and less than 10,000 for WM children before 
2000. Also, the data for the year 2016 were not complete. Hence it was decided that the 
analysis would consider data between the years 2000-2015.  





Figure 3-2: Total number of UK children and UK GP practices per year 
within the THIN dataset  
 
 
Figure 3-3: Total number of WM children and WM GP practices per year 
within the THIN dataset  
Overall, more than 1.5 million children were included in the database during the study 
period (2000-2015) providing over 7.45 million person years of data for analysis. 557,902 
children (37.1%) belonged to the birth cohort (i.e., they were entered into the database at 
birth) and 1315 (0.1%) children died during the study period. Most children in the database 
were from England (79.3%); Scotland, Wales and Northern Ireland accounted for 3.3%,10.2% 
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and 7.2% respectively. 48.8% (732,851) children were girls. 35.7% of all the registered 
children were diagnosed with an allergy or related condition (including allergic 
rhinoconjunctivitis, anaphylaxis, angioedema, urticaria, eczema, asthma, food allergy, drug 
allergy, insect venom allergy) during the study period. About 9.5% (n=143,348) of the 
children overall were from the WM, providing over 750,000 person years of data.  
THIN is a dynamic database- i.e., the number of surgeries included in the database may 
increase or decrease over time as practices opt-in or opt-out of the database. Over the duration 
of the study (i.e., between the years 2000 and 2015), there have been some changes in the 
composition of the dataset. Whereas in the year 2000 over 2/3rds of the dataset comprised of 
children aged 5 or less, this reduced to about a third by the year 2015 (see Table 3-1). The 
proportion of children who were male remained fairly constant during the study period 
(Appendix Table 3.G) 
Table 3-1: Proportion of children in specific age groups within the dataset between 2000-
2015 
Year <=5yrs (%) 6-10yrs (%) >10yrs (%) 
2000 67.49 15.98 16.53 
2001 66.01 16.62 17.37 
2002 63.52 18.26 18.21 
2003 60.75 20.41 18.84 
2004 58.17 22.57 19.26 
2005 55.80 24.36 19.83 
2006 53.52 26.22 20.26 
2007 51.38 27.51 21.10 
2008 49.38 28.19 22.43 
2009 47.54 28.64 23.82 
2010 45.76 29.16 25.08 
2011 44.51 29.17 26.32 
2012 43.00 29.08 27.92 
2013 41.03 29.29 29.67 
2014 39.20 29.52 31.28 
2015 36.73 30.01 33.27 
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3.7.2 Outcome1: Trends in the incidence of allergic disease in the UK 
Annual incidence trends  
The full dataset (i.e., including birth and transferred-in cohorts) was used for this analysis. 
The overall incidence rates for general practitioner diagnosed allergic rhinoconjunctivitis 
(ARC) and food allergy (FA) amongst children aged 0-17 years in the UK have remained 
fairly constant between 2000-2015. The incidence rates of eczema, asthma and urticaria have 
decreased during this period (Figure 3-4 and Table 3-2).   
The overall incidence rate for eczema amongst children is three times higher than that of 
allergic rhinoconjunctivitis and about 30 times higher than that of food allergy (see Figure 
3-4). 
The changes in overall incidence rates between 2000-2015 for most of the conditions 
considered in this analysis are summarised in Table 3-2.  
 
 
Figure 3-4: Incidence trends for eczema, allergic rhinoconjunctivitis, asthma, food 
allergy and urticaria amongst UK children(0-17 yrs). 95% CI are shown. 
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Table 3-2: Changes in incidence rate (per 1,000 person years) of allergies/ related conditions 










































(-35.6 to -39.6) 
 *Allergic Rhinoconjunctivitis #Food Allergy 
Incidence by age groups: 
Since the change in the proportion of young children (Table 3-1) can impact on the overall 
incidence and prevalence rates for allergies, age specific incidence rates for these conditions 
were estimated. The results are presented in Figure 3-5 below. 
The results show that whilst eczema, food allergy and asthma are more common in 
younger children, the incidence of allergic rhinitis is higher amongst older (aged >10 yrs) 
children. Whereas the incidence rates for food allergy appear to be stable across all age 
groups the rates for asthma have reduced, particularly in very young children (aged<=5yrs). 
This is also true for incidence rates of eczema. The incidence rate for ARC amongst children 
aged > 10yrs appears to have been decreasing over the last decade. 
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Figure 3-5: Incidence rates of allergic conditions amongst UK children as per age group. 95% confidence intervals are shown
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Incidence by age 
Physician diagnosed eczema is the most common allergy related condition in early childhood. 
childhood. The incidence is highest in the first 5 years of life, with most children diagnosed 
within the first year of birth ( 
Figure 3-6). Eczema incidence rate reduced considerably after the age of 5 years but was 
still higher than that of most conditions considered in this study. 
 
Figure 3-6:Incidence rate of allergies and related conditions amongst UK children by 
age (between years 2000-2015).95% confidence intervals are shown. 
The diagnosis of ARC peaks at around the age of 9 years. Food allergy, on the other hand, is 
is most commonly diagnosed in children under the age of 2 years. Nevertheless, food allergy 
incidence rates are quite low relative to other conditions in children under the age of 5 years. 
Asthma and urticaria are also more commonly diagnosed for the first time in children aged 5 
  3. THIN database analysis 
42 
 
or under. The incidence rate of these conditions appears to plateau after the age of 10 years 
the UK ( 
Figure 3-6). 
Boys under the age of 10 years are more likely than girls diagnosed with ARC and asthma 
in the UK. Food allergy diagnosis is also more common in boys up to the age of 6 years. 
There were no gender based differences in the incidence rates for eczema (see Figure 3-7). 




Figure 3-7: Gender differences in age related incidence of allergies and related conditions amongst UK children (2000-2015). 95% Confidence intervals are 
shown.
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3.7.3 Outcome 2: Trends in prevalence of allergic disease in the UK 
The full dataset (i.e., including birth and transferred-in cohorts) was used for this analysis. 
Annual prevalence rate 
The prevalence of most childhood allergic diseases in the UK has been steadily increasing over 
the period 2000-2015. The prevalence rate of ARC in the UK in 2000 was 35.1 per 1000 children 
compared with 91.3 per 1000 in 2015, an increase of 160%. 
 
Figure 3-8: Prevalence trends between 2000-2015 of childhood allergies in the UK. 95% 
Confidence intervals are shown. 
Prevalence of food allergy amongst children has showed a 120% increase in the UK between 
2000-2015. During this period, egg allergy and nut allergy prevalence have increased by 81% and 
275% respectively (see Table 3-3 and Figure 3-9). 
Prevalence of eczema also increased during this period, although the prevalence of asthma has 
remained stable (Figure 3-10 and Table 3-3). Urticaria is an acute condition and was, therefore, not 
included in the prevalence estimates. 
 




Figure 3-9:Annual prevalence trends for overall food allergy, nut and egg allergy 
amongst UK children. 95% confidence intervals are shown.  
 
Figure 3-10  : Eczema and asthma annual prevalence trends amongst UK children. 
95% confidence intervals are shown. 
Most childhood allergies and related conditions have become more prevalent during the study 
period, with the exception of asthma. Overall, the prevalence of food and drug allergy are much 








Table 3-3: Changes in UK childhood prevalence rates for allergies (per 1,000 children) between the 























































(-0.14 - 2.1) 
**Children with nut and egg allergy are included in the food allergy estimates
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Prevalence of complex allergies 
The database was further interrogated to estimate proportion of children diagnosed with 
complex allergies, defined in this analysis as the diagnosis of two or more allergic diseases in 
a given child (Appendix table 3.C) 
The number of children with complex allergies has been steadily increasing over the study 
period. The number of children diagnosed with both eczema and allergic rhinitis has increased 
by approximately 350% in the UK (see Figure 3-11 and Table 3-4). There has also been a 
steady increase in the number of children who have been diagnosed with eczema, asthma as 
well as allergic rhinitis during this period. 
Table 3-4: Proportionate changes in the prevalence rates (per 1,000) of complex allergies 












































(368.0 - 885.9) 
 
During the same period, the prevalence rate of a combination of eczema and food allergy 
has increased by over 175% (Figure 3-12 and Table 3-4). Similarly, the number of children 
with these two conditions as well as asthma also showed a 214% increase between the years 
2000 and 2015. 




Figure 3-11:Trends in annual prevalence of allergic rhinoconjunctivitis in 
combination with other allergic conditions amongst UK children between 2000-
2015 (95% confidence intervals shown for each estimate) 
 
 
Figure 3-12:Trends in annual prevalence of food allergy in combination with other 
allergic conditions amongst UK children between 2000-2015 (95% confidence 
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The most striking increase is in the proportion of children being diagnosed with all four 
conditions in childhood in the UK (i.e., eczema, food allergy, ARC and asthma)- over 580%. 
It should be noted, however,  that a very small proportion of children are affected (Figure 
3-12 and Table 3-4). 
3.7.4 Outcome 3: Diagnosis frequency for allergic conditions amongst UK children 
Only children who were in the 'birth' cohort of the database were included in this analysis. 
About 1:4 UK children have been diagnosed with ARC by their GP by the age of 15yrs 
during the study period (Figure 3-13); One in 45 children have been diagnosed with food 
allergy by age 15, nearly 1 in 100 with nut allergy and 1 in 220 with egg allergy (see Figure 
3-14 and Table 3-5). The burden of some of these conditions is evident at an earlier age, with 
1 in 87 children already diagnosed with food allergy by the age of 5 years (see Figure 3-15 
and Table 3-5).  
Eczema, as previously noted, is very frequently encountered in UK primary care with 
nearly 1 in 3 children being diagnosed with the condition by their GP. Asthma and ARC are 
diagnosed later in life but by age 15, nearly one in four UK children within the THIN dataset 
has been diagnosed with each of these conditions by their GP (Figure 3-13 and Table 3-5). 
 
Figure 3-13: Proportion of UK children diagnosed by their GP at least once with an allergy 
at different age points. (Birth cohort only; 95% confidence intervals are shown).  




Figure 3-14: Proportion of UK children per 1,000 diagnosed with food, drug, nut or 
egg allergy at various age points. (Birth cohort only; 95% confidence intervals are 





Figure 3-15: Proportion of UK children per 1,000 diagnosed with allergies by the age 










Table 3-5: Increase in diagnosis frequency of allergies amongst UK children$ (2000-2015) 
Condition 
Diagnosis frequency  
Age 5 yrs* Proportion# Age 15 yrs* Proportion# 
ARC 55.6 (54.6-56.5) 
1 in 18  253.8 (243.3-
264.5) 
1 in 4 
Asthma 72.5 (71.4-73.6) 
1 in 14 230.1(222.6-
237.9) 
1 in 4 








1 in 322 4.5 (3.5-5.7) 1 in 222 




 1 in 3 599.3 (587.1-
611.8) 
1 in 2 
Urticaria 61.0 (60-62) 
1 in 16 155.2 (146.5-
163) 
1 in 6 
$ Children from birth cohort only were included in this analysis*Number of children per 1000 
with the condition; #values rounded to the nearest whole number 
3.8 ALLERGY BURDEN: UK VS WM 
The burden of allergic conditions on primary care in the WM was explored vis-à-vis that 
of the UK. The annual prevalence of allergic rhinoconjunctivitis (ARC) was consistently 
higher in the WM region compared with that of the UK, whereas there was no appreciable 
difference in the prevalence rates for food allergy, asthma and eczema (Figure 3-16). 
The rate of complex allergies was found to be higher for conditions including ARC in the 
WM (Figure 3-17). 
 




Figure 3-16: A comparison of prevalence rates per 1,000 children of allergic rhinoconjunctivitis (ARC), eczema, food allergy and asthma 
for children aged 0-17yrs in the whole of the UK compared with those from WM.. 95% confidence intervals are shown.  
 





Figure 3-17: A comparison of the prevalence rate per 1,000 children of GP diagnosed complex allergies in UK versus WM.. 95% 
confidence intervals are shown.  
 





The incidence rates of food allergy, allergic rhino conjunctivitis (ARC) and urticaria 
amongst children have remained fairly stable in the UK during the study period (2000-2015). 
During this time, the overall incidence of asthma and eczema have decreased steadily. 
However, the incidence rates of eczema are substantially higher in very young children (aged 
≤ 5yr). Eczema, asthma, urticaria and food allergy are all more commonly diagnosed in 
children under the age of 5 years. By contrast, ARC is relatively more commonly diagnosed 
for the first time in older children. Boys, especially those under the age of 6 years, are more 
commonly diagnosed with food allergies, ARC and asthma compared with girls. 
Prevalence rates 
The prevalence rates for all the allergic conditions investigated (except asthma) have 
increased in the UK over the study period. ARC prevalence rates have more than doubled; 
prevalence rates for eczema were higher than that of any other condition investigated in this 
analysis. Despite the fact that overall incidence of eczema fell within the dataset, the high 
incidence in the very young children (relative to children aged over 5 years - see Fig 3.5) 
meant that the total number of children within the dataset with this condition has been 
increasing over the study period. Consequently, between 2000 and 2015, there has been more 
than a 50% increase in eczema prevalence amongst children in the UK. About one in 45 
children in our dataset were diagnosed with a food allergy and one in 100 with a nut allergy 
by the age of 15. About 1 in 3 children were diagnosed with eczema by the age of 5 years and 
over half of all children by the age of 15. 
The International Study of Asthma and Allergies in Childhood (ISAAC), a large multi-
centre study estimating the prevalence of self- reported allergic conditions, found that whilst 
eczema and asthma prevalence had levelled off or decreased in areas with previous high 
prevalence (such as the UK) [91], the prevalence of allergic rhinitis – especially in younger 
children- has increased in most countries [68]. Estimates vary significantly based on the 
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method used (e.g. self-report versus diagnosed by a doctor), definition of allergy itself (blood 
test positivity versus self-reporting of symptoms by patient versus challenge test in a clinic) , 
age groups studied, or, in the case of retrospective cohort studies (similar to those presented in 
this thesis)- the dataset used [92].  
The reasons for the high prevalence of allergies in the Western world are unclear. The 
‘hygiene hypothesis’ which postulates that reduced exposure to dirt increases predisposition 
to allergic disease is currently the most accepted theory [93], but this does not offer a 
complete explanation [94]. It is noteworthy that the prevalence rates of allergy in some low 
and middle income countries have increased significantly within the seven years between 
ISAAC study phase 1 and 3 [68] suggesting that allergy could, perhaps, become a significant 
problem in the developing world in the future.  
Prevalence of GP reported food allergies has increased substantially amongst children 
during the study period. However, while there is broad agreement that food allergies are 
increasing in prevalence, the actual estimates are much debated [95]. This trend has been 
reported globally [96], although the quality of epidemiological data from different countries is 
variable. There was a marked increase in nut allergy prevalence at 275% in our cohort during 
the study period. The increase is in keeping with published literature from the UK and 
worldwide [97-99]. The reasons for such an increase are not entirely clear. Coding practices 
and bias due to practices included in the dataset may play a role, but published literature 
suggests that this may be a real trend. Epidemiological studies suggest that family history of 
allergy, association with other atopic diseases, route of allergen exposure (e.g. through skin), 
timing of exposure to the allergenic food and other dietary factors (such as reduced omega 3 
fatty acids) may all contribute to the risk of developing food allergy [100]. With regards to 
peanut allergy, more recent publications suggest that early weaning (at 4 months of age) with 
exposure to peanut may be protective [101]. However, this is at odds with the Department of 
Health’s previous recommendation (which was rescinded in 2008) advising avoidance of 
peanuts during pregnancy and the first 3 years of life in atopic children [102]. It is not clear 
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whether the previous guidance has contributed to the increase in nut allergy prevalence during 
the last decade (2000-2010). There has, however, been no abatement in the upward trend of in 
prevalence even after the withdrawal of the guidance. 
A previous publication has reported an increase in the incidence of GP diagnosed ARC in 
the UK [103]. Although this study did not report the trends for children in particular, other 
studies have suggested that allergic rhinitis has been increasing over time with each birth 
cohort [104]. Food allergy is more commonly diagnosed in children aged 5 years or less, 
whereas ARC is more commonly diagnosed in teenagers. Boys in our dataset appear to have a 
higher incidence of food allergy, ARC, asthma compared with girls until age 6yrs- this has 
previously been reported in the literature [105, 106]. The reasons for such discrepancy are not 
fully understood. Hormonal differences have been cited as a possible explanation[105], 
although this has not been proven. 
Proportionate changes in allergy prevalence 
The proportionate increase in asthma prevalence was lower compared with that of other 
conditions explored in this analysis. Previous studies and reviews have reported the flattening 
in asthma prevalence rates since 2000 [107]. One study reporting data from the General 
Practice Research Database (GPRD) showed an increase in asthma prevalence during the 
1990s [108]. A more recently published systematic review suggests that the prevalence 
worldwide is perhaps increasing [109]. However, the review included data from self-reported 
and physician diagnosed studies and did not clarify the age groups of the population studied.  
Complex allergies 
The number of children in our cohort with multiple allergies has increased considerably 
between 2000 and 2015. A previous publication using the GPRD database demonstrated that 
children diagnosed with either eczema, asthma or allergic rhinitis were at higher risk of 
developing other allergic conditions [110]. While this may be a global trend [111], the actual 
extent of the problem has not been previously described. An Irish study used the standardized 
ISAAC questionnaire to conclude that the co-existence of atopic conditions amongst children 
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aged 6-7 years had increased between 2002-2007 [112]. The increase in complex allergies has 
implications for the clinical services for allergy given that these children are most likely to 
need specialist input for optimal management. However, as discussed in the previous chapter, 
there are significant issues with specialist availability in allergy [6, 7]. In addition, poor 
referral practices often result in delays in assessment of these children [13].There is a need to 
streamline care pathways in order to ensure that these children are looked after well in the 
NHS.  
Burden in the WM 
The prevalence rates of allergic disease in the WM are broadly similar to those within the 
UK, except for ARC which appears more common in the WM. This is an interesting finding, 
perhaps related to the relatively longer pollen seasons coupled with higher pollen counts noted 
in the central parts of England [113]. The rates of complex allergies in the WM are also 
higher than those of the UK as a whole. This has implications for allergy services, especially 
given that the paediatric allergy specialist availability in the region is known to be poor [114]. 
3.9.1 Strengths and limitations of this study 
This study is the first, to our knowledge, to estimate allergy disease burden for a UK 
region. A major strength is the use of a large, representative national primary care database 
(THIN) which includes data from across the UK. The dataset provided longitudinal data on 
over 1.5 million children spanning over a decade and a half, allowing estimations with high 
statistical power. THIN provides diagnoses documented by a qualified clinician and could be 
considered to provide a more credible estimate than that provided by self- reported allergies. 
However, many mild allergies are managed by patients (and parents) at home using over the 
counter medication without ever consulting general practitioners. Thus, the estimates in this 
study may not reflect the burden of disease in the community. Moreover, as with any health 
database, there could be issues with accuracy of coding and missing data. In addition, THIN is 
a dynamic database and various GP practices may have joined or left the dataset during the 
study period. This may have affected the estimates provided. In addition, the GP surgeries that 
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opt to join the THIN data group may be more pro-active and outcome oriented, leading to a 
systematic bias in the data obtained. It should be noted, however, that data from THIN has 
been shown consistently to be of high quality and completeness as well as generalisable to the 
UK population [82, 115-117].  There are, however, no published data discussing the accuracy 
or generalisability of THIN estimates for different regions of the UK. 
We included all children who were diagnosed with allergic disease in our analysis without 
reference to prescriptions or consultations. This may have provided an overestimate of 
allergies, although it is important to remember that many allergic conditions (including 
allergic rhinoconjunctivitis, eczema, urticaria) are frequently managed using over the counter 
preparations and no prescriptions are often necessary for drug allergies and mild to moderate 
food allergies. In addition, it can be argued that disease diagnosis is an unreliable marker of 
disease burden compared with disease severity (which was not estimated in this analysis). 
Estimating disease severity for most allergies using the THIN database, however, can be 
challenging since there are no reliable Read codes that describe disease severity and many of 
the drugs used in managing these conditions can be obtained over the counter. 
Strengths and limitations in relation to published data 
A previous study estimated UK allergy incidence and prevalence rates for eczema, asthma 
and allergic rhinitis using primary care databases (particularly the GPRD) [22] - results from 
the current study broadly concur with these published estimates. 
 The Europrevall study carried out gold standard double blind, placebo controlled 
challenge tests on all children suspected to have food allergies [81]. Hens egg allergy 
prevalence in this cohort was estimated as 2.18% in the UK (95% CI 1.27–3.47) [118], about 
10 fold higher than the estimations from our analysis. The UK recruiting centre for this study 
was Southampton- it is unclear whether the differences in estimates may be related to 
geography (although this is highly unlikely given the scale of difference) or whether there is a 
significant under-diagnosis of food allergies in UK primary care. 
 





The incidence of primary care physician diagnosed allergic rhinoconjunctivitis, food and 
drug allergy, urticaria amongst UK children has remained stable over the study period (2000-
2015). Asthma and eczema incidence has been falling. The prevalence of all the conditions 
(except asthma) amongst UK children explored in this study, including complex allergies, has 
increased during the study period. The allergy prevalence rates are similar in the WM except 
for allergic rhinoconjunctivitis and complex allergies, which are more prevalent in this region. 
The data suggest that there may be some differences in the regional needs for secondary care 
services which require further exploration. Estimates of demand can be important when 
planning allergy services for children.  
 
While THIN analysis has shown that the prevalence of GP diagnosed allergies amongst 
children is increasing,  it is important to look at the number of children being admitted into 
hospitals with these conditions in order to obtain a more complete picture of allergy related 
demand on the NHS. Analysis of a secondary care NHS database (HES)  is discussed in the 
next chapter.




4 ANALYSIS OF HEALTHCARE DATABASES- THE HOSPITAL 
EPISODES STATISTICS DATABASE 
 
The previous chapter was focused on the epidemiology of paediatric allergy and related 
conditions from the UK primary care perspective. In order to fully understand the pathways 
involved in allergy service provision, it is important to understand the nature and frequency of 
allergy and related conditions presenting to secondary care. The current chapter will focus on 
the burden posed by paediatric allergy on NHS secondary care in England and the WM using 
data from the Hospital Episodes Statistics database (HES).




4.1.1 Admissions related to allergies 
 In the previous chapter the annual trends in incidence and prevalence rates of GP 
diagnosed childhood allergies in the UK were discussed and these were compared with the 
rates for the WM. In this chapter, the burden placed on secondary care due to paediatric 
allergy and related conditions will be discussed. 
For this analysis, the Hospital Episodes Statistics Database (HES) was used. HES is a 
secondary care dataset containing details of all admissions into NHS hospitals in England. 
This dataset does not record Accident and Emergency attendances, nor does it provide details 
regarding outpatient appointments into NHS hospitals. On an average, 125 million records per 
year are included in the database. In addition to NHS admissions, it provides information 
regarding admission of private patients treated in NHS hospitals, patients resident outside of 
England (whose care is delivered within English NHS hospitals) and care delivered by 
treatment centres (including those in the independent sector) funded by the NHS in England. 
Spells where individuals living in England seek treatment by the NHS in the devolved nations 
are not included in the database [119]. 
 As with the previous chapter, the results from England will first be discussed (since 
HES data do not include episodes from Wales, Scotland or Northern Ireland) and comparisons 
will then be made with data from the WM. 
4.1.2 About HES 
 The HES database was initiated in 1989-90 and, in parallel with changes to the NHS 
structure, has since undergone many changes in terms of data collection, coding and 
responsible agency. It is now run by the Health and Social Care Information Centre (HSCIC) 
and the National programme for IT under the Secondary Uses Service (SUS). It includes 
patient admissions care data from 1989 onwards, outpatient attendance data from 2003 
onwards and A&E data from 2007 onwards. HES is updated every month [119]. In order that 
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data remain anonymous, all patient identifiers are removed and, in the case of very rare 
diseases, statistics are suppressed so that individuals cannot be identified using the database.  
 HES data are different from Payment by Results (PbR) data which are submitted by 
NHS Trusts every month to declare their clinical activity for the purposes of financial 
compensation [119]. Unlike PbR, HES data are not updated once released. 
4.1.3 Data captured within HES 
 Each HES record contains a wide range of information about an individual patient 
admitted to an NHS hospital, including: 
 clinical information about diagnoses and operations (except for outpatient attendances 
where no such clinical information is available). Up to 20 diagnoses and 20 procedures 
can be recorded per admission. These are coded as per the ICD-10 (International coding 
of diseases) and the OPCS classification of interventions and procedures (OPCS4) codes. 
 information about the patient- such as age group, gender and ethnicity 
 administrative information, such as time waited, and dates and methods of admission and 
discharge including whether or not the admission was elective (planned) or an 
emergency. 
 geographical information such as where patients are treated and the area where they live, 
electoral ward of residence, Clinical Commissioning Group (CCG) region etc. 
 Socioeconomic data are estimated based on English indices of multiple deprivation (IMD 
2010) which are published for small geographical areas. This is a composite measure that 
uses 38 indicators of deprivation which are grouped into 7 domains including income, 
employment, health and disability, education, skills and training, barriers to housing and 
other services, crime, living environment. Scores from each domain are weighed 
differently to determine the deprivation ranking of the given geographical area [120]. 
The higher the overall IMD rank, the lower the deprivation. 
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4.1.4 Permissions to access the database 
 In order to access the HES database, an application was made to the Data Access 
Advisory Group and the Confidentiality Advisory Group by the Institute of Applied Health 
Research within the University of Birmingham. Approval was provided for a range of 
research projects including this study. Data was made available for the period 2007-2015. 
4.2 HES ALLERGY DATA 
4.2.1 Admissions due to allergies 
Allergy related admissions into NHS Trusts in England may be elective or emergencies. 
Allergy related emergencies 
 Emergency admissions for allergy commonly include those due to anaphylaxis, 
angioedema and urticaria. 
 Anaphylaxis 
 Anaphylaxis is "a serious allergic reaction that is rapid in onset and may cause death" 
[121]. It has previously been reported that the incidence of anaphylaxis in the UK is 
increasing, although there is considerable discrepancy  in the proposed incidence rates for the 
condition which have been reported to vary between 5 to 40 per 100,000 population [75, 77, 
122, 123]. The lifetime prevalence estimates worldwide vary between 0.05 and 2% [124, 
125].        
Angioedema 
 Angioedema refers to non-itchy, painless swellings of the skin and mucous 
membranes which may nor may not be related to an underlying allergy [126]. The condition is 
normally not serious but can be rarely life-threatening, especially when the swelling affects 
the tongue or the inside of the throat.  Patients may attend A&E department when symptoms 
are distressing or serious. 
Urticaria 
 Urticaria refers to a group of skin disorders characterised by the development of 
localised, itchy, transient wheals [127]. This is a common skin disorder that can lead to a 
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significant impairment in an individual's quality of life. The condition may or may not be 
related to an underlying allergy. Whilst most individuals with urticaria are managed by GPs or 
specialists in the outpatient clinics, some may have severe symptoms and discomfort 
prompting a visit to the emergency department. 
Elective admissions for allergies 
Immunotherapy (Desensitisation treatment) 
 Some children with allergic rhinitis (hay fever/ house dust mite allergy and related 
conditions) are electively admitted to hospital for administration of desensitisation treatment 
[128] (also known as specific allergen immunotherapy or SIT) as day case admissions given 
the prolonged duration of observation required after every dose (up to 1 hour) and the 
possibility of anaphylaxis during treatment. Allergen SIT in the UK can only be administered 
in specialist centres- primary care practitioners are not licensed to provide this therapy. It can 
be given either subcutaneously (i.e., via injections- SCIT therapy) or through tablets under the 
tongue (sublingual or SLIT therapy).  
Elective day case admissions are usually planned for injection SIT whereas tablet SIT can 
be delivered mostly at home although a couple of elective admissions will be offered to 
patients (usually for treatment initiation or for monitoring those experiencing side-effects).  
Challenge tests 
 In children with suspected allergies (usually food allergies), challenge tests with the 
implicated allergen are sometimes planned to either confirm or rule out allergy. These are 
done under supervision of experienced clinical staff and are marked as a day-case elective 
admission. 
4.3 AIM AND OBJECTIVES 
The aim of this study was to estimate the number of admissions into the NHS hospitals in 
England due to conditions related to paediatric allergy between 2008 to 2014. 
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The objectives were: 
1. To estimate the admission rates for children into English hospitals  for the following 
conditions: 
i. Allergy emergency versus elective admissions 
ii. Emergency admissions: 
 Anaphylaxis  
 Urticaria 
 Angioedema 
2. To compare the admission rates between English and WM children for  
i. Anaphylaxis 
ii. Urticaria  
iii. Angioedema 
3. To compare admissions for allergen specific immunotherapy for English and WM 
children 
4.4 METHODS 
4.4.1 Data collection 
 Diagnosis and symptom related information in HES are coded using the ICD-10 
clinical coding system, whereas clinical procedures are coded using the OPCS4 system [119]. 
The conditions of interest and the corresponding codes used in this analysis were drawn from 
the published literature [122, 129], including a special publication from the HSCIC with a 
focus on allergies [128]. The list of conditions of interest to this study and the relevant ICD-
10 codes are shown in Appendix Table 4.A 
 In addition to the diagnostic codes, other data which were felt to be relevant including 
age, sex, ethnicity, region where treatment was delivered, IMD data (see section 4.1.3), dates 
of admission and discharge etc. were extracted for each allergy related admission [130]. The 
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region in which the patient resided at the time of the admission was derived from the GOR 
(Government Office region of Residence) code which is routinely collected within HES [131].  
The relevant population data (for England and the WM) were derived from the ONS mid-
year population statistics [132]. 
Data were extracted by an experienced analyst (Mr Gavin Rudge, University of 
Birmingham) on the 31st of August 2016 based on the requirements specified by the 
researcher (LD). 
4.5  ANALYSIS 
 The data were analysed using Stata® 13 and graphs were created using Stata and 
Excel® 2010. Admissions/ treatments for anaphylaxis, as well as those for allergic rhinitis 
were focused upon. Admissions for asthma in children were not considered in this analysis. 
 The University had access to HES data for the years 2007-2015. Since the HES data 
span the financial year (i.e. 1st April to 31st March of the following year), the complete 
annual estimates (1st January- 31st December) were available only for the years 2008-2014. 
The data shown in this chapter, therefore, are estimates for 2008-14. In order to estimate age 
and gender-specific admission rates for England (and WM) for these conditions, the relevant 
mid-year population estimates for children using the data published by the Office of National 
Statistics (ONS) were used [132]. 
4.5.1 Assumptions 
The following assumptions were made during this analysis: 
i. The coding data and all the other entries made into the dataset were considered to be 
accurate  
ii. Anaphylaxis coded within any of the 20 available diagnostic code options per admission 
was considered significant and was included in the  analysis 
iii. Urticaria and angioedema were assumed to cause the admission if they were included 
within the first 3 diagnostic codes only.  
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iv. Individuals presenting with anaphylaxis may also have urticaria and angioedema. To 
prevent double-counting, those individuals listed as being admitted for anaphylaxis were 
removed from the urticaria and angioedema admission statistics. 
v. All treatment codes (up to 20 per admission) were considered in estimating the 
admissions for desensitization (i.e., SIT) 
4.5.2 Admission rates 
Age and sex specific admission rates for various allergies and related conditions were 
estimated using population estimates provided by the ONS [132]. 
4.6 RESULTS 
 There were 87,048 finished admission episodes of hospital admissions for children 
with allergies (identified using ICD-10 and OPSC4 codes- see Appendix Table 4.A) between 
the years 2008 and 2014. 44.9% of these were recorded as elective admissions and 54.6% 
were emergency admissions (0.5% were not specified as either). 59.5% were boys; 65.9% 
were identified as white; 3.7% were of mixed ethnic origin; 13% were Asian, 5.5% were of 
black origin and 2.8% were labelled ‘other’ whereas ethnicity data were unavailable for 9.2% 
of the children. 31.3% of the children were aged 5 years or less.   
Over 90% of the children had no more than 4 diagnostic codes and 2 procedure codes 
entered per admission. Breakdown of the admission data by geographical regions is shown in 
Appendix Table 4.B. The data from West Midlands (WM) accounted for 8.3%, the North 
West of England accounted for over a quarter and London for a fifth of all allergy related 
admissions for English children between 2008 and 2014. The proportion of children in 
England and the WM in the age groups 0-5 yrs, 6-10 yrs and 11-17 years has remained fairly 
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4.6.1 Allergy related admission rates  
Emergency versus Elective admissions 
 There has been a steady increase in the number of English children admitted into 
hospital either electively or as an emergency with any allergy related diagnostic code as 
shown in Figure 4-1 (See also Table 4-1), with a 75% increase between 2008 and 2014. 
 
Figure 4-1: Allergy admission rates for children in English NHS (Elective versus 
Emergency) 
Admissions due to Anaphylaxis 
 The rate of admission of children into hospitals in England with anaphylaxis is shown 
below (Figure 4-2). Boys have had higher admissions rates for anaphylaxis between 2008 and 
2014 compared with girls. 




Figure 4-2: Anaphylaxis admission rates with 95% confidence intervals for 
children in England. Admission rates for boys and girls are shown separately.  
 
 
Age variation in anaphylaxis 
 Variations in anaphylaxis admission rates based on the age of the child were further 
explored. All children in the dataset were divided arbitrarily into two groups: those aged 5 
years or less, those aged between 6-17 years. The trends based on age and gender are shown 
in Figure 4-3 below. Boys aged 5 or less have higher rates of anaphylaxis admissions 
compared with girls. These differences in admission rates are not apparent in older children.  
 




Figure 4-3: Age related differences in anaphylaxis rates: Anaphylaxis rates per 100,000 and 
95% confidence intervals for children in England aged 5 years or less versus those aged 6-17 
years. 
 
Anaphylaxis- underlying aetiology 
Figure 4-4 shows the underlying conditions that contributed to anaphylaxis amongst 
English children during the study period. Where the underlying allergen is neither food nor a 
drug (see Appendix Table 4.A for the relevant ICD-10 codes), the individual is classified in 
HES as having anaphylaxis due to unknown aetiology. Iatrogenic causes (i.e., treatment 
related causes) for anaphylaxis include reactions to drugs or serum. 
Food allergens are the dominant cause for anaphylaxis amongst English children. Hospital 
related anaphylaxis, our data suggests, is very rare. There has been an increase in anaphylaxis 
rates due to food as well as due to unknown conditions during the study period. 




Figure 4-4: Anaphylaxis rates per 100,000 children (and 95% confidence intervals) 
in England based on the underlying allergic aetiology (2008-2014).  
Table 4-1 shows the changes to admission rates for various emergencies in England. A 
notable finding is the fact that there has been up to a 50% increase in the number of children 
being admitted with anaphylaxis during the study period (i.e., a span of 7 years). The increase 
appears to be spread out amongst all age groups, although there is a suggestion that boys aged 
5 years or less have had a higher increase than most others (see also Figure 4-3).  
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Table 4-1: Proportion change in the emergency admission rates for various allergic 
conditions amongst English children between 2008- 2014 
  (n=) 
(2008) 
Rate* (2008) (n=) 
 
(2014) 
Rate* (2014) % change 
Emergency 
Admissions 





(44.21 - 44.50) 
Anaphylaxis 
(All) 
743 6.63  
(6.2-7.1) 
1113 9.6  
(9.1-10.1) 
44.77 
(43.13 - 46.65) 
Male  401 7.11  
(6.4-7.8) 
608 10.2  
(9.5-11.0) 
43.95 
(41.70 - 46.67) 
Female 342 6.37  
(5.7-7.0) 
505 8.93  
(8.2-9.7) 
40.16 
(38.00 - 42.80) 
Age ≤5 yrs 245 6.59  
(5.8-7.4) 
400 9.74  
(7.9-9.6) 
47.96 
(44.45 - 52.42) 
Age 6-17 yrs 498 6.66  
(6.1-7.2) 
713 9.52  
(8.8-10.2) 
43.10 
(41.41 - 45.07) 
Food related 642 5.73  
(5.5-6.0) 
851 7.34  
(7.1-7.6) 
28.10 





375 3.23  
(2.9-3.6) 
37.27 
(34.97 - 40.19) 
Iatrogenic 41 0.37  
(0.3-0.5) 
77 0.66  
(0.5-0.8) 
81.50 
(70.02 - 103.07) 
Urticaria 474 4.23 615 5.31 25.39 
Angioedema 163 1.46 285 2.46 68.97 
*Rate per 100,000 children
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4.6.2 Comparing emergency allergy admission rates for WM children with those for 
English children (2008 to 2014) 
The admission rates for anaphylaxis were broadly similar in WM and England during the 
study period. The admission trends for urticaria, angioedema and anaphylaxis are shown for 
England and WM in Figure 4-5Error! Reference source not found..  
Admission rates for angioedema and urticaria have been increasing over the study period 
in England as well as the WM. 
 
Figure 4-5: Emergency admission rates per 100,000 children for allergy related 
conditions, England versus WM. 95% confidence intervals are shown. 
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4.6.3 Elective admissions  
Specific allergen  Immunotherapy Treatment (SIT)  
The trends in admissions for SIT (or allergen desensitisation treatment) in England and 
WM are shown in Figure 4-6. The rate of total appointments for SIT per year is compared 
with that for children starting treatment for the first time. The graph shows that the 
immunotherapy trends for WM are low compared with that of England overall.  
Most of the SIT treatments offered to children were for allergic rhinitis. Figure 4-6 
highlights the differences in treatment trends between England and WM. Although there has 
been an upward trend in the number of children being offered the treatment over the last few 
years, the overall rates remain low in the WM. 
 
Figure 4-6: Differences in SIT treatment start rates for children in England vs WM. The 
rate for new treatments each year initiated is shown in blue. 
The age trends in SIT in England are shown in Figure 4-7. A similar sub-group analysis 
was not carried out for WM given the relatively low numbers. More teenagers are being 
offered desensitisation in England, and there has been a decrease in the number of children 
aged 5yrs or under receiving these treatments. 




Figure 4-7: Age specific SIT treatment admission trends per 100,000 
children in England. 95% confidence intervals are shown. 
Changes in the proportion of children being electively admitted to the NHS for allergies 
are detailed in Table 4-2 and Table 4-3. The data show that although the admission rates for 
SIT have increased in the WM during the study period, the rates lag substantially behind those 
for England overall. This is true for both modalities (subcutaneous and sublingual) of 
immunotherapy and also for the diagnosis for which treatment is offered (allergic rhinitis vs. 
other).The number of children being offered SIT (new admissions) are also very low in the 
WM. In fact, the rates for children starting subcutaneous immunotherapy have fallen slightly 
in 2014 compared with 2013 (see Figure 4-6). 
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*Rate per 100,000 children           ** these analyses were not carried out for WM due to low numbers   
 Number 
(2008) 
Rate* (2008) Number 
(2014) 
Rate* (2014) % change 
SIT 429 3.83  
(3.5-4.2) 
1789 15.43  
(14.8-16.1) 
303.01 
(285.06 - 324.62) 





(36.62 - 42.49) 
Subcutaneous 195 1.74  
(1.5-2.0) 
1452 12.52  
(11.9-13.1) 
633.16 
(562.88 - 694.62) 
SIT (aged 13-17 yrs)** 227 6.94  
(6.1-7.8) 
1023 32.83  
(31.0-34.6) 
372.92 
(343.73 - 410.34) 
SIT (age ≤ 5yrs)** 51 1.37  
(1.0-1.7) 
37 0.90  
(0.6-1.2) 
-34.25 
(-38.64 to -31.74) 
New admissions 138 1.23 
 (1.1-1.4) 
414 3.57  
(3.3-3.9) 
189.9 
(160.33 - 181.64) 





(313.24 - 435.56) 
New admissions (SLIT) 89 0.79 
 (0.7-0.9) 
181 1.56  
(1.4-1.7) 
96.54 
(85.62 - 111.74) 
SIT- allergic rhinitis 367 3.28 
 (3.2-3.9) 
1091 9.41  
(9.1-10.2) 
187.29 
(160.33 - 181.64) 
SIT- other 62 00.55  
(0.4-0.7) 
698 6.01  
(5.58-6.45) 
986.4 
(833.70 - 1239.95) 















*Rate per 100,000 children              
 Number 
(2008) 
Rate* (2008) Number 
(2014) 
Rate* (2014) % change 
SIT 29 2.35  
(1.52-3.19) 
84 6.68  
(5.3 -8.07) 
184.13 
(152.98 - 249.70) 
Sublingual 17 1.38  
(0.73-2.03) 
8 0.63  
(0.2-1.08) 
-53.84 
(-46.87 to --73.14) 





(384.97 - 1005.77) 
New admissions 16 1.30  
(0.86-1.73) 
23 1.83  
(1.19-2.47) 
41.01 
(37.50 - 42.76) 
New admissions (SCIT) 9 0.73 
 (0.48-0.98) 
16 1.27  
(0.71-1.83) 
74.39 
(48.43 - 87.08) 
New admissions (SLIT) 7 0.57  
(0.23-0.91) 
7 0.56  
(0.4-0.72) 
-1.91 
(-21.02 to 73.61) 
SIT- allergic rhinitis 20 1.62  
(0.92-2.32) 
66 5.25  
(4.01-6.49) 
223.71 
(179.33 - 335.51) 
SIT- other 9 0.72 18 1.43 96.19 




4.7.1 Principal findings 
Admission rate 
 Our analysis found that there has been a steady increase in the rate of admissions for 
allergy and related conditions amongst children in England as well as the WM between 2008 
and 2014. The rate of emergency admissions has increased, with nearly a 44% increase in the 
admissions for anaphylaxis; 25% and 69% increase in admissions due to urticaria and 
angioedema respectively in England during the 7 year study period. An increase in emergency 
allergy admissions in England was reported in previous publications [122, 133] and similar 
trends were reported from Australia [134]. Although the estimates in the current study are 
only for the paediatric population, the trends are in keeping with that from the published 
literature.  
Anaphylaxis rates 
Anaphylaxis rates appear higher for boys aged 5 years and under compared with girls- the 
reason for this is not clear. This gender gap in early years anaphylaxis has been previously 
reported in the literature [135]. Data from UK primary care presented in the previous chapter 
shows that boys are more commonly diagnosed with nut allergy, food allergy, ARC and 
asthma compared with girls. As discussed previously, hormonal causes and genetic causes 
have been suggested, but no definite reason for this gender gap has been found so far [74, 
105]. Food allergy is diagnosed most frequently in the first 5 years of life and is the 
commonest cause for anaphylaxis amongst children, accounting for more than 60% of all 
admissions for childhood anaphylaxis. An increase in the prevalence of GP diagnosed food 
allergy amongst children was demonstrated in the previous chapter (Figure 3-9). This may be 
linked to the increase in anaphylaxis rates.  Susceptibility to food allergies in early childhood, 
new research suggests, is likely due to skin exposure to food and can be modified by early 
dietary exposure to appropriate food allergens [136]. These findings can be used to potentially 
help reverse the current upward trends in childhood anaphylaxis. 
  Chapter 4: HES analysis     
79 
 
  Drug or serum induced anaphylaxis account for less than 10% of all anaphylaxis 
amongst English children, although the rate appears to be increasing over time. The trends in 
WM were similar to those seen in England. These data are in keeping with published 
literature [122, 128]. Some recent publications have suggested a significant difference in 
anaphylaxis rates based on ethnic origins of the population [123], but detailed analysis using 
ethnicity data was not possible using HES.  
Elective admission 
Allergen specific immunotherapy (SIT) has been shown to be clinically effective and cost 
effective in the management of allergic rhinitis [137] and also in the management of 
individuals with severe anxiety following anaphylaxis due to wasp or bee stings 
[138].Elective admissions for allergy, especially those for SIT (specific immunotherapy or 
desensitisation treatments) have been steadily increasing between 2008 and 2014. SCIT 
(injection based SIT) appears more popular for treating children with allergies in England. 
The rate of SLIT (tablet based SIT) related admissions have remained stable over the period 
2008-2014 in England. The low numbers may reflect the fewer number of admissions 
required for SLIT therapy. Whereas multiple treatments in the hospital or clinical setting are 
required for SCIT therapy, SLIT typically requires only a few hospital visits (sometimes just 2 
per year). Nevertheless, this discrepancy is still evident when only new patients being offered 
the treatment are considered. This preference for SCIT is interesting since there is no evidence 
to support its efficacy over SLIT in children [139]. The use of SCIT is highest in adolescents 
(aged between 13 and 17 years), although our data suggests that children under the age of 5 
are also being offered this treatment in England. 
Our data suggests that SIT is underused for children within the WM. Fewer children are 
started on desensitisation therapy in the WM compared with the average for England overall. 
The proportion of children being offered desensitisation for allergic rhinitis in the WM also 
compares poorly with the English average. This is especially pertinent, given the higher rates 
of ARC amongst WM children compared with the rest of the UK (Figure 3-16). The 
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increasing trends in SIT for children in England are encouraging and suggest that there is a 
trend towards improved management of children with allergies. Nevertheless, the overall rates 
for SIT in England are still very low.  Less than 1:600 children who present to their general 
practitioners with allergic rhinoconjunctivitis are offered this treatment in England and the 
rate in WM is less than 1:1800. This suggests either that the children in WM have much less 
severe disease compared to their counterparts across the country or that they do not have 
adequate access to specialist services. The former scenario is unlikely, given that there is no 
difference in the emergency admission trends for allergy in the WM compared with rest of 
England. Heterogeneity in coding may be another possible explanation [140], although this is 
unlikely to exclusively affect the WM region. SIT is only offered in specialist centres in the 
UK [141]. Difficulty in accessing specialists is the most likely explanation for these very low 
SIT rates. The problems with specialist access appear to be particularly severe for children in 
the WM. 
4.7.2 Strengths and limitations of the study 
The strength of this study is that it is the first to look specifically at the trends in paediatric 
allergy admissions using HES database. The analysis also looked at various subgroups of 
children (such as boys versus girls, children aged 5 years or less versus 6-17 years) in addition 
to estimating regional trends in admission rates for allergy (i.e., those from the WM region). 
This is also the first study, to our knowledge, to analyse trends in SIT across England using 
HES database.  
There are some limitations of this study. For the purposes of this analysis, we assumed that 
HES data coding was accurate. HES database is used for purposes of reimbursement 
(although this analysis did not use PbR data) and hence it is likely that the data collection is 
fairly complete. However, like any other large health dataset, coding in HES can be inaccurate 
[140, 142]. Anaphylaxis, in particular, is often miscoded [123] and the codes available are 
limited (for example, there are no codes for insect venom related anaphylaxis). Also, HES 
does not record diagnoses for outpatient episodes. Accident and Emergency data are also not 
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recorded within this database. Children presenting with acute allergic conditions such as 
urticaria and angioedema are often managed in Accident and Emergency departments and 
discharged. Hence this analysis does not fully estimate the burden posed by paediatric allergy 
on NHS secondary care. 
Despite all these limitations, HES remains the largest dataset for hospital admissions in 
England and Wales. Clinicians are generally aware of the importance of the dataset and  are 
keen to be engaged in the collection and usage of these data [143].  
4.7.3 Strengths and limitations in relation to published studies 
 There have been previous publications looking at anaphylaxis rates in the English 
population using the HES database [122] and the HSCIC has published an allergy special 
analysis report in 2014 which estimated emergency and elective admissions for allergy [128]. 
Our findings are consistent with the results of these two publications.   
4.7.4 Areas for further research 
Further research looking into the pathways of patients admitted for emergencies into the 
NHS (before and after admission) may be helpful in understanding efficiency of the available 
NHS primary care and specialist allergy services. In addition, analysis of outpatient and 
Accident and Emergency data will also help in the understanding of the extent of the problem.  
4.7.5 Summary of database analysis 
Chapters 3 and 4 demonstrate that there has been increasing demand on the NHS primary 
and secondary care services for paediatric allergy. Prevalence of GP diagnosed allergies has 
been steadily increasing as is the rate of elective and emergency admissions into NHS 
hospitals for allergy and related illnesses. Rate of complex allergies amongst children is also 
increasing. Whilst the trends in allergy prevalence are similar in the UK and the WM, allergic 
rhinoconjunctivitis is more commonly diagnosed in WM children. 
Data from HES highlight the deficiencies in primary and secondary care provision for 
paediatric allergies. The rates of anaphylaxis are increasing; and emergency admissions for 
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urticaria and angioedema are also on the increase. Urticaria and angioedema can, in a majority 
of cases, be managed effectively in primary care with appropriate use of antihistamines and 
other drugs [144]. Provision of tailored individual management plans can help reduce the 
occurrence of anaphylaxis in vulnerable children [145].  
The provision of SIT can be used as a proxy for specialist access to allergy services, given 
that SIT is only offered by specialists in the UK. Increases in SIT rates for allergic rhinitis and 
other conditions are encouraging and suggest that more children are receiving these 
treatments where appropriate. However, the number of children being offered these treatments 
is very low in England as a whole. Considering that not all children with allergic 
rhinoconjunctivitis consult their general practitioners in the first place, it is reasonable to 
assume that most of the children presenting to the GPs have at least moderate symptoms. 
Despite this, less than 1:600 children in England (and even fewer children in WM) have 
received SIT in 2014. Allergic rhinoconjunctivitis in children is an often ignored issue which 
can have significant implications for exam performance, career [146] and quality of life of the 
individual [147] and considerable societal economic costs [148, 149]. SIT is a disease 
modifying treatment modality for ARC and is cost effective [150]. Better service pathways 
will help improve access to this treatment. 
4.8 CONCLUSIONS  
Demand on NHS primary and secondary care due to paediatric allergy and related 
conditions is increasing. Whilst the prevalence of GP diagnosed allergic rhinoconjunctivitis, 
eczema, food allergy and drug allergy is on the increase, the prevalence of asthma has been 
stable amongst children between 2000 and 2015. The prevalence rate of complex allergies is 
also increasing. These UK trends are mirrored in the WM. Emergency admission rates for 
anaphylaxis, urticaria and angioedema are also increasing in England and the WM. Allergen 
specific immunotherapy rates for children are poor in England with a very small proportion of 
children diagnosed with ARC receiving this treatment, reflecting the paucity of allergy 
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specialists across the country. Given the severe shortage of paediatric allergists in the WM, 
the SIT rates for this region are even lower. 
Analysis of these databases has revealed that there may be issues with access to secondary 
care services for paediatric allergy, particularly in the WM. In order to explore this further, a 
qualitative study was planned. This is discussed in the next chapter.
   
 
 
5 A QUALITATIVE STUDY TO UNDERSTAND PARENT 
EXPERIENCES WITH PAEDIATRIC ALLERGY PATHWAYS IN THE 
WEST MIDLANDS 
Analysis of the primary and secondary databases discussed in the previous two chapters 
has suggested that there are barriers to accessing specialist services for children with allergies, 
particularly in the WM region. In order that the current pathways may be better understood, 
talking to parents who had experienced these services was necessary. Hence, a qualitative 
study was planned to ascertain parent experiences with paediatric allergy services in the WM. 
The methodological basis for qualitative studies, the objectives of the study and the findings 
are discussed in this chapter.




Allergy services in the UK are clearly very heterogeneous  (as discussed in Chapter 2) and 
are perceived  as being ineffective in combating the 'allergy epidemic' [7]. Previous 
publications have suggested that specialists in allergy, particularly paediatric allergy, are in 
short supply [114]. In addition, general practitioners feel especially anxious about managing 
children with allergies [151].  
In the WM, allergy services for children are offered in 12 NHS hospital trusts (See Section 
1.2). The population of the county is currently 5.6 million - roughly a tenth of the population 
of England- and service pathways for the region are disparate. This is partly because of the 
unique ethnic mix of the region and also the variations in urban/ rural services. In addition, 
most of the specialist allergy services for the region are concentrated in larger, urban centres.  
In order to explore and understand what parents thought about the existing paediatric 
allergy services in the WM, a qualitative study was planned. Since parents access healthcare 
on behalf of their children, semi-structured interviews with parents of children attending 2 
specialist clinics (Royal Shrewsbury Hospital in Shropshire and Birmingham Heartlands 
Hospital in Birmingham) were carried out. Choosing parents attending specialist allergy 
clinics provides relevant information regarding the entire allergy care pathway (primary and 
secondary care) in the WM, thus providing a fairly comprehensive view of the positive and 
negative aspects of the service.  
 Data obtained from this qualitative study will provide attributes for the planned 
discrete choice experiment (DCE), which aims to obtain preferences from an unselected group 
of parents within the Midlands region. The DCE is discussed in detail in Chapter 6.  
 In this Chapter, after a brief introduction to the principles of qualitative research, the 
methods employed for this particular study will be presented. The results obtained will be 
discussed and existing literature will be used to help contextualise the findings. The Principal 
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investigator (LD) will reflect on the influence of her experiences as a consultant immunologist 
on her role as a researcher during the interviews as well as during the analysis of this study. 
5.2 QUALITATIVE RESEARCH 
Qualitative research has its origins in social science theory and considers the following: 
 Ontology  - the reality of what exists and what should be studied,  
 Epistemology - what can be studied and how can we study this 
 Methodology -the techniques that can be used to obtain this knowledge [152, 153]. 
Qualitative research can be broadly defined as ontological and epistemological approaches 
that are “directed at providing an in-depth and interpreted understanding of the social world of 
the research participants by learning about their material and social circumstances, their 
experiences, perspectives and histories” [154]. The aim is, therefore, to obtain knowledge 
regarding behaviours, perceptions and experiences of individuals which are intangible in 
quantitative research. The focus is on questions such as “why” or “how” rather than “how 
many” [155]. 
In keeping with this difference in focus, there are differences in  
i. recruitment  
ii. data collection and  
iii. data analysis techniques  
between qualitative and quantitative research. These will be discussed briefly below. 
5.2.1  Recruitment in qualitative research 
Subject recruitment in qualitative research is substantially different from that of 
quantitative research. Whereas in the latter the emphasis is mostly on avoiding selection bias 
and selecting a probabilistic (random) but representative population for the study [156], 
recruitment for qualitative studies is usually non-probabilistic and aimed at best ascertaining 
elements of particular interest to the researcher [154]. This is appropriate since interviewing 
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individuals without any knowledge of the subject of interest is unlikely to yield useful 
information. Subjects are generally chosen not to be representative of the population, but 
because they possess characteristics relevant to the study [157]. 
Qualitative sampling can be purposive or criterion-based (i.e. chosen because of 
characteristics that allow detailed exploration of themes of interest to the researcher), 
convenience based (i.e., chosen according to ease of access to the researcher without any 
definite sampling strategy), opportunistic (flexible recruitment based on opportunities that 
arise during field work), snowball sampling (using initial recruits to identify further 
respondents for the study) [154, 158] . Theoretical sampling is a form of purposive sampling 
used in the development of grounded theory wherein each interview is analysed before the 
next interviewee is chosen in order that emerging theories or ideas can be developed and 
refined [154]. Very often, studies use a combination of these techniques to recruit subjects 
into their studies. 
Sample size in qualitative studies, therefore, is not decided prior to the start of the study on 
the basis of tests for statistical significance. It is determined on the basis of saturation, i.e., no 
new themes emerge from further interviews. The definition of saturation can differ based on 
the study protocol and objective [159]. 
In this study, sampling was purposive- i.e., parents were chosen in order that a broad range 
of allergic conditions and ages of children could be represented within the study. Recruitment 
was opportunistic and varied based on the clinical pressures within the outpatient department 
on a given day.  
5.2.2 Data collection in qualitative studies 
The ways in which data are collected and analysed are determined by basic 
epistemological assumptions and the characteristics of the researcher. Depending on the study 
objectives, data can be collected in  
 Single research episodes, such as:  
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o in-depth individual interviews  
o focus groups – where a group of individuals discuss the topic of interest 
with the researcher recording and facilitating the process 
 Longer term studies, for example:  
o ethnographic observations- where the researcher observes subjects in their 
natural environments for a period of time 
o panel studies - data is collected over time using the same cohort of 
participants to understand the impact of change (e.g. an intervention) 
 Typically, sample sizes in qualitative studies are small since vast amounts of data can be 
obtained from even a limited number of participants. There are no set criteria for determining 
sample sizes- it is largely a matter of judgement, although some guidance has been provided 
[154]. Drawing meaningful conclusions from very small samples can be difficult, just as 
ensuring detailed analysis of large samples can be challenging [160].  Sample sizes, therefore, 
vary depending upon the purpose of the study; For example, studies aimed at developing new 
social theories (grounded theory) carry out data collection alongside analysis until there is 
data saturation - i.e., no new concepts emerge with subsequent units of data collection [161]. 
Ethnographic studies, in which the investigator becomes a participant within the community 
being investigated in order to gain an in-depth insight into their behaviours and beliefs, may 
need significantly more units of data collection. On the other hand, phenomenological studies 
(which aim to understand experiences from a subjective point of view) may require fewer 
participants [160] depending upon the study objective.  
Interviews typically consist of open-ended questions, based on a guide which is designed 
to ensure that the topics of interest to the interviewer are covered. The questions serve to keep 
the interview focused on the topic, whereas the content of the interview is driven by the 
interviewee. As far as possible, leading questions are avoided and the participant is allowed to 
steer the conversation within the bounds of the topic. Interviews are usually audio (or video) 
recorded with the consent of the interviewee and the interviewer typically notes down salient 
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behavioural or contextual observations that may be useful during analysis [153].  Audio 
recordings are then transcribed with a view to preserving the naturalness of the speech and the 
interview as much as possible. The transcript should be an exact reproduction (verbatim) of 
the interview and should be suitable for the use of any researcher- even those not directly 
involved with the study [162]. 
In this study, one-off semi- structured interviews of eligible parents were carried out by the 
principal researcher (LD). Interviews were audio recorded and later transcribed verbatim by 
an external transcription agency. Some of the field notes jotted down by the researcher were 
also used in the reporting of the results (for example, comments made after the audio 
recording was stopped.) 
5.2.3 Analysis of qualitative data 
Analysis in qualitative research depends upon the study objectives and the ontological and 
epistemological stance of the researcher. In any qualitative analysis, transcripts need to be 
read repeatedly until the researcher is very familiar with the data. It is often recommended 
that interim analyses be carried out during data collection to ensure that the emerging avenues 
of inquiry are identified and pursued appropriately [163].  
Qualitative data can be analysed in many different ways.  For example- narrative analysis 
places emphasis on the way individuals use language to interpret and narrate their experiences 
[164]; discourse analysis concentrates on spoken and written language and its importance in 
the understanding of cultural perspectives and identities [165];  thematic analysis is a method 
“for identifying, analysing and reporting patterns or themes within data” [166]. Grounded 
theory, on the other hand, is dedicated to discovering new concepts embedded within the data. 
This is possible by constantly comparing concepts across subjects and dimensions in an 
iterative fashion, with data analysis being carried out continuously alongside data collection 
[161].  
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Identification of codes or themes in qualitative analysis can be either inductive (i.e., 
derived de novo from the available data) or deductive whereby codes are decided a priori with 
the help of available literature or expert knowledge. Whereas some methods- such as 
grounded theory- would necessarily require all coding to be inductive, others such as thematic 
analysis are more flexible and can accommodate both types of coding systems. 
 Framework analysis falls under the broad umbrella of thematic analysis in qualitative 
research. Its hallmark is the ‘matrix output’ which consists of cases and codes organised in 
rows and columns respectively [167]. Such organisation of data facilitates ‘constant 
comparison’, an iterative process that allows the researcher to compare data across as well as 
within cases in order to develop codes, conceptualise subject matter of the interviews and to 
understand the relationship between various codes/ categories [168]. Framework method can 
accommodate both inductive and deductive approaches to coding and is not wedded to a 
particular theoretical or philosophical approach to qualitative analysis [167]. Such flexibility 
is important in order that participants can express their views on topics that the interviewer 
may not have originally anticipated, but may be important to the research topic.    
 In this study, framework analysis was employed and data were distributed into 
themes which were derived both de novo (inductive) and a priori (deductive). 
5.2.4 Comparison with quantitative studies 
On the surface, qualitative research can be perceived as vastly different from quantitative 
research. The ‘laxity’ around recruitment and lack of structure during interviews, may appear 
lacking in rigor and probity. However, this is not the case. As with any research, the value of 
outputs from qualitative research will depend upon the appropriateness of the data being 
collected to the questions being asked [157]. The advantage of purposive sampling for 
interviews is that it allows for wider exploration of particular aspects that have been identified 
during the research. This can, to some extent, avoid selection bias that arises from using a 
convenient sample for research [157].  
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Both qualitative and quantitative methods, therefore, are important in academic research 
and carry their own advantages and disadvantages. Indeed, they can be used in combination to 
provide a wealth of data, especially in hitherto unexplored areas [155]. For example, an 
analysis of a national registry of individuals with food related anaphylaxis revealed a higher 
risk amongst adolescents [169]. The reasons for such an increase were then explored using a 
qualitative study which showed that some adolescents with food allergy do not perceive their 
allergy as a significant problem and that at least in some cases such an attitude stemmed from 
a lack of memory of their original allergic reaction [170]. Such information can be useful in 
creating targeted educational campaigns. 
The data obtained from the current qualitative study will be used to develop attributes for a 
Discrete Choice Experiment (discussed in Chapter 6) which aims to understand and rank the 
preferences of parents for allergy services within the WM region.  
5.3 METHODS 
5.3.1 Centres and participant selection 
This study included parents of children who were seen at two specialist allergy clinics 
within the WM region namely, the Royal Shrewsbury Hospital in Shropshire (semi-rural 
location) and the Heartlands Hospital in Birmingham (an urban location). These centres were 
chosen since they are geographically sufficiently separated (see Appendix Figure 1.A) to 
prevent overlap of services and experiences. In addition, both these centres are secondary 
referral units for allergy and thus parents attending these would have had experienced primary 
and secondary care services for their child’s allergy. 
Royal Shrewsbury Hospital 
 The Royal Shrewsbury and Telford Hospitals NHS Trust are the main providers of 
acute medical care for about half a million people in the North Western region of WM. The 
Paediatric allergy clinic is staffed by two experienced clinical nurse specialists who have had 
post graduate specialist training in allergy. The service is outpatient based and clinics are 
carried out at both Shrewsbury and Telford sites.  
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 The service provides clinical assessment, diagnostic testing, challenge testing for 
children with suspected (or confirmed) allergies. There is also access to a dietician with 
specialist interest in allergy and the opportunity to refer patients to other related specialisms 
(e.g. dermatology, ENT, ophthalmology, gastroenterology) where appropriate. There is a 
visiting allergy consultant who assists twice a year to help out with the most complicated 
patients. There are no facilities for desensitisation treatment for children and Adult allergy 
services are not offered at this centre. 
Birmingham Heartlands Hospital 
 The Heart of England NHS Foundation Trust based in Birmingham is one of the 
largest Hospital Trusts in England. It includes Birmingham Heartlands Hospital, Solihull 
Hospital and Community Services, Good Hope Hospital and Birmingham Chest Clinic and 
serves around 1.2 million people in and around Birmingham. 
 Paediatric allergy clinics are manned by two experienced, trained paediatric nurse 
specialists and a consultant paediatric immunologist. Outpatient services are offered for 
paediatric allergy at Birmingham Heartlands hospital, Solihull hospital and the Birmingham 
chest clinic, including clinical assessment and diagnostic testing with challenge testing for 
children with suspected (or confirmed) allergies weekly. There is also access to a dietician 
with specialist interest in allergy and the opportunity to refer patients to other related 
specialisms (e.g. dermatology, gastroenterology, respiratory, ENT, ophthalmology) where 
appropriate. Additionally there is provision for desensitisation treatment to grass pollen and 
facilities exist for transition to adult allergy clinics for older children. 
Participants 
 Parents aged at least 18 years or over with children aged between 0-16 years were 
included. The children should have a confirmed diagnosis of allergy or allergic disease. 
Parents aged less than 18 years of age, and those unable to provide informed consent or 
unable to understand or converse in English were excluded. 
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 This study was given ethical approval by the Newcastle and Northtyneside1 National 
Research Ethics Committee (NRES) [Application number: 14/NE/1060] and was sponsored 
by the University of Birmingham. It also received approval from the Research and 
Development units of the respective hospitals. It was accepted as a portfolio study by the 
NIHR Clinical Research Network (UKCRN ID 16953). The approval document is included in 
the appendix (5.A). 
 Participants were recruited from these clinics opportunistically. Sampling was 
purposive- participants were chosen in order that a broad range of allergic conditions, as well 
as patient age group were represented [157]. 
 The study was carried out in two phases; 6 interviews were carried out in phase 1 
(between Sep 2014 and Dec 2014) and 12 interviews were carried out in phase 2 (between Jan 
2016 and Jun 2016) to accommodate parental leave taken by the researcher (LD). There were 
no notable changes to either of these services during this period. No additional staff were 
recruited, nor did any staff member leave during this period. 
 Parents were invited by the clinical staff in either of the two recruiting centres to take 
part in the study. They were provided with verbal information regarding the study and with an 
information sheet (Appendix 5.B). If they were interested in taking part in the study, they 
were advised to sign a consent form (Appendix 5.C) and to also complete a demographic 
information form which included questions regarding age of participant, age of the child, 
allergies, contact details etc. (See Appendix 5.D). The interviewer (LD) contacted the parents 
by telephone to further explain the study, to confirm the consent and to arrange for a suitable 
time and place to carry out the interview. Parents could choose between telephone or face-to-
face interviews as per their preference. 
 Two interim analyses were carried out during the project (Dec 2014 and then in Apr 
2016) to choose characteristics of further participants and to amend the interview guide in 
order to include emerging themes and also to capture a wider range of experiences within the 
study.  
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 Participants were informed that they could withdraw from the study before, during or 
after data collection. Recruitment was continued until no new themes emerged from further 
interviews i.e., until inductive thematic saturation was achieved [159]. 
5.3.2 Interviews 
Interview guide 
Interviews were semi structured and were carried out using an interview guide (Appendix 
5.E). The guide was developed by the principal researcher (LD) based on her clinical 
experience and in consultation with PhD supervisor (Dr Carole Cummins), paediatric 
consultant colleagues (Dr Scott Hackett at Heartlands Hospital and Dr Martyn Rees at Royal 
Shrewsbury Hospital), and colleagues within the Institute of Applied Health Research at 
University of Birmingham. 
The topic guide covered a range of issues which were felt to be important in order to 
understand the experiences of parents whilst accessing primary and secondary care services 
for their child’s allergy. Questions relating to initial symptoms of allergy, experiences with 
primary care, issues with access to GPs (if any), referral to secondary care, experiences with 
emergency services (if applicable), experiences with secondary care, suggestions for service 
improvement (if any) were included.  
Following the interim analyses, modifications were made to the interview guide in order to 
explore emerging themes (e.g. issues with labelling, costs etc. for children with food allergies, 
effect of allergy on the child/ family). 
Interviews and transcription 
 Interviews were carried out either face-to-face or over the telephone as per the 
participants’ preference. Interviews lasted between 30-75 minutes and all interviews were 
carried out by the principal investigator (LD).  
 Interviews were audio recorded with the parent’s consent and were transcribed 
verbatim by an external transcription company approved by the University of Birmingham. A 
comprehensive confidentiality agreement was provided by the company which was 
  5. Qualitative study 
95 
 
considered appropriate for the study. Each transcript was checked for accuracy against the 
audio files by LD. 
5.3.3 Analysis 
 Data in this study were analysed using the Framework method as described by Gale 
et al [167].  
 Given that the study was aimed at understanding experiences of parents with primary 
and secondary care services in the WM region, certain codes were deduced based on study 
objectives (e.g. preferences for clinician seen in secondary care, access issues with primary 
and secondary care) whereas others (e.g. effect of allergy on child/ parent/ family; activities 
affected by allergies such as shopping/socialising/eating out; being taken seriously by 
physicians) were derived from the data. 
 Recruitment was continued until it was felt that no new themes were emerging from 
further interviews. The transcripts were analysed using the NVivo 11 software. Transcripts 
were read and re-read before classification into broad themes. These were then reviewed in 
order that the codes could be further refined and a relationship between various themes could 
be deciphered. Some transcripts were coded independently by other researchers within the 
health economics unit (Drs Louise Jackson and Hareth Al-Janabi) and discussed in order to 
ensure consistency in coding.  
5.4 RESULTS 
A total of 18 parents were interviewed, 11 were recruited from the Royal Shrewsbury 
Hospital and 7 from the Birmingham Heartlands Hospital.  Most parents were aged between 
26-40 years (see Table 5-1) and almost all (17/18) were mothers. The ages of children ranged 
between 7 months and 16 years and a wide range of allergies and related diagnoses were 
covered as shown. 
12 interviews were carried out over the telephone and 6 were conducted in the home of the 
interviewee (as per the preference of the interviewee).  
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Table 5-1: Details of the interviewees 
No ID Interview* Parent age  Child 
age 
Allergy 
1 P 01 Direct 26-40 yrs 1-5 yr Eczema, nut 
2 P 03 Direct 26-40 yrs <1 yr egg 
3 P 06 Direct 26-40 yrs 1-5 yr Milk, soya 
4 P 07 Telephone 26-40 yrs 1-5 yr eczema, asthma 
5 P 08 Direct 26-40 yrs 1-5 yr Plum 
6 P 09 Direct 26-40 yrs <1 yr Multiple food intolerances 
7 P 11 Telephone 26-40 yrs 1-5 yr Eczema, milk intolerance 
8 P 12 Telephone 26-40 yrs 1-5 yr Nut allergy;  
9 P 13 Telephone 26-40 yrs 5-10 yr Egg, peanut allergy 
10 P 14 Telephone 41-55 yrs 1-5 yr Peanut, baked beans, egg 
11 P 15 Telephone 41-55 yrs 14 yr Peanut and macademia 
12 P 16 Telephone 41-55 yrs < 1 yr Milk, egg and wheat  
13 P 17 Telephone 26-40 yrs 1-5 yr Peanut 
14 P 18 Telephone 41-55 yrs 10-15 yr sesame 
15 P 19 Direct 26-40 yrs 1-5 yr Egg 
16 P 20 Telephone 41-55 yrs 10-15yr Peanut, cat, dog 
17 P 21 Telephone 41-55 yrs >15 yr Hay fever 
18 P 22 Telephone 41-55 yrs 10-15 yr Dairy, egg, sesame, nuts 
*Direct refers to a face-to-face interview 
Detailed analysis of the interview transcripts resulted in the identification of the following 
themes. 
1. Initial symptoms of allergy 
2. Previous experience with allergy 
3. Experiences related to allergy services 
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5.4.1 Theme 1: Initial symptoms of allergy 
 There was a wide variety in the presentation of allergy amongst children whose parents 
were interviewed for this study. Symptoms were sometimes very typical of allergy and 
parents found it easy to link the symptoms with a trigger.  
"So when she was about seven to eight months old, I gave her some scrambled egg. She ate 
the egg, to begin with, and then about five minutes later she started to struggle to breathe and 
she started to go very red." [P13; 6 yr old with egg and peanut allergy] 
“...he must have been about two-ish and had a piece of bread that had a few sesame seeds 
on the, the crust and just had a reaction with hives around the mouth and sort of itchiness and 
that kind of thing, which was then later confirmed with skin prick tests in hospital.” [P18; 11 
yr old with sesame allergy] 
In some instances, although children had fairly severe symptoms over a long period of 
time, it was difficult to obtain a diagnosis, much to the parent’s distress. 
“Every single bottle he had, we had projectile vomiting, diarrhoea.  He was never settled 
in between his bottles.  He would scream throughout the feed. We’d had him physically 
arching and screaming and clenching with his stomach. It was frightening ...”  [P6; one year 
old with milk allergy]  
5.4.2 Theme 2: Previous experience with allergy 
Allergy often manifests quite unexpectedly and can be very distressing at presentation. 
This is especially true when parents feel at a loss to explain the sudden deterioration in their 
child's health, since this adds a lot of uncertainty into their daily lives. Some parents had 
already, however, had some experience with allergy, usually since other family members had 
experienced similar symptoms. This sometimes gave them extra confidence in diagnosing and 
managing their own child's allergies. 
"… my dad is a hay fever sufferer, my sister has hay fever and is asthmatic and so, being 
familiar with it in the family, [I] sort of picked up on it as soon as she sort of started with the 
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same thing, ....each sort of summer it would re-appear so, you know, we were fairly sorted 
that it was hayfever …" [P21; 16 yr old with hay fever] 
"having had an older son with food allergies and suffering with allergies myself, I kind of 
knew ...[what to do]" [P18; 11 yr old with sesame allergy] 
"...it helped that my husband had got eczema as well because he knows how to recognise 
when there’s flares going on, he knows when to kind of step in when there’s a reaction 
happening and give antihistamines and things like that,  so that was good." [P1; 5 yr old with 
eczema, egg and peanut allergy] 
Others specifically were worried because of lack of such experience: 
"because I don’t know anybody with an allergy, well, nor does my husband.  It is all very 
new territory, so it’s a bit like nerve-racking I guess and we’re worried about her obviously" 
[P17; 3 yr old with peanut allergy] 
The reasons for developing allergies were speculated upon. Some parents were anxious 
about their children directly inheriting allergies given that there were other members within 
the family with these problems. This caused them to access healthcare for clarification, 
although no specific allergy symptoms were manifested by the child. 
"..he hasn’t had  a reaction to nuts because as far as I’m aware I’ve never exposed him to 
nuts, because my husband’s allergic to nuts we don’t really have nuts in the house.  And 
because I’d kind of, wasn’t 100% sure whether my husband could have passed it on to him...."  
[P7; 3 1/2 yr old with eczema and asthma] 
Parents with allergies and related conditions assume responsibility and feel guilty when 
their children do manifest the symptoms. 
"I think my husband was just particularly disappointed because he knew what it was like to 
live with it and probably felt a bit guilty that he’d passed that on to [our son]"[P1; 5 yr old 
with eczema, egg and peanut allergy] 
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5.4.3 Theme 3: Experiences relating to allergy services 
 Since all the parents included in our study were already reviewed in the specialist 
clinic, they all had experienced primary and secondary care services for allergy in the region.  
We asked them questions specifically aimed at ascertaining their opinions and experiences 
with these services. 
Analysis of the data revealed 6 sub themes directly related to allergy services. These 
included: 
i. Being taken seriously 
ii. Receiving timely and  appropriate health care 
iii. Clinician seen in hospital 
iv. Support with allergy management 
v. Issues with information 
vi. Suggestions for improvement 
Each of these sub themes are discussed in detail below. 
i.  Being taken seriously 
Parents whose children had allergies valued having a mutually respectful relationship with 
their doctor- especially their General Practitioner, who was usually their first contact with the 
health care system. They felt thoroughly distressed when they perceived the attitude of the 
doctor as dismissive. 
"..I think he was about eight weeks old when I first went to the doctor and just got fobbed 
off left, right and centre because he hadn’t got a rash....  " [P6; one year old with milk 
allergy] 
".. in the early weeks,  it was just being put down to, ‘Maybe you’ve got a milk imbalance 
or something,’ and nothing was really taken seriously." [P9; 8 month old with multiple food 
intolerances] 
  5. Qualitative study 
100 
 
"I don’t really feel like my GP has been part of this journey .. in fact, the first GP I saw 
sort of tried to downplay everything..." [P14; 5 yr old with peanut, beans and egg allergy] 
On occasion, parents felt that poor advice from their doctor could have harmed their child.  
“.. he [the GP] said, with regards to whether it was nuts or not, he wasn’t sure but if we 
wanted to, we could try it again -which was a bit of ropey advice - but we actually did and it 
did come up again badly, so we avoided any nuts in the house.” [P17; 3 yr old with peanut 
allergy] 
“the lady doctor that I saw said ‘oh, no, she needs to have at least four or five episodes 
[before we refer]’ …. but because she[the child] was so bad, I didn’t wanna run the risk of 
giving it to her just for her to have another episode so we could say ‘yes, it’s definitely egg or 
not it’s not egg’ so I just cut out egg.” [P19; 20 month old with egg allergy] 
Such experiences meant that the parents felt the need to look for alternate avenues for 
better advice or management of their child. Sometimes this involved seeing different GPs 
within the same practice, even if this meant waiting a few extra weeks.  
“…I suppose if I want to be diplomatic about it, there are GPs that I would prefer to see as 
opposed to one or two others.  Some are quite dismissive. " [P11; 2 yr old with eczema and 
milk intolerance] 
"... because the Doctor I wanted to see that, he was one of the children’s Doctors, you 
know, she’s seen right from being little, I normally have to wait, maybe 3, 4 weeks but that’s 
because I want a specific Doctor ..because that’s who [the child] been seeing all along." 
[P21; 16 yr old with hay fever] 
This was also sometimes true of secondary care services. On occasion, when parents were 
reviewed in a specialist clinic, they came away confused and feeling that the condition and 
tests have not been fully explained. This caused a feeling of anxiety and frustration. 
“Yeah, so we went in for these tests and they said, ‘Yes, he’s allergic to nuts probably.   
Bye, bye and good luck.  Hope you work it out.  I hope he doesn’t die from a nut, you know, 
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thing’. That, that’s, that’s kind of how I felt. Not – they weren’t like that but.. overall nothing 
was explained terribly well.” [P14; 5 yr old with peanut, beans and egg allergy] 
Sometimes, the parents felt that there was a disconnect between their anxiety for their 
child and the attitude of the physician towards the condition. This could sometimes be 
reassuring, but did cause frustration on other occasions. 
 “I guess it kind of felt like it wasn’t a big deal because he[the specialist] sees it every day; 
whereas, obviously we’re like worried parents..” [P17; 3 yr old with peanut allergy] 
“I’d come out sometimes and I’d be so frustrated because I felt like, ‘You weren’t 
listening’.  They [the GPs] just wouldn’t listen to me.  It was as if – you know, ‘You’re just an 
overreacting mom’.” [P6; one year old with milk allergy] 
Parents greatly valued having doctors acknowledge their 'gut instincts' with regards to the 
wellbeing of their children.  
"finally the one lady doctor I insisted on seeing at her surgery said, ‘Well, yes.  I’ve got 
medical qualifications but where your child’s concerned, you’re the expert’, which I finally 
thought, ‘Well, yeah.  I do know him’ and I know – like I say, I know feeding patterns and I 
know normal" [P6; one year old with milk allergy] 
 “He [the GP] just said, if ever you reach the point where it’s interfering with life or that 
there’s too much going on...., come back because I can always refer her, and we can just get 
it sorted out once and for all.” [P21; 16 yr old with hay fever] 
When the parents felt 'listened to' and that their GPs were sympathetic, they were generally 
accepting of the treatment and management plans, even if they were not always convinced 
about their efficacy. 
".. I didn’t feel at any point that when I went it was like, oh it’s not you again.  Because at 
one point, I did go quite often. I’d say definitely with the E45 I thought, because that’s the 
first one I got, I thought well that’s not eczema cream, but I can’t really fault them for trying 
the different creams.”  [P7; 3 1/2 yr old with eczema and asthma] 
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"..... yeah, [the GPs] are helpful. They’re trying to find the different creams and all the rest 
of it, but I think it’s quite an inexact science in terms of what creams will not react with the 
child and all the rest of it." [P13; 6 yr old with egg and peanut allergy] 
Parents seemed to suggest that doctors who were more confident with allergy management 
were easier to talk to and tended to manage their children appropriately.  
"And our GP was very good actually and was able to prescribe pro-topics rather than 
steroids and manage him that way. She was very supportive and made the initial referral". 
[P1; 5 yr old with eczema and nut allergy] 
“I said, ‘Do you think I need to be referred?’ Because it’s easy to avoid plum… 
and he said, ‘Well, I think you ought to be referred to see if he’s allergic to any other stoned 
fruit, so that you’re not avoiding it for the rest of his life, when he could actually eat it’.” [P8; 
4 yr old with plum allergy] 
In contrast, parents were very critical of doctors who would not acknowledge their lack of 
knowledge with regards to managing their child. 
“I think a lot of doctors tend to think that they know everything and [they] don’t really 
know how to deal with situations where they don’t have all the knowledge  and I don’t know 
whether that’s because they feel that there’s an expectation from their patients that they 
should know everything.  I think with the first GP I saw, there was some degree of making it 
up as they went along.” [P14; 5 yr old with peanut, beans and egg allergy] 
Parents sometimes felt that their child as an individual was perhaps disadvantaged due to 
the clinician's insistence on following set management protocols.  This caused frustration and 
a feeling of helplessness, which one parent described as ‘bullying’. 
“[The specialist] wouldn’t write a letter explaining [my son’s] allergies until they made 
him have a food challenge which infuriated me because he’s been in several times with a 
reaction to milk ….  So I had to take him in to witness them – rub milk on, his lips, watch him 
go into reaction and I’m there thinking, ‘Why the hell have you had to do that to my son, just 
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to write a letter saying, ‘Yeah, he’s got a dairy allergy?’ So in that way, I did feel bullied by 
the Clinic sometimes” [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
ii. Receiving timely and  appropriate health care 
  As with any other medical condition, accessing appropriate healthcare in order to get 
timely and competent advice is a priority for parents who suspected that their children had 
allergy. They hope to have fairly easy access to emergency services when their child has a 
severe reaction, to their general practitioner when they need the child reviewed and a referral 
to an appropriate specialist when the condition appears complex and an expert opinion is 
warranted.  
 In most instances, those who need to engage the help of emergency services felt that 
these were useful. The 111 service was useful to some parents who needed emergency advice. 
“I thought 111 was helpful, like the woman I spoke to there she was really nice and sort of 
calmed me down and, ‘cos I was quite panicked, and her advice was good in the sense that 
she sent me to the GP quickly.” [P3; 10 month old with egg allergy]  
In some circumstances, although it would have perhaps been more appropriate to contact 
999 services, the 111 service was helpful in the management of the child in an acute 
emergency. 
“so we phoned 111, and went through all of the sort of protocol there of went to the first 
person, the second person and then the third, and while we were on the phone, and she [the 
child]was just like completely lifeless and they said, ‘Give her the EpiPen now’ but 
despatched an ambulance already, so my husband administered it in her leg, and then we 
waited for the ambulance to arrive, and by the time they got there –she was actually alright..” 
[P17; 3 yr old with peanut allergy] 
Some experiences were quite traumatic, with parents caught completely unaware by the 
reaction. 
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“..his face started to swell pretty immediately and his voice went, and we had to sit on the 
car park floor and I gave him his EpiPen and had to shout to somebody to try and phone an 
ambulance.  Well, they all think you’re a bit mad, don’t they?  So nobody – they were just 
walking past. Eventually, somebody did phone and we had a Fast Response Unit. So that was 
a very severe reaction.” [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
Overall, experiences with emergency services were positive. All the parents who accessed 
these services for their child’s allergy felt that they were effectively and efficiently looked 
after and then referred to the allergy services as appropriate. 
 Experiences with accessing GP services were more variable. Some parents found that 
GPs made special provisions for children and therefore accessing appointments was quite 
straightforward. Others found that getting a same day appointment with their GP can be very 
difficult and stressful.  
“if you need an urgent appointment, they’ll normally ask you a few questions. ‘What’s it 
relating to?’ type of thing. But you can normally get in within a week”. [P8; 4 yr old with 
plum allergy] 
“Sometimes you can [make an urgent appointment], sometimes you can't.  It all depends 
on what the problem is.  I mean, the receptionist will sometimes say they’ll get a doctor to call 
you back, and the doctor will say ‘oh, no, she needs to be seen today, bring her up’ or ‘no, 
that can wait till tomorrow, bring her up tomorrow’.  And you can always speak to a nurse if 
you don’t wanna wait.  The nurse will always speak to you, so…  So in that respect it’s, it’s 
okay.” [P19; 20 month old with egg allergy] 
“… trying to get an appointment with them was like near on impossible unless you were 
prepared to kind of go to their sit and wait surgery which is a bit difficult to do if you've got 
other children with you” [P12; 6 yr old with peanut allergy]  
“you have to phone at 8 o’clock in the morning and then they’re busy and then by the time 
you get through, all the appointments are gone and then they say to you, ‘Is it an emergency?’ 
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and you have to tell the secretary what the symptoms are and then they tell the doctor and 
then the doctor will say, ‘That doesn’t sound like an emergency’.”  [P16; 7 month old with 
milk and egg intolerance] 
“– it can sometimes take half-an-hour of phoning to actually get an appointment in the 
first place, just because when the surgery opens at 8.30 in the morning.  But pretty much for 
any problem –it’s almost like a bit of a lottery.  You try and phone to get through and it’s – I 
think the switchboard just gets overloaded and it’ll just come up with the engaged tone.  It’s 
not unusual for me to then look at my phone – because I keep hitting recall, recall, recall, and 
I’ve actually tried to call about 120 times.  And that’s no exaggeration.”  [P11; 2 yr old with 
eczema and milk intolerance] 
In some instances, although parents were able to access services, they were dissatisfied 
with the consultation. 
“There were a couple of times when I realised who the GP was going to be and my heart 
sank a little bit, just because I knew that I was gonna be straight in and straight out.  I mean 
at times we’ve been in there for 20 or 30 seconds before, ‘Oh that’s not a problem...see you.’  
It was that kind of thing.  It’s no good and you just kinda think, ‘Well, somebody’s just trying 
to sort of get through the patients here probably because he’s been overbooked or whatever 
else.’  Do you see what I mean?” [P11; 2 yr old with eczema and milk intolerance] 
“– you’re very rushed in appointments as well and I don’t think you get time to explain 
fully what it is that you’re trying to get across” [P6; one year old with milk allergy] 
Some General Practitioners were recognised by parents as having a special interest in 
allergies or related specialities (e.g. dermatology), which gave them a lot of confidence in GPs 
ability to manage their children. Parents were very appreciative of the care they obtained from 
these GPs and sometimes preferred them over clinicians in secondary care. 
“.. the GP had a specialist interest in kind of dermatology and .. so she was very helpful 
with eczema support… I think she’d done all she could, and then it was actually she 
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[who]advised that we looked at getting some allergy testing done so made the referral to the 
[allergy] clinic.” [P1; 5 yr old with eczema and nut allergy] 
“I think the one guy who used to run it when O* was little was – he was something to do 
with the Eczema Campaign.    So when it came to the skin, I was, I was happy to go.  As long 
as the GP has some kind of specialist knowledge about the allergy, then that’s fine.” [P22; 15 
yr old with dairy, sesame, nut and egg allergy] 
“I’ve never felt that the treatment has been poor from the GPs at all, in fact more recently, 
we were prescribed him an emollient which was fantastic, which was relatively new on the 
market.  So it’s always been a positive experience when I go to the GPs.  They’re  fantastic.” 
[P18; 11 yr old with sesame allergy] 
Referrals to specialists in the NHS are possible only via the General Practitioners or 
through the Emergency department within the hospital. The process was quite straightforward 
for a few parents. 
“I saw a GP and explained everything that had happened and she…yeah, just referred us 
straight on.” [P3; 10 month old with egg allergy] 
“[We] saw the GP or the nurse practitioner, I can't remember now, but they referred me 
and a few weeks after that we went to see [the specialist nurse]. … they've been very, very 
good.  I can't fault them at all.” [P15; 14 yr old with peanut and macademia allergy] 
Securing a referral, however, was a stressful process for some parents. They describe their 
frustration since their child was not being adequately managed in primary care and yet they 
faced problems with being referred to a specialist. Parents sometimes had to be quite 
determined and, occasionally, well planned to secure a referral. 
“I’d sat and refused to leave until I had a referral.  I said, ‘I don’t want to discuss it 
anymore.  I want him referred’ because a friend of mine actually told me you can – they can’t 
refuse to refer you.  So, I said, ‘I’m not leaving now until he gets the referral’.” [P6; one year 
old with milk allergy] 
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“I kind of planned my attack [for a referral].  I was prepared to go in and say, ‘Well, I’m 
not leaving until I get a referral to whatever’, but I chose my doctor carefully.  So I 
specifically made an appointment with one of the female doctors at my surgery; She took a 
look at him and by the time I’d walked out, I didn’t just have a referral; I had an 
appointment.” [P14; 5 yr old with peanut, beans and egg allergy] 
Once a specialist referral was made, most parents expected to wait a few days before being 
able to actually consult a specialist for the first time. Most NHS hospitals, as per the directive 
from the department of health, try to ensure that waiting time for first specialist appointment 
is no more than 18 weeks. While some parents were accepting of this, others were not happy 
about the wait. 
“Yeah it [the wait] was a while, but I think on the letter it kind of said within 18 weeks or 
something, they try to get an appointment so it was within the time and it wasn’t something 
that I was desperately [worried about], so I was fine with that.” [P8; 4 yr old with plum 
allergy] 
“..had it have been something that was recurring frequently I would’ve been a bit 
disappointed at the wait time, but I think because I’d already made the decision to cut egg out 
it was just one of those things.” [P19; 20 month old with egg allergy] 
“The appointment letter came through pretty quick, it came through within about three 
weeks, but when you opened the letter all of a sudden we had to wait another three months to 
be seen.  That was very frustrating.” [P11; 2 yr old with eczema and milk intolerance] 
“I had a quite frustrating experience trying to ring the service, being bounced around from 
one secretary to another, and then being told that it was the practices fault because they’d 
used the wrong fax number or something which was a bit frustrating.  It was a bit frustrating 
that some of the back office basics were letting down the service in terms of getting in.” [P1; 5 
yr old with eczema and nut allergy] 
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Overall, most parents were happy with the care they obtained in specialist centres. They 
found the consultations thorough and the clinicians very personable. The clinics were 
described as efficient and effective.  
"...‘thorough’ was a word that definitely came into my head when I was with her [the 
specialist nurse]..." [P14; 5 yr old with peanut, beans and egg allergy] 
"... the food allergy service has always been extremely thorough and supportive." [P18; 11 
yr old with sesame allergy] 
"It was brilliant.  The, the staff there were fantastic.  We arrived, we were seen at our 
appointment time at the Outpatients." [P19; 20 month old with egg allergy] 
However, some parents had less than satisfactory experiences with secondary centres. This 
was especially true in the case of a parent who was seen by a general paediatrician at a 
secondary care hospital prior to being referred to an allergy specialist. 
"I wasn’t overly satisfied.  On a personal level, the people there were very nice but in 
terms of the service, no - not overly satisfied really." [P14; 5 yr old with peanut, beans and 
egg allergy] 
The reaction to follow-up care was mixed. While some found them useful, others were 
critical. They questioned the usefulness of short consultations and also the organisation of 
follow-up clinics.  
"[the follow up] was very useful because up until a couple of weeks back [my daughter] 
wouldn't entertain eating a nut.  So now she is eating other nuts, and she is absolutely fine.  
[The specialist nurses] at the hospital, you know, they were the catalyst to push her to do that. 
So from that point of view, it has been very useful" [P15; 14 yr old with peanut and 
macademia allergy] 
".. we only really get about ten minutes in the appointment and .. so it's not kind of an in-
depth appointment really, it just I feel like there should be a little bit more ;.. it's the worry of 
knowing that the reaction is so severe, that anaphylactic shock that's really scary to me so I 
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feel like having a ten minute appointment once a year isn't really enough." [P12; 6 yr old with 
peanut allergy] 
"When we go to Clinic now, we’ll go and see [the nurse] and they’ll then do a skin prick 
test which just seems to get worse every time and then there’s not really anything else they 
can do, is there?  So you go in and you do get to a point where you think, ‘We know he’s still 
allergic.  ...They just do the skin prick test,– the size of the reaction seems to get bigger and 
then they’ll just go, ‘Carry on avoiding’" [P22; 15 yr old with dairy, sesame, nut and egg 
allergy] 
iii. Clinician seen in hospital 
In both of the secondary care centres chosen for recruitment in this study, most of the 
consultations are carried out by specialist nurses trained in allergy. A majority of the parents 
that were interviewed were unaware of this and had, in fact, presumed that they had been seen 
by a doctor (although they were actually reviewed by the specialist nurse).  
"I thought she [the specialist nurse] was a doctor." [P6; one year old with milk allergy] 
and [P3; 10 month old with egg allergy] 
 A few parents had been seen the specialist nurses over a few years and had developed 
a good relationship with them over time. They trusted their experience, knowledge and 
competence and were happy with the current clinic set-up. 
".. I think she’s probably had more specialist training in that area than some of the doctors 
have.  She very experienced and I trust her one hundred per cent." [P20; 10 yr old with 
peanut, cat and dog allergy] 
Some suggested that nurses are more approachable than doctors and hence the 
consultations tended to be more informal whilst still being effective.  
"It’s almost a bit more laid back – or maybe it seems more informal; in which case, it’s 
easy to, you know – I find it very easy to explain to [the nurse] the difficulty that I have being 
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a parent of boys with food allergies and I think they also feel like they can tell her things as 
well." [P18; 11 yr old with sesame allergy] 
Some parents felt that specialist nurses were perhaps better informed than doctors since 
they are focused on a specific disease area whereas doctors may not have a lot of in-depth 
knowledge in the field. 
"I’ve got much more faith, at the moment, in nurses than I have with doctors. I just think 
they don’t seem to look down their noses as, ‘I’m a GP.  I know everything.  You know 
nothing’ which is how I’d been treated for so long.  They [Nurses] are not under as much 
pressure and the minute I walked in, I thought, ‘No, they are purely here for him [my son]’.  
You know,– it wasn’t like a conveyor belt; if you’ve got a ten minute appointment, on you go.  
It was however long it took was fine and we were the last ones of the day, so it didn’t matter 
how long it took." [P6; one year old with milk allergy] 
"To be honest, I think sometimes a specialist nurse knows more than a doctor that is with 
too many areas. And, and I think because they, they know more about specific things, if you 
wanted to ask, about research or things like that, I think they, Nurse Specialist would know 
more than the paediatrician would." [P9; 8 month old with multiple food intolerances] 
"to be honest with you, they tell you at the beginning so initially, I was a bit surprised to 
begin with but when she then started talking about everything that she’d been doing - I just 
felt confident that she was the right person to deal with it [the allergies]. So she just seemed 
really on the ball, to be honest, so it didn’t worry me." [P17; 3 yr old with peanut allergy] 
Whilst most parents did not express a preference for being seen by doctors in the specialist 
clinics, some felt that there should be a doctor available as 'back-up' in case of complex 
conditions where the nurse may be overwhelmed. 
"So I think, [with] a more sort of knowledgeable, nursing type individual, -we would 
actually feel quite good about that.    So as long as all the mechanism’s there to say okay, 
well, in the first instance there’s a specialist nurse to talk to but if there’s still a possibility…, 
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like a backup, there’s a way of referring back to a consultant again. I think that’s potentially 
something that can work quite well." [P11; 2 yr old with eczema and milk intolerance] 
"I think it's always nice to see a consultant and have more tests and what have you [if the 
child was having more reactions].  If it's an ongoing daily battle then I think the more help 
you have the better you're advised, really, aren't you?" [P15; 14 yr old with peanut and 
macademia allergy] 
However, a few parents explicitly preferred seeing a doctor and were disappointed when 
this was not possible. 
".. we didn’t see the consultant, which I must admit is what I’d expected, given that the GP 
had referred us... But I guess while we’ve seen the nurses and not the consultant there’s 
perhaps that nagging doubt that if we’d seen the consultant would the advice have been 
slightly different." [P1; 5 yr old with eczema and nut allergy] 
iv. Support with allergy management 
Parents were generally pleased with the care they got from hospitals. Often, the allergy 
clinics put them in touch with other services such as dermatology or dietetic services so that 
the parents can be given adequate advice regarding management of their children. Sometimes, 
such referrals take a long time to materialise and this can cause enormous distress to parents. 
This is especially true when the child has been quite unwell – parents may be left without any 
support or information during the period between initial assessment at the hospital and the 
follow up appointment. 
“It was all fuss, fuss, fuss, big, big, big problems in a hospital bed for weeks with all these 
tubes and things and then it was like, ‘Off you go and see what happens’.  It just – I just don’t 
understand.” [P16; 7 month old with milk and egg intolerance] 
Sometimes, it was not possible to obtain co-ordinated care between various specialists, 
even when this was perhaps warranted. 
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“..he has an eye condition – they call it Giant Capillary Conjunctivitis which is another 
allergy condition... but I mean the Allergy Clinic doesn’t deal with that kind of allergy.  It 
would only deal with food allergies, so .. for his eyes, he was under another consultant.. So 
[the ophthalmologist] -all he could do is just say, ‘We’re going to deal with what’s put in 
front of us’.  Whereas obviously, there’s something there that’s triggering this off ….  It was 
an allergy, so – but he didn’t understand allergies” [P22; 15 yr old with dairy, sesame, nut 
and egg allergy] 
Children who have suffered serious reactions as well as their parents appear to manifest a 
lot of anxiety and isolation that is perhaps not being directly addressed by the healthcare 
system. 
"..that asthma [attack] then stopped him – he had to stop all sort of sporty activity for 
about a month because he was struggling to get his breath  and then, after that, he struggled 
to get back into anything sporty and now, he doesn’t – he’s not into sport whatsoever.  So it 
did [have] a big knock-on effect to his life.  Whether it like scares him, I don’t know but – he 
stopped his cubs, he stopped his gym, he stopped his trampolining."  [P22; 15 yr old with 
dairy, sesame, nut and egg allergy] 
Some parents try to ‘get on with it’, whilst acknowledging the stress associated with 
managing allergies in their child. 
“… actually having children with food allergies is really stressful, but you get on with it, 
don’t you?  Because you have to. And you don’t realise just the impact it has until they’ve 
grown out of it and all of a sudden, you think, ‘Oh, phew!  Thank goodness’.” [P18; 11 yr old 
with sesame allergy] 
Some parents feel that such stress should be more openly acknowledged and managed by 
the clinicians. 
“Is [counselling] offered to children and parents that have had that life-threatening ordeal 
which is terrifying?!  Is that ever followed up?  Does anyone ever actually follow them up and 
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give them a phone call and say ‘would you like someone to talk to’?” [P20; 10 yr old with 
peanut, cat and dog allergy] 
 
v. Issues with information 
As with any other childhood condition, parents greatly valued reliable information 
regarding their child’s allergies. Information was generally obtained from the clinicians, 
through peer groups or from the internet. Clinics were sometimes able to provide information 
that parents found very useful. 
“… they did have a Nutritionist who then told me these things, that were available on the 
market, which I would never have known about and .. a lot of things we then got on 
prescription,– I mean we were wheat free as well.” [P22; 15 yr old with dairy, sesame, nut 
and egg allergy] 
“Since seeing [the specialist nurse], I came home with a cookery book and we’ve made 
him chocolate cake that the whole family ate.” [P6; one yr old with milk allergy] 
“She [the specialist nurse] was really good, gave us a lot of information and explained 
what to do and, she suggested that we try her with very well cooked egg, because she [the 
child] had had it before, and we were both pleased..” [P3; 10 month old with egg allergy] 
However, some parents had a period between seeing their GP (or A&E) and being seen by 
the specialist when they experienced an information hiatus.  
“.. we didn’t leave the GPs or the hospital (A&E) with anything other than sort of what 
we’d been told verbally, which was quite limited really.” [P3; 10 month old with egg allergy] 
Most parents obtained information from peers (fellow parents) by having informal 
conversations with them. This provided them with practical tips and also a sense of ‘not being 
alone’. 
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“I have a good friend whose son is very allergic to milk and eggs and I spoke to her and 
she said, ‘Oh, maybe he’s allergic to milk as well’.  So I then rubbed a bit of milk on his arm 
and sure enough, he came up in hives” [P18; 11 yr old with sesame allergy] 
“I go to a group, a little meet up with other mums who are also weaning and trying 
different diets but you compare notes, you know.  I run into people here and there and have 
conversations about it.” [P16; 7 month old with milk and egg intolerance] 
Lack of such support can lead to a feeling of isolation and increased anxiety. 
“… primarily, I was the only one [with this problem].  I only knew that other mum for a 
short time and then she moved away I was the only one whose child was going through this, 
so [having a local parent support group] might have been quite a good idea.” [P14; 5 yr old 
with peanut, beans and egg allergy] 
Many parents also used the internet to obtain information regarding allergies. Accessing 
peer groups on the internet was particularly popular (e.g. mumsnet, netmums) as these seemed 
to provided emotional as well as practical support to most of the mothers interviewed. The 
accessibility and anonymity of these forums as well as the empathy that these scenarios 
generated from other users was particularly comforting to our interviewees. 
“NetMums is a great one because it’s one of them you can put the daftest question 
regarding a child that if you think it’s stupid and there’s always a mum that somebody’s been 
through it and, you know, they can give you advice…”[P6; 1 yr old with milk allergy] 
“… I’ve gone on Facebook and I’ve joined [a group] for people .. that have got children 
with allergies and I’ve found that quite helpful, that people put things on like ‘ooh, I’ve just 
found out this contains egg’ or ‘I’ve just found this product and this doesn’t contain egg and 
my daughter loves it’ and so I’ve found that really helpful.” [P19; 20 month old with egg 
allergy] 
Whilst parents appreciated the support provided by internet, most also expressed some 
reservations about relying solely on such information. They recognised that the information 
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obtained was not always accurate and can sometimes be misleading. Parents do prefer 
obtaining information from reliable websites (eg. NHS direct). However, some found these 
inadequate and disappointing. 
“Sometimes (my husband) will say, ‘oh no! Don’t look on the internet’ because you know I 
can be a bit of a, oh my God this sounds like he has this or that or the other” [P7; 3 1/2 yr old 
with eczema and asthma] 
“To be honest there’s more advice outside the NHS website– at least in my experience -
when it comes to allergies and things like that.  I mean generally the NHS website is brilliant, 
especially for general sort of issues on kids and things.  They do give you a very unbiased – a 
well-balanced bit of advice.  But when it came to allergies and intolerances it was next to 
useless really.” [P11; 2 yr old with eczema and milk intolerance] 
vi. Suggestions for improvement 
Parents generally appreciated the services that they received. Some were very happy with 
the pathway overall and did not envisage the need for improvements. 
“… if everything continues the way that it’s gone, then that’s spot on.” [P17; 3 yr old with 
peanut allergy] 
 However, most parents felt that there was room for improvement. Access to GPs, referral 
practices, secondary care appointments (including follow ups) could be better. Information 
provision could also be improved and follow up visits could be made more informative. 
Parents were critical of the premises used by one centre (Birmingham Heartlands Hospital) 
for their clinic. 
“ It’s a very nice building but it’s just not fit for purpose. I mean it’s convenient to get to 
but they haven’t got any parking. It’s a very tight set of doors – it’s very old buildings.  The 
first thing you’re greeted with is a set of stairs and then some very small tight doors and then 
another set of stairs.  We had to struggle up the stairs.  We had to carry the pushchair up the 
stairs.” [P11; 2 yr old with eczema and milk intolerance] 
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 Some parents felt that knowledge base of GPs with regards to allergies should improve, 
especially because of their role as gate keepers into the system. 
“…better equipped GPs, in terms of that sort of first response; having a bit more advice to 
give knowledge wise, and a stronger mechanism there to sort of refer onto specialists.” [P11; 
2 yr old with eczema and milk intolerance] 
Access to secondary care (in terms of obtaining referrals) and also the inflexibility of 
appointments were also sticking points for some parents. 
“our experience was that wasn’t great in terms of the route; we didn’t have any control 
over the appointment as family, we kind of got told this is the date you will go.  We didn’t 
have a lot of choice in terms of when the appointment was which I could see would be difficult 
for other families potentially in terms of access.” [P1; 5 yr old with eczema and nut allergy] 
“Before you even get to your appointment because there's quite a wait for your 
appointment at the allergy clinic, it would be useful to be given information from the GP so 
that you know what to expect and a bit about what to avoid in the meantime and things like 
that..” [P12; 6 yr old with peanut allergy] 
“… the waiting times for the appointments should not be so long, because we’ve  been 
waiting months for the appointment.” [P9; 8 month old with multiple food intolerances] 
Parents also felt that there needs to a facility that acknowledges and addresses the anxiety 
that is brought on by allergies. Some felt that the psychological trauma brought on by 
allergies is often ignored. 
“One of the best things that they could do is give [the parents] somebody that they can 
speak to without feeling they were taking up their time. Their sole purpose would be to [let 
you] unload your baggage on them.” [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
Another issue that was brought up was the lack of adult allergy clinics for grown up 
children, especially in Shrewsbury region. 
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“I mean especially now [my son] is older, I don’t even know where we go.  We haven’t got 
anywhere to go.  There’s no Adult Allergy Clinic” [P22; 15 yr old with dairy, sesame, nut and 
egg allergy] 
“It's just a shame it'll all finish in the next 18 months.  That's a real shame because they're 
still youngsters and teenagers can get complacent and it's good to have that reminder and 
that check-up, you know.” [P15; 14 yr old with peanut and macademia allergy] 
5.4.4 Theme 4: Effect of allergy on daily living 
Effect on the family 
 A diagnosis of allergy in a child has implications for the life style of all the members 
within the family. One of the issues that parents found difficult was the fact that it was 
sometimes difficult to convince family members about the seriousness of a condition when 
the child looked quite well otherwise.  
"My nan, she’s 92.  She said, ‘Allergies?  Never had allergies in my day’." [P6; one yr old 
with milk allergy] 
“I mean they’re not worried like I am.  I think it’s slightly different being a parent. I’m 
probably more worried than I should be rationally.  They don’t seem to have that sort of fear 
factor ..” [P18; 11 yr old with sesame allergy] 
"my father-in-law loves nuts and he eats them all the time and when he’s eating nuts, I'm 
wiping around after him – ‘What have you touched?’  He’s like, ‘Don’t worry about it.  She’ll 
be fine’ – this, that and the other" [P17; 3 yr old with peanut allergy] 
In most cases, siblings- even those who are quite young themselves, assumed a lot of 
responsibility to ensure that children with allergy were safe.  
"I mean, the girls are very, very aware of his allergies.  It’s like my little, littlest one had a 
bowl of chocolate cereal and she dropped it and she went, ‘Oh mummy, pick T up quick while 
I get them all’.  So, they know not to feed him. They check everything.  They know not to sit 
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there and give him something.  If you ask them why, they’ll say, ‘Because it makes him very 
sick'." [P6; one yr old with milk allergy] 
Relationships with friends and family 
Allergy in children can cause a lot of anxiety within families. Children who seem 
otherwise well can become very ill within a few minutes if exposed to substances that they are 
allergic to. This anxiety is especially pronounced when children have food allergies and when 
they are at risk of life threatening reactions such as anaphylaxis. Parents are often worried 
about delegating the care of their child to others, including family. Sometimes elaborate 
arrangements have to be made to ensure that parents can leave their children in someone 
else’s care for a few hours.  
"I’ve written a really long -probably too long- kind of list of everything that she’s allowed 
to have and not have and what she likes and I – you know, prepare all the food the night 
before and it’s very pedantic, isn’t it?    To make sure, you know, that everything’s right for 
her." [P16; 7 month old with milk and egg intolerance] 
" Well, you know, most of my others, by the time they were a year old, they’d been and 
stayed at their auntie’s for the night but with him– I’m still quite anxious..." [P6; one year old 
with milk allergy] 
 The implications could extend beyond the safety of the child, in some cases. 
"my fiancé found it quite difficult because he’d never seen [my son] have a reaction, he 
just kind of didn’t believe the things that I said; It got to a point where, you know, we never 
had dairy in the house but he insisted on having it.  So that’s broke – that has helped break 
our relationship up ..." [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
Childcare arrangements  
Parents need to ensure that everyone who looks after their children is aware of the risks 
and management of symptoms, when they arise. 
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"He has had a couple of [episodes] where he’s been sick when he’s had, he’s eaten 
something it’s reacted that badly with hives but I think you know how to manage it, school 
know how to manage it and he goes to kind of an after school club as well.  So everybody 
knows, everybody’s got Piriton. Everybody knows if it’s really serious it’s 999, everyone’s got 
inhalers and things like that - so I think that side of it is quite well managed really." [P1; 5 yr 
old with eczema and nut allergy] 
" I had advised the child-minder of what had happened, and just said that I will obviously 
provide all her food but [she] just needs to be careful what [she is] giving her, really, and 
there’s certain biscuits that [the child] can have, there’s certain biscuits that she can't.." 
[P19; 20 month old with egg allergy] 
Schooling 
Parents were able to choose nurseries and child minders who were sympathetic to the 
health issues of the child and were able to accommodate these whilst providing care. 
However, in some instances, primary schools were found less accommodating. This caused a 
lot of stress and had significant implications for the child and the family. 
"I think I’ve noticed a big difference going from nursery to school, I think nursery perhaps 
had more time to put the cream on and do it for him.  I think at school there’s more of an 
emphasis on [the child] doing it himself, which he’s sometimes a bit reluctant to do" [P1; 5 yr 
old with eczema and nut allergy] 
"We didn’t have difficulties until we started to try and get him into Primary School and 
then you found that people were not that forthcoming or happy to change anything in order 
for him to be included in all the activities. Yeah, we ended up picking a school that wasn’t 
even in our catchment area because they were the ones who were, you know, more than 
willing to [take care of him]" [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
Some schools are, however, very supportive and ensure that appropriate steps are taken to 
keep the child safe. This is, obviously, very reassuring for the parents. 
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"And the school, the, the school she's at is very, very thorough about it.  They've got a nut-
free policy at school.  And if they have cake sales everything has to be labelled correctly and, 
you know, they are very, very good because - and I think there's another girl in her class 
who's allergic to all nuts so they are super, super careful" [P15; 14 yr old with peanut and 
macademia allergy] 
Self management 
As the children themselves grew older, they start to take responsibility for the condition 
and shoulder the burden of management. Parents were cautiously happy about this since it is 
quite difficult to maintain control over the children's life and diet as they grow up. 
"She’s very good, she just sort of gets on with it really and you know, she’s, if she’s going 
to a friend’s house who’s got a cat and a dog, she’ll just either have had anti-histamine 
before she goes or has you know, things with her to deal with it, yeah a little bit like me really, 
it’s just sort of, it’s just part of life and you just get on with it."  [P21; 16 yr old with hay 
fever] 
“He’ll go into town, he’ll manage – he knows what he can eat – I mean, it’s a lot easier 
now than it ever used to be, believe me.  I think he’s man enough now to say, ‘Can you swap 
the chopping board’ and he’ll always have a bite and check  that he doesn’t get a tingle and 
then he’ll go ahead and eat it" [P22; 15 yr old with dairy, sesame, nut and egg allergy] 
"Yeah he's really good I mean he's more vigilant than most adults because if he's not sure 
about something he won't have it, I think he's scared himself really, he doesn’t want to have to 
use the epipen because he knows it's a needle." [P12; 6 yr old with peanut allergy] 
Nevertheless, delegating the entire responsibility of allergy on to the child can be very 
stressful for the parents, even if the child is 'old enough' to take care of themselves. Parents 
find themselves torn between the need to keep their child safe, but also to avoid cosseting 
them and impair their growth into confident adults. 
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"Well, he hasn’t been away without me so far.  He’s always got me in tow but I mean for 
holidays but there’ll come a point where he goes, you know, with friends . I mean he is very 
sensible and grown up but there are always times, aren’t there, when we make mistakes or 
we’re just not sure?  So it’s that independence but it’s like anything, isn’t it? I suppose all 
parents worry about their children making their way into the world because there’s all sorts 
of things that potentially could happen.  This is just one of many, isn’t it?" [P18; 11 yr old 
with sesame allergy] 
"She's got to lead her life and I can't wrap her up in cotton wool.  You know, they go on 
school trips.  So she's, she's got to take a bit of responsibility for herself and she is, she is very 
good at that and she knows if she's not sure she won't, she won't eat it, whatever's in 
question." [P15; 14 yr old with peanut and macademia allergy] 
Social aspects 
Allergy affects other aspects of a family's life. Eating out as a family can become a 
difficult task, which many parents choose to avoid.  
"... when you go to a restaurant, she loves like spaghetti bolognaise and macaroni cheese 
and that sort of stuff which you always find on a children’s menu, and when you ask them if it 
contains egg ‘Ooh, we don’t know; we buy it in packets’.  So she obviously can't have that but 
then if my son wants spaghetti bolognaise and she can't have it then that poses a problem 
because she can't have pasta ..." [P19; 20 month old with egg allergy] 
Social events such as birthdays, family gatherings could get stressful. 
"[Sometimes] you can see other people thinking, ‘Well, just because he’s got an allergy, it 
doesn’t mean that the others should miss out,’ type of thing." [P8; 4 yr old with plum allergy] 
"if it's someone's birthday or something he generally can't have the birthday cake ...It does 
bother him a little bit because I mean like if there's a chocolate birthday cake he's like 'oh I 
can never have chocolate birthday cake' so I think that upsets him.." [P12; 6 yr old with 
peanut allergy] 




Other activities, such as shopping, that are normally routine (and perhaps mundane) for 
most families become very difficult for some of these parents. They found that 'quick trips ' to 
the shops were not easy and picking things 'off the shelves' for their children can be unsafe.  
"when I could tell that he wasn’t having dairy, it took...ooh, about an hour to pick up six or 
seven jars of baby food because I had to read every one of them and the security guard 
started to follow me round the store because I’m picking up, looking and putting everything 
back.  So, I sort of turned around and explained to him and I thought, ‘This is just the first of 
many’" [P6; one yr old with milk allergy] 
"But it was a case of reading the labels, being an avid label reader.  Your shopping took a 
bit longer because you had to read the fine print and pay attention, you know, rather than just 
throwing it in the trolley." [P20; 10 yr old with peanut, cat and dog allergy] 
“I’m quite fastidious now.  Anything that we buy that’s new, I read the label, and read the 
label, and the read the label again.” [P18; 11 yr old with sesame allergy] 
Parents find the different labels such as 'may contain', ' packaged/ manufactured in a 
factory with', 'traces of' etc quite confusing. While some avoid products with any mention of 
the allergens, others choose to avoid only those products that explictly state that the allergen 
is present. There was no clear understanding of what the different labels meant and what 
could be avoided to keep the child safe. 
“if it says, 'May contain peanuts,' or, 'traces of peanuts or macadamia nuts,' then I don't 
buy it.  If it says, 'It may contain traces of nuts,' generally I do buy it because everything says 
that.” [P15; 14 yr old with peanut and macademia allergy] 
“some of them do say ‘made in a factory that uses egg products’, so I tend to stay away 
from that ; but it’s just when it says on the side ‘may contain egg’.  You know, one tin might 
and one tin might not?  It’s, that’s what I find a bit confusing.” [P19; 20 month old with egg 
allergy] 
  5. Qualitative study 
123 
 
“Yeah a lot of it is hard because you don't know if it's just the company trying to cover 
their back or is it genuine user risk... you're not sure.” [P12; 6 yr old with peanut allergy] 
Cost 
Unlike gluten free diet for coeliac disease sufferers, 'free-from' foods for allergies cannot 
be obtained on prescriptions. Hence in some instances- especially dairy allergy- allergies had 
a significant impact on household finances. 
“I mean the cost of soya milk alone is a lot higher.  But you don’t eat just to sustain 
yourself, we’ve got taste buds and we eat to enjoy our food as well, so there’s an aesthetic 
element to it as well.  But it’s not just that; it’s the fact that you’ve got to double up on 
everything that you buy then as well.  So again when we were making pizzas and things like 
that, buying extra pizza bases that didn’t have any dairy products in them or any tomato or 
any of that kind of thing.”  [P11; 2 yr old with eczema and milk intolerance] 
“... it’s an expensive range.  It’s silly what you pay, you know, for non-dairy food and it’s 
– there’s more children that are coming up with allergies.  It’s not fair.”  [P6; one yr old with 
milk allergy] 
5.5 DISCUSSION 
5.5.1 Principal findings 
This study shows that parents experience significant barriers in accessing primary and 
secondary care allergy services for their children. Access to primary care was difficult in 
some cases, with others reporting a worsening over time. Many parents found getting same 
day appointments with GPs very difficult and given that they were anxious regarding their 
child's health, they describe helplessness and frustration in their inability to access timely 
medical advice.  Referrals to secondary care were also identified as being a problem, in some 
cases the parents had to wait many months and resort to extraordinary practices (e.g. refusing 
to leave the GP surgery) before referrals could be made. Experiences with secondary care 
were generally positive, although the long waiting times and the quality of follow up 
appointments were criticised by some parents.  
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Parents described a variety of presenting symptoms of allergy in their child. These varied 
from mild rash to a serious anaphylactic episode. In some instances, the diagnosis was quite 
apparent at the outset whereas in other cases, the culprit agent was difficult to identify and 
took repeated physician appointments. Where there was some family history or other 
experience with allergies, parents found themselves a little more confident about managing 
these in their children.   
In any case, what parents appeared to value highly in the management of allergies was the 
acknowledgement from others, specifically physicians, that they are indeed justified in their 
concerns for their child's health. Even in situations where the physician was not able to offer  
a diagnosis, parents greatly appreciated being listened to and taken seriously.  As a 
consequence, they expected to be referred to a specialist if the GP is unable to help. Referral 
practices, however, are quite variable all across the region. The reasons for this are not fully 
understood, but studies suggest that income deprivation, sex and age may influence referral 
rates for certain conditions[171]. Even when referrals have been made, the waiting time to see 
a specialist in allergy is usually quite long. Depending upon the seriousness of the allergy and 
the severity of ongoing symptoms, whereas some parents were upset about the waiting time, 
others were more tolerant.  
 Access to reliable and appropriate information was an issue which many parents found 
wanting. Many do try to access online information, but are wary about reliability of most 
websites. Many of the mothers interviewed found peer support websites (such as netmums, 
mumsnet) very useful, mainly for the advice but partly for the empathy that they get from the 
other users. A few were unhappy about the lack of information from reliable sources (such as 
the NHS information website) regarding allergies. Although there are some good websites 
offering advice on allergies (RCPCH, Allergy UK, anaphylaxis campaign)- these are clearly 
not well publicised and GPs ,and consequently parents, remain unaware of their existence. 
Improving GP knowledge of these websites is relatively easy and can provide considerable 
dividends in the management of these children. 
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In general, parents rely heavily on others such as family members, child minders, nursery 
staff, school personnel to help them look after their children. When children have allergies, 
particularly food allergies, parents find it stressful to delegate childcare to others. This is often 
because children, who otherwise look well, can become seriously unwell if exposed to the 
culprit agents or foods. Parents are worried that others may not take the allergies as seriously 
as they should and may subject their children to unnecessary risks. Easily accessible, reliable 
information may be helpful in providing families with some support in this regard. 
Shopping for 'free from' foods and problems with labelling of food substances can 
seriously blight the quality of life of these families. Parents are unable to just ' pick foods off 
the shelves’ and have to spend a lot of time reading through small print on the labels. Whilst 
parents have welcomed the recent improvements in labelling across the UK [172], shopping 
continues to be difficult - sometimes compounded by the additional cost of allergen free foods 
and their impact on the family budget. Apps such as food maestro® can also be helpful and 
could be offered to parents/ patients with food allergy [173]. 
The range of narratives in this study was broad and depended, to some extent, on the 
geographical area of residence, the age of the child, pre-existing allergy knowledge of the 
parents (if any), the nature of the child’s allergy symptoms. These could be considered as 
‘fixed factors’ in service delivery - attributes that cannot be altered. However, parents did 
allude to other issues that were directly related to the quality of service received. These 
included poor access to GP services, poor knowledge of GPs with regards to allergy, issue 
with procuring referrals to secondary care, prolonged waiting periods to see a specialist even 
after a referral has been made, poor information access, need for psychological support in 
some cases and lack of transition to adult allergy services in some areas. Any plans for service 
re-organisation and service improvements in allergy within the WM area should, therefore, 
take into account these factors in order to be effective.  
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5.5.2 Strengths and limitations of this study 
This is the first in-depth study into parent experiences with allergy services in the UK. We 
interviewed parents attending two specialist allergy centres within the WM which allowed us 
to capture a range of experiences, since these parents had accessed both primary and 
secondary care services for their children. The specialist clinics were geographically distant 
(about 50 miles apart) and therefore there was no overlap of services (in terms of GP practices 
and supporting services such as dieticians). 
The sample size for this study is much smaller than that of quantitative studies. This is, 
however, not a limitation as such and is in keeping with other published qualitative research. 
The depth of information obtained from this study cannot be obtained from a quantitative 
study (e.g. a questionnaire study) using a large patient sample.  
One of the limitations of this study could be the limited number of children with specific 
allergies (see table 1). Interviewing more parents of children with milder allergies (such as 
hayfever) as well as those with serious allergies (e.g. with history of anaphylaxis) could give 
us further information regarding the differences in experiences in these scenarios. However, 
the purpose of these interviews was not to evaluate the service pathways for specific allergies 
but to understand parent experiences with general NHS paediatric allergy services in the WM 
and hence an unselected population was preferred.  
Almost all of the children included in this study were reviewed by specialist nurses. 
Although the experiences in specialist clinic were mainly positive, it is possible that there may 
have been variations in experiences if more parents had been seen by consultant allergists or 
immunologists. In addition, the experiences of parents attending clinics run by general 
paediatricians not formally trained in allergy which are likely to be important in the WM 
(since such clinics constitute a majority of secondary care provided in the region) were not 
explored in this study. 
Another potential limitation was the under-representation of fathers in our study. The 
recruitment process was modified after the interim analyses to attempt to recruit more fathers 
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but this was not possible. Although there may be differences in how parents perceive 
allergies[174] it is not clear whether interviewing more fathers could have changed the 
findings in this study. 
As with most other qualitative studies, the data obtained are valid only to the population 
surveyed (i.e. parents in the WM whose children suffer with allergies). The results are not 
generalisable to other areas in the UK or, indeed, to other countries. 
5.5.3 Strengths and limitations in relation to other studies 
A previous report into allergy services has reported anecdotes relating to service pathways 
in the UK. These were comments made by callers to a help-line rather than those related to in-
depth interviews. This is the first study to explore parent or patient experiences with allergy 
pathways. 
Other studies have been published which report children’s experiences relating to health 
care services in general [175]; pathways of care related to specific conditions such as diabetes 
[176], children with special health needs [177]; healthcare access for a selected group of 
people – e.g. Elders in rural West Virginia [178]. However, none of these studies have 
evaluated experiences related to complete service pathways (i.e., primary and secondary care, 
supporting services) for a particular condition.  
5.5.4 Plans for further research 
As previously discussed, attributes obtained from this study will form the basis for a 
quantitative study (a discrete choice experiment) which aims to understand parent preferences 
for paediatric allergy services in the WM region. 
Interviewees in this study were limited to those to attended specialist clinics run by 
personnel specifically trained in allergy. However, a majority of paediatric allergy services in 
the WM and other regions of the UK are provided by non-specialists (e.g. paediatricians or 
nurses not trained in allergy).Interviewing parents who attend non-specialist secondary care 
clinics can potentially add to the results of this study and will be considered in the future. 




Paediatric allergy services in the WM region are disparate. Parents experience difficulties 
in accessing primary and secondary care services and also obtaining timely and appropriate 
information regarding their child’s allergies. Whilst some GPs were described as competent 
and sympathetic, others were found to lack knowledge regarding allergies- causing parents a 
lot of distress. Experiences with secondary care were mostly positive although there were 
some issues with the usefulness of follow up clinics in some cases, lack of adult allergy 
clinics and also issues with referral to other specialists, where needed. Some of the 
participants felt that extra services such as counseling for parents whose children have severe 
allergies, better organisation of parent peer groups should be facilitated by the NHS. 
5.7 REFLECTION 
Although it would be preferable (in any research) to ensure that the researcher has no 
influence on the results, this is not possible in qualitative research. The issue, therefore, is 
what degree of researcher influence is acceptable – currently there is no consensus regarding 
this issue[179].  
In this study, the principal researcher (LD) was the interviewer and this could have 
influenced the conduct of the interviews, the analysis and the interpretation. The researcher 
was unlikely to have been completely objective given that she had many things in common 
with the interviewees (who were mostly working women with young children). In addition, 
LD is a clinician with expertise in allergies and her knowledge in this disease area would have 
definitely influenced this project. For example, it was difficult not to sound surprised when 
one of the parents suggested during the interview that her GP advised her to feed her child 
peanuts when the clinical history suggested that she was very likely to be allergic to them. 
The surprise in the interviewer’s tone may have modified the mother’s description of that 
event and perhaps changed the tone of the rest of the interview. 
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Whilst there may be no feasible method of avoiding such influences on the study, it is 
important for the influences to be made explicit in order that the results can be interpreted in 
the given unique context [180]. Overall, every effort has been made to ensure that the context 
in which the quotes are presented is a true reflection of the (interviewer’s interpretation of the) 
interviewee’s intent. 
Whereas it was important to understand what parents experienced in the WM when 
accessing allergy services for their children, more important for service planning would be to 
find out their preferences for these pathways. A quantitative survey of parents across the WM 
was therefore planned to understand what parents preferred while attending specialist services 
for allergy. The details of this study are explained in the next chapter.
   
 
 
6  PARENT PREFERENCES FOR SPECIALIST ALLERGY SERVICES IN 
THE WEST MIDLANDS 
In the previous chapter, a qualitative study aimed at understanding the experiences of 
parents accessing NHS allergy services for their children in the West Midlands (WM) region 
was discussed. Parents faced barriers accessing services and, on occasions, felt that they had 
received a sub optimal service. They also highlighted the impact their child's allergy on many 
aspects of daily living. The service pathways related issues raised by parents (See 5.4.3) were 
used to further plan a quantitative study known as a discrete choice experiment (DCE) aimed 
at understanding preferences of parents in the WM for specialist paediatric allergy services. 
After briefly introducing stated preference methods and choice experiments, this chapter will 
discuss the design of the study, pilot studies undertaken, details of analyses and results of the 
DCE followed by a discussion and conclusions.
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6.1.1 A few definitions 
Preferences 
The Oxford English dictionary defines preference as a 'greater liking for one alternative 
over another'. In economic terms, preference is the ordering of alternatives based on their 
relative utility, resulting in either hypothetical or real world choices [181].  
Utility 
 Utility in economics is a measurement of satisfaction or happiness obtained by consuming 
a given product or good [182]. Although the utility derived from goods is subjective and 
varies from a given individual to another, consumer choice theory dictates that all consumers 
necessarily act rationally and make decisions aimed at maximizing utility [182]. 
Opportunity costs 
This is defined as the benefit forgone by choosing to invest resources on the given good or 
service rather than the next best alternative [182]. For example, the opportunity cost of 
investing in a new car may be a family holiday. A ‘trade-off' is a similar concept and refers to 
giving up on a particular good or service in favour of another. 
6.2 BACKGROUND 
As the discussions on healthcare broaden and the public get more interested in their health 
services, the pitfalls of focusing exclusively on health related outcomes have become more 
apparent [183, 184]. Quality of life instruments such as the EQ-5D, it is argued, measure 
health benefits almost to the exclusion of all other outcomes [185, 186]. Yet there are data to 
suggest that non-health outcomes make a substantial difference to the health and well-being of 
individuals and their families. For example, providing advanced end of life planning 
improved mental health outcomes for families after the death of their loved ones [187]; 
distance from a hospital can have substantial impacts on families with children suffering 
chronic medical conditions [188]; negative staff attitude towards individuals abusing drugs 
can result in suboptimal care [189]. Nevertheless, none of these outcomes can be captured 
adequately with the use of generic quality of life instruments. Indeed, the emphasis on health 




related outcomes can narrow the focus of clinicians providing healthcare resulting in poor 
patient experience [190].   
Recently, there has been interest in considering broader patient views regarding health 
outcomes as well as health care related experiences [191]. Understanding patient preferences 
for health care can improve the efficacy and efficiency of health pathways. Shared decision 
making (SDM), an initiative championed by the UK government for better NHS care, aims to 
involve patients not only in decisions regarding their own health but also in commissioning 
and designing of healthcare [192].Such involvement has been shown to improve experiences 
with health pathways as well as outcomes for patients. In addition, SDM can help reduce 
variations in quality of services and thus contribute significantly to commissioning [192]. 
Indeed, the idea of involving  the public in health policy has been gaining momentum in the 
UK and elsewhere [193]. Studies have shown that the public want to be consulted about 
planning health services [194]. 
Allergy services in the UK, as discussed in Chapter 2, are inadequate and in need of 
improvement. There have been suggestions that preferences of local population should be 
considered in allergy service planning [3]. This will help improve public involvement in 
health services as well as increase accountability of commissioners and health care 
practitioners [191].There are various methods by which public involvement in service 
planning can be achieved. Preference elicitation is one such technique which is widely used 
[195].The methods used to understand preferences are rooted in economic theory and have 
been successfully used in areas such as transport, environment planning , market research as 
well as health [196]. Some of the preference elicitation methods are discussed below. 
6.2.1 Preference elicitation methods 
Eliciting individual preferences to inform health policy is firmly rooted in welfare 
economics [197]. Preference elicitation methods can be broadly classified into two types- 
those that elicit revealed preferences and those that capture stated preferences [198].  




 Revealed preferences [RP] can be understood by examining actual consumer 
behaviour in real-life market scenarios [199]. For example, a person weighs up various factors 
before choosing a particular shampoo from a supermarket shelf. These characteristics or 
‘attributes’ may include brand, cost, colour, advertising, smell or a host of other relevant 
features. By choosing a particular product or good from amongst a raft of similar products, the 
consumer has expressed or ‘revealed’ their preference. By studying the revealed preferences 
of individuals over a period, it will be possible to understand the attributes that dominate their 
choices [196]. 
Revealed preference [RP] data cannot be used for valuation of health care programs or 
pathways since open markets do not generally exist in the health sector [200, 201]. Another 
issue is that RP does not allow evaluation of services that the individuals have never faced 
[201]. Stated preference [SP] experiments (discussed below) are therefore preferred in the 
elicitation of health and health care related preference data [196]. 
SP experiments usually involve providing respondents with hypothetical alternatives 
which differ on the basis of certain characteristics or attributes [200]. The respondent is 
expected to choose an alternative that maximises her utility considering all attributes and by 
trading-off between them rationally. The choices they have made can be used to understand 
the value placed on individual attributes and the importance of one attribute relative to 
another [200, 202]. The biggest criticism of SP is that the preferences may not have any 
consequence beyond the hypothetical- i.e., the individual is not necessarily committed to the 
choice and may choose differently when faced with a real life situation [200]. However, the 
imbalance of information between the providers and consumers in the health care sector 
results in patterns of consumption that are not based solely on consumer preferences [201]. In 
addition, SP methods are uniquely suited to help understand preferences of individuals for 
goods and services  before investments can be made and are being used increasingly in health 
care. 




 There are various types of direct SP elicitation methods described in the literature. 
Broadly, SP methods fall into two categories based on the outputs generated,  those that elicit 
ordinal preferences and those in which the preferences are cardinal [200] (See Fig.6-1).  
 
 
Fig.6-1: Stated Preference Methods: Adapted from Ali S and Ronaldson S (2012) 
6.2.2 Cardinal methods of preference elicitation 
 Cardinal methods of preference elicitation are defined as those where the respondent 
expresses his/her utility numerically or quantitatively. Typically, these exercises can be used 
to elicit utilities for one health state or process at a time [200]. Examples include visual analog 
scores, standard gamble, time trade-off and contingent valuation methods.  
Visual analog scoring (VAS)  
VAS exercises involve scoring on a pre-determined scale by the respondent to indicate 
their preference for the given good. The scales may be numerical, categorical, vertical, 
horizontal (see Figure 6-2) or perhaps be a picture (e.g. visual thermometer as used in EQ-5D 




quality of life measure) [203]. Although limited in its scope, VAS is a popular preference 
elicitation tool since it is easy and quick to complete [195, 204]. One of its major drawbacks 
is that it does not involve trade-offs and VAS is, therefore, not a preferred method for utility 
elicitation [205]. 
 
Figure 6-2: An example of a visual analogue scoring chart for pain 
Standard gamble 
A Standard gamble (SG) technique allows individuals to gamble between a period of 
sudden death and perfect health rather than remain in a state of poor health [206]. A typical 
question, for example, would be: 
"Would you be willing to accept a 25% chance of sudden death and 75% chance of good 
vision instead of living with complete blindness for 10 years?" 
The probabilities of death and full health are then altered until the person becomes 
indifferent to the alternatives (see Figure 6-3 below). 
SG exercises are cognitively difficult, although good test-retest consistency has been 
reported [195]. SG assumes that all respondents are willing to trade risk of death, although in 
reality this may make some individuals very uncomfortable. Risk averse individuals can 
provide very little utility information regarding various health states in these exercises [207]. 





In the SG example shown, the subject is offered two alternatives. Alternative 1 would be to 
continue in the same health state as previously (e.g. Blindness) for a period of t years. 
Alternative 2 would give an option of living in full health for t years or facing the risk of 
sudden death. The probability (p) at which the person becomes indifferent to the two 
alternatives is considered the preference value for health state1. 
Figure 6-3:An example of a Standard gamble exercise  
Time trade- off 
 In a Time trade-off (TTO) exercise, the respondents are asked to quantify the amount of 
time they are willing to forego in order to move from a state of poor health to perfect health. 
(For instance, given 10 years in complete blindness, how many years of life would you be 
willing to forego in order to have good vision) [206]. This technique is considered easier to 
complete than other techniques (such as SG, see above) and is considered to have logical 
consistency and good test-retest reliability [208]. TTO method has been used in the valuation 
of UK general population tariffs for the EQ-5D [208]. 





In the TTO example shown above, the respondent can choose between living in health state 1 
for x years or living in full health for y years (where y <x). The value of y is varied until the 
respondent is indifferent between the two alternatives. The preference value is then estimated 
as x/y. 
Figure 6-4: An example of  a time trade-off exercise  
Contingent valuation 
Contingent valuation (CV) is a direct survey approach which uses a questionnaire (or 
interview) to create a realistic but  hypothetical market to understand the respondents 
willingness to pay [WTP] or willingness to accept [WTA] estimates for variations in a service 
(or good) [209]. The value estimates obtained in these studies are contingent on the 
hypothetical scenario presented to the respondents [210]. Questions can be formatted in an 
open-ended way e.g. "How much would you be willing to pay to see a doctor rather than a 
nurse at your local surgery?" However, such questions can be seen as leading and biased. For 
instance, the question above may be seen to assume that seeing a doctor is better than seeing a 
nurse. In addition, most individuals find it difficult to value non-market goods [210]. Valuing 
health services is especially difficult for individuals who benefit from publically funded 
health care systems [211]. 
A referendum CV, on the other hand, is designed such that respondents can either agree or 
disagree with a given statement. An example is shown below (Fig.6-5). 





Fig.6-5: An example of a referendum CV format for health care 
Although these exercises are simple to complete and can be undertaken with large 
numbers of individuals at a time, they have many important limitations in health valuation. 
Firstly, they can be used to weigh up only one attribute at a time. Secondly, WTP estimates 
are often found to correlate poorly to the magnitude of benefit, resulting in 'scope 
insensitivity' [212]. They may also vary considerably across surveys, limiting their 
importance as a marker of the strength of public opinion [213]. In addition, in countries such 
as the UK, where consumers do not commonly pay for their healthcare, WTP estimates may 
be blighted by 'protest voting' whereby respondents may refuse to engage meaningfully  in the 
exercise [210, 211]. 
Overall, one of the main criticisms of cardinal methods of preference elicitation is the 
restrictive design that allows respondents to consider only one particular characteristic or 
process at a time. That is, these techniques do not provide reliable information regarding the 
relative desirability of one good compared with another [213]. Choosing between different 
attributes allows respondents to consider opportunity costs and therefore provides a better 
understanding of strengths of preference for individual characteristics. This can be especially 
useful in planning new service pathways where several options exist. Estimating the strength 
of preference can be achieved using ordinal methods, some of which are described below. 
 
 




6.2.3 Ordinal methods of preference elicitation 
 In contrast to the cardinal methods, ordinal methods require respondents to order 
preferences without attempting to quantify their degree of preference for one alternative over 
the other [200]. Ordinal preference exercises are generally less cognitively challenging for 
respondents compared to techniques such as TTO and SG, which demand a very high degree 
of abstract reasoning [214]. However, it should be noted that responses in ordinal preference 
elicitation studies rely strongly on the respondent's understanding about individual 
conditions/characteristics included in the study and their willingness to trade-off between 
them [200]. 
Examples of ordinal methods include: 
Ranking exercises  
In this method, respondents may be provided with a set of alternatives and be asked to 
provide a complete ordering of the choices ranging from the best to the worst and the states 
in-between [215]. For example, respondents may be given details of different health states 
(such as total blindness, total deafness, major depression, rheumatoid arthritis and dementia) 
and then asked to rank them from most disabling to least disabling. 
Whilst ranking methods are easy to carry out and to complete, they only provide utility (or 
desirability) information regarding one condition relative to another [216].  Detailed 
information regarding preferences (e.g. which characteristic of a condition would make it 
more or less desirable than another?) cannot be provided by this method. 
Best-worst scaling (BWS) 
BWS is a type of ranking exercise where the respondent is requested to identify the best 
and the worst attributes amongst those provided [217]. An example is shown below (Fig 6-5). 





In the BWS example above, the respondents are asked to choose the most and least desirable 
attributes regarding a given service or good. 
Figure 6-6: An example of best-worst scaling exercise.  
BWS allows respondents to trade-off between choices at the attribute and level stage. 
Some researchers prefer BWS since they are cognitively less cumbersome compared to other 
stated preference methods and also allow respondents to weigh up all the attributes and levels 
against each other. However, BWS is a relatively new technique and more experience will be 
needed to fully understand its strengths and limitations [218].   
Ordered categorical responses 
 Using a defined set of response categories (such as excellent, good, fair and poor for 
example), respondents are asked to value the combination of attributes in a given choice set. 
For example, a ‘good’ clinic may have a moderate waiting time to see a consultant whereas an 
'excellent' clinic may have a short waiting time to see a consultant with dietician support 
within clinic [214]. Whilst this is also considered a cognitively easy task to complete, 
ordering of these data does not provide information regarding the strength of preference 
[198]. For example, the difference in strength of preference between excellent and good may 
be different from that between fair and poor. 
Choice experiments 
 Choice experiments involve asking respondents to choose between different bundles of 
attributes rather than rating or ranking them [196].These techniques force respondents to 
trade-off some characteristics in favour of others. Most of the choice methods were described 
under the umbrella of 'conjoint analysis (CA)' in the past. However, the theoretical 




underpinnings of CA are in psychology and not in economic theory [219]. CA is considered a 
descriptive method that attempts to fit a statistical model to a set of ranking or rating data 
[219]. Errors in CA are unexplainable and are considered to be ad hoc. This method does not 
allow for interpretation of changes to consumer behaviour in response to changes in choice 
[219].   
The other increasingly popular choice method is the Discrete choice experiment (DCE). 
DCEs require respondents to choose between two or more sets of hypothetical alternatives 
which are described by different levels of characteristics (or attributes). Typically in a DCE, 
at least one attribute of the alternative is varied across respondents systematically for every 
choice set. The responses are then used to understand the value placed by the respondents on 
the levels of each attribute (see In the DCE example shown above, respondents are expected 
to weigh up the levels of each attribute provided and to trade-off between them to choose one 
particular option. 
Figure 6-7) [220]. 
 DCEs have theoretical underpinnings in the random utility theory (RUT). Unlike conjoint 
analysis, unexplained factors affecting choice and utility (see [Equation 6-2]) are accounted 
for in a DCE.  Individuals are expected to trade a less favourable level of an attribute for a 
better version of another. In doing so, it is assumed they weigh up all the available 
information and then select the option that provides the highest utility value [221]. This 
allows the ranking of attributes against each other when setting priorities in health care [222] 
The origin of DCE is also strongly rooted in psychological theory. The technique has been 
successfully employed in market research, environmental economics, transport economics 
and, increasingly in the last decade, in health services related research [222]. DCEs have been 
shown to be methodologically robust, with good internal validity and consistency [201].  





In the DCE example shown above, respondents are expected to weigh up the levels of 
each attribute provided and to trade-off between them to choose one particular 
option. 
Figure 6-7: An example of a DCE.  
Allergy services in the UK, as previously discussed, fall considerably short of the demands 
placed on them. This is especially true of paediatric allergy services, given that there are very 
few paediatricians trained specifically in paediatrics as well as in allergy management [15]. 
While it has to be acknowledged that there is a shortage of trained doctors in allergy, a 
broader view of service delivery may be needed if viable solutions are to be developed to 
tackle this crisis. Although parents interviewed in the WM were happy to see either nurses or 
consultants in secondary care (as discussed in the previous chapter), little is known about 
public preferences regarding seeing consultants (versus nurse led clinics), allergy information 
provision, and support services in allergy. Many aspects of a respondent's preferences can be 
explored in a single, well designed DCE. A simple questionnaire regarding allergy services 
would fail to provide information regarding the strength of preferences of the respondents for 
individual attributes (for example, would they prefer seeing a consultant even if it means that 
they have to wait longer? Do they value the need for good information more than dietician 
input in clinic?). A DCE is best suited in these scenarios since respondents are expected to 
‘trade-off’ between different levels of the attributes by weighing up all the information and 
choosing a scenario that provides most utility [197].  




A DCE was therefore planned for this study. 
6.3 DISCRETE CHOICE EXPERIMENTS 
DCEs in health care allow the construction of choice experiments using hypothetical 
market data to suit the research question [223]. They evolved out of information integration 
and axiomatic conjoint measurement theories in psychology and random utility theory in 
economics [223].   
6.3.1 Theoretical underpinnings 
The random utility theory states that individuals make choices in order to maximise their 
utility [199]. Therefore, given a choice between option i and a option j, as per the random 
utility model, an individual n would choose i over j if and only if  
[Equation 6-1]   Uni > Unj                        Ɐ i≠ j 
where U refers to the utility associated with the given option. 
The Random Utility Model also states that an individual’s utility for a given alternative 
can be expressed as follows: 
[Equation 6-2]                        Uni = Vni + εni                                                                                                         
Where Vni represents the deterministic or measurable component of the overall utility, 
whereas εni represents the random or unobservable component [201]. The random component 
of choice could be due to observable or unobservable variables, unobserved individual 
characteristics (e.g. past experiences), measurement or specification errors.  
Combining [Equation 6-1] and [Equation 6-2], we can infer that option i can be chosen 
over option j only if 
[Equation 6-3]                         Vni + εni > Vnj + εnj                                                              
     Or  
[Equation 6-4]   Vni - Vnj >  εnj   - εni                                                               
Thus the probability of choosing option i over option j (Pni) can be represented as  




[Equation 6-5]   Pni = Pr (Vni - Vnj >  εnj   - εni) 
Since deterministic utility is most commonly estimated using a linear utility function, the 
utility associated with choice i as shown in [[Equation 6-2] can be represented as follows: 
[Equation 6-6]       Uni = α + β1x1n + β2x2n + .......+βixin + εni                      
where α is a constant and the betas (β) provide information about the strength of 
preference for each attribute x within the choice set [197]. 
6.3.2 Choosing attributes  
Various sources can be used to derive attributes for DCEs. These include expert review 
[224], literature search [225], informal discussions with selected stakeholders [226],  
discussions with service providers [227], existing policy/ professional recommendations 
[228], existing health outcome measures [229] and qualitative studies [230]. 
Interviews and focus group discussions not only allow for identification of a wide range of 
relevant attributes but also help define levels that apply to the particular population. Hence, 
the use of qualitative studies in planning discrete choice experiments has been favoured by a 
few opinion leaders in the field [198, 230, 231].However, given that the aim of qualitative 
studies (to obtain in-depth information) can be at odds with that of DCEs ( to ascertain 
preferences using very concise or targeted attributes) [230], there may be some difficulty in 
directly translating qualitative data into a form that suits choice experiments. On the whole, it 
is important to be explicit about the source of the attributes and the reasons why they were 
chosen [231]. 
For the purposes of the current DCE, attributes were derived mostly from the qualitative 
study discussed in the previous chapter. The choice of attributes is further explained in the 
methods section of this Chapter (See section 6.5.1). 
6.3.3 DCE design 
A full factorial design in a DCE is one that considers every possible alternative within the 
choice experiment. This is only practical for small studies with very few attributes and levels 




[232]. For most DCE studies, a fractional factorial design- which incorporates a selection of 
choice situations- is preferred. There are different types of fractional factorial designs; all of 
these are aimed at producing a practical number of datasets incorporating complex model 
specifications, where necessary [233]. Examples include orthogonal designs, D-efficient 
designs and D-optimal designs. All these designs provide attribute level balance (i.e., each 
level appears with equal frequency within an attribute) [232, 233], but vary in some 
significant aspects.  
Orthogonal designs, for instance, ensure that each pair of levels appears with equal 
frequency across all attributes, providing an additional balance within the survey [233]. When 
orthogonal designs are unavailable or are deemed too inflexible for the given data, D-efficient 
or D-optimal designs are employed [234]. These use a D-efficiency score or the D-score, 
which is an estimate of the optimality of the proposed  against a comparator design [233]. The 
higher the D-score, the better the model specification. D-score depends upon the coding 
scheme and model specification including attribute levels and interactions as well as Bayesian 
priors for the model coefficients specified in the design construction [233]. The model 
specifications strongly affect the design and the response efficiency of the model design and 
should therefore be carefully chosen when models using D-scores are specified [233]. 
Orthogonal designs are generally favoured since they are easy to construct and allow for 
independent estimation of the influence of each attribute on the choices of the respondents 
[232]. In addition, orthogonality minimises the variance of parameter estimates and ensures 
that the model does not suffer from multi-collinearity [232]. An additional advantage is that 
'blocks' can be used when the design requires many choice sets to be given to a single 
respondent. For example, when the orthogonal design contains 32 choices, these can be 
presented to 2 respondents in blocks of 16 each or to 4 respondents with 8 choice sets per 
block. However, each block is not orthogonal in itself and responses should be analysed in 
combination with the other blocks. 




 Other drawbacks of orthogonality are that it can result in implausible choice situations 
within the survey (e.g, severe illness may be combined with good mobility or vice-versa) or 
produce obviously dominant choices which yield little preference information [233]. In 
addition, orthogonal designs completely disregard relationships between attributes. They do 
not support subset analysis since it is not possible to maintain orthogonality in subsets [196, 
232]. Despite this, they are thought to be the most efficient and are the most commonly 
employed designs for DCE. 
In the current study, an orthogonal design without blocking was used in the pilot studies as 
well as in the final survey. 
6.3.4 DCE participants 
The results of choice experiments can vary based on the respondents chosen. For example, 
an exercise involving the public, doctors and NHS managers revealed considerable 
disagreement with regards to the ranking of services in the order of priority [215]. Whilst the 
public prioritised heart transplant operations and intensive care treatment for premature 
babies, doctors and managers gave more importance to antismoking education for 
children[215].Many DCEs in the past have surveyed patients [228, 235, 236] although more 
recently there has been a trend towards surveying taxpayers or public [224, 237]. Surveys of 
patients generally reveal strong preferences towards non-health outcomes or processes, 
whereas the public (or taxpayers) tend to prefer health focused attributes [238].  
There are other issues to consider while recruiting participants into DCEs- these exercises 
can be cognitively challenging and therefore, individuals with impaired cognition such as 
those with acute psychotic schizophrenia or dementia cannot be included in these studies 
[233]. DCEs require participants to have (or be able to acquire) a good understanding of the 
attributes and levels being described in order to be able to trade-off as expected. Hence the 
design of these questionnaires should be given ample thought, with sufficient information 
given to respondents regarding the attributes while ensuring that they do not lose interest. 
Multiple iterations and pilot studies are needed before design can be finalised  [223]. Since 




the explicit objective of DCEs is to be able to measure preferences beyond health [239], it is 
important that the study population be carefully chosen after considering the study objectives 
and the possible limitations (e.g. generalisability) [238]. For example, a study assessing 
preferences for breast cancer follow-up would recruit individuals who have been diagnosed 
with breast cancer [240] whereas preferences for GP access could be elicited from general 
population [237]. 
Since the current study aimed to understand parent preferences for paediatric allergy 
specialist services in the WM region, parents of children aged between 0 to 16 years residing 
in the region were recruited from the general population. 
6.3.5 Sample size 
There are no definite guidelines on how sample sizes can be estimated for choice 
experiments. Orme et al. proposed a 'rule of thumb' technique [241] to calculate the minimum 
sample size (N) for a DCE which can be expressed as 
 [Equation 6-7]                             𝑁 = 500 𝑚𝑎𝑥
(𝐿𝑘)
𝐽 𝑥 𝑇
                                                        
Where J is the number of alternatives per choice set, T is the number of choice tasks, Lk is 
the maximum number of levels per attribute k.  
However, published  DCE literature suggests that responses in healthcare surveys are more 
variable and heterogeneous [242] compared with  DCEs in other areas (such as transport or 
environment). Therefore larger sample sizes are needed. In addition, where blocking is used 
in surveys (see section 6.3.3), sample sizes need to increase accordingly.  
The statistical efficiency of a DCE can be improved by increasing the total number of 
responses either by increasing the number of choice sets per respondent or by increasing the 
sample size within the study [233]. Since the former can result in reduced response efficiency 
(due to respondent inattention or fatigue), increasing sample size is a preferred option for 
improving the predictive power of a DCE [233].   




Figure 6-8 shows the effect of simulated sample sizes from three separate healthcare DCEs 
on the estimate precision [233]. Researchers plotted the  mean precision estimates against 
different sample sizes for each of the datasets [243].  It is clear that although the studies had 
different mean precision estimates, there was a rapid increase in precision up to sample size of 
300 and further increases accrued very small increments in precision.  
A sample size between 300 and 500 was planned for this study in order to allow for 
statistical analysis within a minimum acceptable level of statistical precision (standard error 
<0.05). 
 
Figure 6-8: Effect of sample size on precision estimates of DCEs. This figure is taken 
from Johnson et al[233]. 
6.4 OBJECTIVES OF THE STUDY 
1. The main objective of this study was to ascertain the values placed by parents 
from the WM region on selected attributes relating to paediatric allergy specialist 
services.  
2. Other objectives included understanding how these preferences vary for: 
 Parents who have children with allergies 




 Parents who have an income of £43,000 or more per year 
(i.e., over the HMRC threshold for high income earners for 
England in 2016) 
 Parents who have experienced secondary care services for 
their children (in any disease area) 
6.5 METHODS 
6.5.1 Attribute development 
 The qualitative study that contributed to the development of attributes for the DCE is 
discussed in detail in Chapter 5. The themes directly relating to allergy service delivery are 
discussed in section 5.4.3. Since the overall aim of this work to provide recommendations for 
improving specialist services, four of the six attributes were chosen to be included in the 
DCE. The rationale for this choice as well as that of the levels of the attributes is shown in 
Table 6-1. Attribute development evolved as the pilot analyses were carried out and responses 
and suggestions were accrued. In addition to attributes from the qualitative study, an attribute 
related to out of pocket costs was included in the study in order to calculate the willingness to 
pay estimates from the responses. Although four different levels of costs were used in the 
pilot surveys, only three of these (£25,£50 and £100) were included in the final survey as 
discussed in Table 6-2 since respondents strongly rejected the £200 option during pilot 
surveys.  
6.5.2 Sample size 
  As per the Orme equation ([Equation 6-7]), given that this study had 2 alternatives 
per choice set, 18 choice tasks per individual and a maximum of 3 levels for attributes (see 
Table 6-1 and Section 6.5.3), the minimum sample size required was estimated to be 42 [500 
x (3/ 2x18) = 42]. 
However, in order to ensure statistical efficiency a greater sample size was deemed 
necessary. A minimum sample size of 300 was aimed for as discussed in 6.3.5 . 




Table 6-1: Attributes chosen for the DCE from the qualitative study 
Theme Reason for choosing (or omitting) 
attribute 
Levels Rationale for levels and notes 
Being taken 
seriously 
No.; Taking patients seriously (or not) 
is an attitude trait of doctors and 
therefore is not amenable to 
intervention.  
Not applicable Not applicable;  This theme was not deemed suitable 




Yes. Parents had mixed reactions 
about seeing nurses in clinic rather 




Nurse specialists are cheaper to train than 
consultants. They are generally well received 
although a few patients prefer to see a doctor. 
However, a significant proportion of paediatric 
allergy services in the UK (and WM) are provided by 
paediatric consultants who may or may not be 
formally trained in allergy. After discussion with 
colleagues and appraising literature, this level was 
added after pilot 2 to provide a more realistic option 
for service provision. 
Final survey 
Nurse specialist- allergy trained 
Consultant (not trained in allergy) 




Yes. Access to specialist care was 






The UK Department of Health stipulates that patients 
should wait no more than 18 weeks to see an NHS 
specialist after initial referral for a non-emergency 
appointment. The demand on allergy specialist 








services are high and waiting times below 8 weeks 
are currently unrealistic. These options remained the 




Yes. Parents often required additional 
services to help with the management 
of issues related to allergy (e.g. 
changes to diet if food allergy; 
dermatology input for eczema; 
psychologist input for children with 
anaphylaxis) 
Pilots 1-3 
No additional support 
Dietician only 
Dietician+eczema support 
Some specialist clinics offer dietician services within 
the same appointment. Others have good access to 
dermatology services. These were included in the 
survey given their importance to the management of 
allergies. However, after discussion with colleagues 
and reviewing responses from pilot surveys, it was 
felt that the access to additional services was a more 
important factor than the make-up of these services. 
This is especially true since the need for additional 
services can vary depending on the clinical needs of 
the child.  
Final survey 
No additional support 
Additional support available 
Issues with 
information 
Yes. Some parents complained of a 




Verbal information only 
Verbal+ Written information 
Parents mentioned the need for more information 
provision in clinics. A few parents felt that they 
received very little information and hence the 'no 
information' option was included in the pilot studies. 
However, based on feedback, it was decided to drop 
this option since it was felt to be unrealistic (since 
some information is imparted at any clinical 
appointment). Some parents in the qualitative study 
Final survey 
Improved NHS.net website 
Verbal information  
Detailed written information 





Table 6-2: Cost attributes used in the study 
 Attribute Levels Rationale 
Out of pocket costs Pilot 1 
None 
Cost attributes were not included in the initial pilot. However, after consulting literature and 
discussing with colleagues experienced in the use of DCEs in health care (such as Prof Ryan from 
Aberdeen) it was felt that cost attributes could be important to the study. Using monetary 
attributes within DCE helps understand the willingness to pay for the various attributes and levels. 
The levels were chosen arbitrarily, with the highest cost reflecting about half the estimated cost of 
a private specialist appointment. A higher rate (£200) was used in the pilot analysis, but 
respondents found the cost too high and were not able to trade this level off other attributes and 
levels, (i.e.) the choice set with £200 was not being chosen irrespective of the options given with 






mentioned the lack of information on trusted 
websites such as NHS.net. Others were happy to 
search the internet themselves for information 
although some were wary of this approach. Although 
this was initially not included, it was later added as 
per feedback from pilot studies. 




6.5.3 Choice of design 
 Within the final DCE there were 5 attributes; 4 with 3 levels each and 1 attribute with 
2 levels (see Table 6-3). Therefore a full factorial design (i.e., a design that incorporates all 
possible different choice situations) would have  to include [(3x3x3x3x2) x (3x3x3x3x2)= 
38x22] 26,244 combinations of choice sets. Clearly, this would neither be feasible nor 
practicable. An orthogonal design (see section 6.3.3) was specified using Ngene® software 
(see Appendix 6.A for details) which determined that a questionnaire containing minimum of 
18 choice sets would be needed for the final survey.   
Table 6-3: Attributes and levels used in the DCE (main study) 
Attribute Levels 
Clinician seen Nurse specialist- allergy trained 
Consultant- no allergy training 
Consultant- allergy trained 
Allergy information provided Improved NHS.net website 
Verbal information 
Detailed written information 
Additional support in clinic Additional support available 
No additional support  
Waiting time for clinic 8 weeks 
12 weeks 
18 weeks 
Out of pocket costs £25 
£50 
£100 
6.5.4 Developing the questionnaire 
 Multiple pilot surveys using volunteers from the University of Birmingham were 
carried out in order to optimise the survey questionnaire. The questionnaire had 3 sections as 
shown in Table 6-4.  
The initial surveys (Pilots 1, 2 and 3) were carried out using surveymonkey® software. 




Ngene® software (Version 1.1.2; ChoiceMetrics Ltd) was used to specify the design of the 
choice experiment . This survey employed an orthogonal design.  
Table 6-4: Layout of the DCE survey 
Section 1 Welcome and brief introduction to the survey 
Explanation about paediatric allergy services and a brief note regarding each 
attribute within the study 
Section 2 A brief explanation on how to answer the choice part of the questionnaire 
Choice sets 
Section 3 Demographic questionnaire 
Thank you 
Eligibility for amazon vouchers (pilot 4 and main population survey only) 
6.5.5 Ethics approval 
Pilot surveys 1,2 and 3 were aimed at questionnaire development and included only 
colleagues. Hence these did not warrant ethics approval. Ethics approval was obtained from 
the University of Birmingham for the interim population survey (pilot 4) and for the final 
survey (reference: ERN_16-1181). The approval letter is included in the appendix (6.B). 
6.5.6 Pilot surveys 
Pilot survey 1 
 The first pilot survey was aimed at ascertaining whether or not the respondents could 
understand the background information provided. An initial email was sent to colleagues 
within the Institute of Applied Health Research [IAHR] in the University of Birmingham 
requesting the participation of those who had children aged less than 16 years. Those who 
volunteered were sent a shortened version of section 2 (7 choice sets), but with the full 
versions of Section 1 and 3. Cost attribute was not included (see Table 6-3). Volunteers were 
requested to provide feedback either via email or directly to the principal investigator (LD).  
Pilot survey 2  
  A further survey using colleagues was carried out using the modified sections 1 and 
3 and the complete section 2 [36 choice sets]. Colleagues who responded to this survey may 
or may not have had children under the age of 16. 




Pilot survey 3 
 A 'Think aloud' study was carried out using 1 volunteer from the University of 
Birmingham. The respondent was given brief instructions regarding the study and was 
advised to complete the survey whilst the investigator stayed in the room. She was 
encouraged to verbalise her thoughts while completing the questionnaire. The think-aloud 
exercise was recorded although the hand notes made by the researcher during the exercise 
proved adequate for analysis.  
6.5.7 Final survey 
Population survey 
The population survey of parents was carried out with the help of a market research 
company called M.E.L. Research [244]. The company was commissioned to contact parents 
of children under the age of 16 years in the WM region on behalf of the investigators. Ethical 
approval was obtained from the University of Birmingham for the study (see section 6.5.5). 
Since NHS patients were not recruited, NHS ethics was not required (see Appendix 6.B) 
Contact data for individuals are obtained by the research company through data suppliers. 
Individuals who 'opt-in' to take part in surveys are registered onto a database by the 
contractors. The contact information for these individuals is updated by the data suppliers' 
every 12 months, so that only those individuals who are willing to remain in the database can 
be contacted. Unlike a few other market survey companies, each individual participating in 
this survey was not paid for their participation. However, respondents who completed the 
survey were eligible for inclusion in a prize draw for a gift voucher. Participation was 
voluntary and those who wished to be taken off the panel (to avoid further emails) could do so 
by contacting either the researcher or the company directly.  
An interim analysis was carried out after 75 responses were received in order to ensure 
that the respondents did not have difficulties with understanding the survey and completing it. 
The respondents were also requested to answer two specific questions regarding the 
questionnaire - "How was the format of the questionnaire?" (choices included too easy, 




neither easy nor complicated, too complicated) and "How long was the questionnaire?" 
(choices included too short, just right, too long). 
If the interim results showed that the questionnaire was well understood and was fairly 
easy to complete, it would be sent out to a larger proportion of parents across the WM. 
6.5.8 Data storage and transformation 
Data were received by the researchers from the third party (i.e. M.E.L. Research) who 
provided anonymised and coded responses in .xls format to the researcher (LD) for the 
analysis. These data were transformed into .dta files for statistical analysis. Password 
protected university computers were used for data storage. 
6.6 DATA ANALYSIS 
6.6.1 Analysis of the pilot studies 
The objective of the initial pilot (instrument development) surveys was to ensure that: 
 The formatting of the questionnaire was sound with all the attributes explained in 
a clear and concise manner 
 All the important attributes were included within the survey 
 The choice sets were easy to understand and respondents could trade-off attributes 
as expected within the study 
 The DCE was theoretically valid - i.e., higher levels of willingness to pay and 
longer waiting times were not preferred by the respondents. 
 The objective of the interim analysis (pilot 4) was to confirm that: 
o The survey was being understood by the unselected group of parents and 
that the trade-offs followed a priori expectations. 








6.6.2 Quantitative analysis 
In a DCE, each individual is expected to choose from a series of choices and thus multiple 
observations are available for analysis from each respondent. Hence, multinomial random 
effect models such as probit, logit, clogit are preferred in observable utility estimation in DCE 
[245]. Of these, conditional logit (or clogit)has been shown to be consistent with the random 
utility theory. It has been specifically developed to relate choices with the utility of attributes 
within the choice models and is generally preferred in DCE analysis [246]. 
Following from [Equation 6-5], the probability of choosing option i over option j using 
logit model can be shown as follows:  







Conditional logistic regression in this study was carried out using Stata15® (Statacorp, 
USA). The dependant variable was choice (i.e., whether or not the option was chosen) and the 
independent variables were the attributes. The regression coefficients obtained from the 
analysis reflect the utility value estimates for each attribute. The size of the coefficient 
represents the extent of preference and the sign on the coefficient reflects whether the given 
attribute level increases or decreases utility compared with the baseline level [236]. The 
difference between coefficients demonstrates the utility of one attribute level compared to 
another [221]. 
6.6.3 Coding in DCE analysis 
Effects coding and dummy coding are two commonly used methods for categorical coding 
within a DCE. In both of these approaches, one level within each attribute is used as the 
reference point for estimating the utility values for the other levels [223]. In dummy coding, 
there may be an issue with identification of the omitted and reference variables leading to 
errors in intercept estimation, which is dealt with in effects coding. This is explained in some 
detail in Appendix section 6.C. 




The issue of errors in intercept estimation does not apply when conditional logit estimation 
(which suppresses intercepts for groups) is used. Effects coding does not provide additional 
data in this situation and was therefore not used in this analysis. 
6.6.4 Marginal rates of substitution 
The marginal rate of substitution of a given attribute is an estimation of the strength of 
preference for that attribute in relation to the overall utility associated with the choice. 
Marginal utility χ of an individual attribute (k) can be shown as follows: 
[Equation 6-9]   ΔV/ΔXk = 𝜒𝑘                                          
This is represented by the beta estimates (β) within the clogit equation. 
The difference between marginal utility estimates for the different attributes provides an 
estimate of preference of one attribute over the other [247].  
Including a cost attribute in the DCE allows for the estimation of willingness to pay 
(WTP) values for the different attribute levels. This is a monetary value that provides a 
common metric against which all the attribute levels can be compared and is intuitively better 
understood as strength of preference for the given attribute.  
The WTP estimates can be calculated as follows: 
 [Equation 6-10]                               𝑊𝑇𝑃𝑘 =
𝜒𝑘
𝛽𝐶𝑜𝑠𝑡⁄  
where χ is the marginal utility for attribute k and βCost is the utility estimate for the cost 
attribute. 
6.6.5 Subgroup analysis 
In this analysis, the respondents were divided into subgroups based on certain 
characteristics ( income level, whether or not they had a child with allergy, whether or not 
they have accessed paediatric secondary care services) and the data re-analysed to estimate 
utility values for each of these groups [248]. 
 





6.7.1 Pilot survey1 
A total of 20 colleagues across the University of Birmingham were sent a link for the 
survey via email. A reminder was sent at the end of week 1 and week 2 respectively to the 
non-responders. 17 responses were received, an overall response rate of 85%. Colleagues 
commented on the format of the survey overall, the explanations given about the various 
attributes, the levels used and the overall design of the survey. Only 7 choice sets per 
respondent were included in this pilot and no cost related attributes were presented. Some of 
the suggestions/ comments received are shown in the appendix (6.D). 
6.7.2 Pilot survey 2 
Of the 84 people emailed with a link for this survey, 27 responded (32%). This survey had 
36 choice sets. The questionnaire was also sent to selected colleagues who have some 
experience with choice experiments in order to obtain more specific and in-depth comments 
(see Appendix 6.E). Almost all the respondents found the survey too long and tedious. They 
also commented on some specific attribute levels (e.g. "No information" at a clinical 
appointment was felt to be unrealistic as every clinical consultation would be expected to 
provide some information). 
An a priori assumption was made for the study that increasing waiting time and costs 
would be undesirable to the respondents. This was checked by carrying out a clogit analysis 
of the pilot data. The graphs shown in Figure 6-9 demonstrate that the results were in keeping 
with this hypothesis. 
6.7.3 Pilot survey 3 (Think aloud study) 
The participant commented on how long the questionnaire was. She felt that the 
explanations given regarding allergies were complex and not amenable to quick reading. 
Some of the pictures provided during the explanations were distracting. She found the 
questions repetitive and got bored part way through. The £200 option for out of pocket costs 




was dominating her choices. She felt that weblinks to allergy related websites for further 
information (for those interested) at the end of the survey may be useful. 
 
Figure 6-9: Trends in the β estimates for waiting time and willingness to pay in pilot survey 2. 
6.7.4 Population survey (Interim analysis) 
Using data from pilots 1,2 and 3, a DCE questionnaire (Appendix 6.G) was finalised. 
Interim analysis was carried out on the first 75 completed responses of the population survey 
to ensure that the questionnaire was generally easy to complete (Table 6-5). 
Table 6-5: Impressions regarding questionnaire: Interim analysis of population survey 
Questionnaire specifics N(%) 
How did you find the questionnaire?  
Very easy 59 (78.7) 
Neither easy nor difficult 15 (20) 
Very complicated 1 (1.3) 
How long did you find the questionnaire?  
Too short 1 (1.3) 
Neither short nor long 57 (76.0) 
Too long 17 (22.7) 
A clogit regression analysis was carried out to estimate the utility values associated with 
the levels within  the waiting time and cost attributes to ensure that the apriori assumptions 
were met (Figure 6-10). 





Figure 6-10: Trends in β estimates for waiting time and cost: interim analysis of population 
survey 
The results from the interim analysis were deemed satisfactory and no further changes to 
the questionnaire format or content were made. The questionnaire was sent out to a larger 
population sample with a view to obtaining a total of at least 300 responses (including those 
used in the interim analysis). 
6.7.5 Population survey (Final analysis) 
Data from pilot surveys 1, 2 and 3 were not included in the final analysis.  
A five attribute, two alternative, forced choice DCE was sent to 10,000 members of the 
general population deemed suitable for the study (parents with children under age 16 years 
residing within the WM) by the survey company.  Most individuals (9,499; about 95%) did 
not open the email at all. Of the 501 who clicked on the survey, 176 (35.1%) did not answer 
any questions, 34 (6.8%) were not eligible (did not have children), 11 (2.2%) started the 
survey but did not complete it, 280 (55.9%) completed the survey. Thus, 280 valid responses 
were received, an overall response rate of 2.8%. The response rate amongst those who 
acknowledged the survey was 55.9%. 
The demographic characteristics of the respondents are summarised in Table 6-6. Most of 
the respondents were female, white and employed,  aged between 35 and 55 years. Each 
respondent had an average of 1.5 children (SD=0.21). About half of the respondents had 
children with allergy and/ or eczema. About 40% had children with asthma. 
 




Table 6-6: Summary of demographic characteristics of individuals providing completed 
responses for the DCE. 
Characteristic N (%) 
Total 280 (100) 
Female 244 (84.1) 
Age group  
18 to 24 yrs 7 (2.5) 
25 to 34 yrs 51 (18.2) 
35 to 44 yrs 124 (44.3) 
45 to 54 yrs 93 (33.2) 
≥ 55yrs 5 (1.8) 
Children  age$  
0 to 1 yrs 28 (10) 
2 to 5 yrs 96 (34.3) 
6 to 10 yrs 137 (48.9) 
11-16 yrs 165 (58.9) 
History of allergy or related conditions  
Child with eczema 139 (49.6) 
Child with asthma 110 (39.3) 
Child with allergy 145 (51.8) 
Consulted GP for allergy or eczema 119 (42.5) 
Consulted hospital consultant for allergy/eczema  
Never 189 (67.5) 
In the last 1year 44 (15.7) 
In the last 2 to 5 yrs 47 (16.8) 
Annual household income  
0 to 18,500 61 (21.8) 
18,500 to 23,000 43 (15.4) 
23,000 to 30,000 32 (11.4) 
30,000 to 43,000 41 (14.6) 
more than 43,000 63 (22.5) 
Prefer not to answer 40 (14.3) 
Education*  
No education 10 (3.6) 
Entry level (including A level) 124 (44.3) 
Higher education 110 (39.3) 




Employment status*  
Employed 193 (68.9) 
Not employed (incl student, retired) 17 (6.1) 
Looking after home/family 50 (17.9) 
Ethnicity*  
White 176 (62.9) 
Black 17 (6.1) 
Asian 68 (24.3) 
$Respondents may have more than one child under age 16 yrs *May not add up to 100% since 
only major categories included 
The results of the conditional logit analysis for the DCE are shown in Table 6-7. The a 
priori assumptions discussed previously (decreasing utility values with increasing waiting 


















Utility values for each of the levels are measured against a baseline level as shown: 
Table 6-7: DCE results: Utility values for levels of various attributes in the DCE 
Attribute Utility scores Std error 95% CI 
Person    
Nurse specialist (allergy trained) (Reference)   
Consultant-no allergy training -1.289*** 0.053 -1.39 to -1.18 
Consultant - allergy trained 0.578*** 0.053 0.47 to 0.68 
Information    
Improved NHS choices website (Reference)   
Verbal information -0.631*** 0.056 -0.74 to -0.52 
Detailed written information -0.497*** 0.054 -0.60 to -0.39 
Support    
No additional support (Reference)   
Additional support available 0.277*** 0.044 0.19 to 0.36 
Waiting time    
8 weeks (Reference)   
12 weeks -0.781*** 0.056 -0.89 to -0.67 
18 weeks -1.20*** 0.057 -1.31 to -1.09 
Out of pocket costs    
£25 (Reference)   
£50 -0.6*** 0.054 -0.71 to -0.50 
£100 -0.722*** 0.055 -0.83 to -0.61 
*** P<0.0001 
All the attributes and levels included in the DCE were good predictors of choice (p<0.0001 
for all). The highest preference weight (or utility score) was associated with seeing a 
consultant trained in allergy. Longer waiting times (up to 18 weeks) were seen as particularly 
undesirable, associated with second worst utility values in the DCE (Table 6-7).  
A specialist nurse consultation had higher utility scores and was hence more preferred than 
consultation with a consultant not trained in allergy, although a nurse was less preferred than 
a consultant trained in allergy. Detailed written information in clinics was valued higher than 
being provided with verbal information only. However, improving online information through 
websites like NHS choices was the most preferred option for accessing allergy information in 




the DCE. Respondents preferred to have supportive care (availability of dietician or 
dermatology nurse) within the same clinic appointment. Shorter waiting times and lower out 
of pocket costs were preferred. However, respondents did not differentiate too much between 
out of pocket costs of £50 and £100.  
Consulting an allergy specialist nurse rather than a consultant not trained in allergy 
provided 3 times more utility and consulting a trained allergy consultant yielded 4.5 times 
more utility than reducing the waiting period from 18 to 12 weeks. The preference weights for 
seeing a nurse (as opposed to a consultant not trained in allergy) were the same as those for 
reducing the weighting time from 18 to 8 weeks. This suggests that respondents were willing 
to wait longer to see practitioners who were specifically trained in allergy.  
Having a better NHS choices website rather than written information was about twice  
more desirable compared with having additional support in clinic. 
6.7.6 Marginal rates of substitution 
Willingness to pay or accept estimates (WTP or WTA respectively) were calculated for 
each of the levels of the attributes. These are shown in Table 6-8. In essence, all those levels 
which have a WTP estimate are preferable compared with the comparator level whereas WTA 
estimates suggest that the comparator level is more acceptable than the proposed one. 
For instance, seeing a consultant who was not trained in allergy in secondary care was less 
preferable to seeing a nurse specialist or an allergy trained consultant. Seeing an consultant 
trained in allergy compared with one not trained in allergy had a WTP estimate of £218.9 (-
151.1 to -67.8), which was higher than the WTP estimate for reducing waiting time from 18 
weeks to 8 weeks (£141.2). In other words, respondents seemed to value seeing an allergy 
consultant even if they had to wait quite long to do so. Similarly, respondents preferred to 
wait up to 18 weeks to see an allergy specialist nurse rather than see a consultant who was not 
allergy trained. 




An improved NHS website information regarding allergy and related conditions was more 
preferred than having additional support within an allergy clinic.  
Table 6-8: Willingness to pay or receive estimates for each level of the attributes 
Attribute WTP *(£) Lower CI Upper CI 
Person    
Nurse specialist (allergy )  Comparator   
Consultant-no allergy training -151.1  -163.3 -138.9 
Consultant - allergy trained 67.8  55.5 80.1 
Information    
Improved NHS website Comparator - - 
Verbal information -72.7  -85.4 -59.9 
Detailed written information -54.3  -66.6 -41.9 
Support    
No additional support Comparator - - 
Additional support available 30.0  19.8 40.1 
Waiting time    
8 weeks Comparator - - 
12 weeks -90.2  -102.9 -77.4 
18 weeks -141.2  -141.2 -154.3 
*Positive monetary values suggest that the alternative is preferred to the comparator level 
(WTP); Negative values indicate that the comparator level is preferred (WTA) 
6.7.7 Subgroup analysis 
Logistic regression analysis performed after dividing the respondents into subgroups as 
discussed in section 6.4 did not show significant variations from the baseline analysis. The 
highly preferred options (Allergy trained consultant, improved NHS choices website for 
information, need for additional clinic support and preference for lower waiting times and 
costs) were the same for all the subgroups analysed.  The results are shown in appendix Table 
6.F. 
 





6.8.1 Principal findings 
This study found that the parents in WM strongly preferred to see consultants trained in 
allergy in specialist centres. They also strongly preferred to have improved, reliable online 
information regarding allergies, additional services for allergy (such as dietician and 
dermatology support) and shorter waiting times to see specialists. Least preferred options 
were consultants who were not specifically trained in allergy and long waiting times. 
A DCE was used to ascertain these preferences. Using DCE to understand preferences of 
the general public regarding health service delivery and service pathways has been explored 
previously [226]. This DCE is the first, to our knowledge, to focus on preferences for 
paediatric allergy specialist services. 
One of the themes that emerged in the qualitative study – being taken seriously- was not 
included in the DCE. This is because it was felt that this characteristic would not be amenable 
to change via intervention (all medical students are taught to take their patients seriously). 
Also, previous studies have shown that an option such as this could dominate choice in a DCE 
[249]. This is unsurprising because all other options could be rendered meaningless if a doctor 
does not take their patient seriously. In terms of informing policy, it was felt that the 
conclusions of the qualitative study provided evidence compelling enough to make a case for 
improved training. Inclusion of this theme in the DCE, therefore, was not felt necessary. 
There are some very important findings in this study that can directly inform allergy 
service pathways. Firstly, parents strongly preferred to see a clinician trained in allergy rather 
than a consultant who had no formal allergy training. Allergy services in the UK are currently 
delivered mostly by consultant allergists and immunologists, but a significant proportion of 
service delivery is borne by other specialists (e.g. dermatologists, respiratory physicians, ENT 
specialists) with no formal training in the field [6]. This is especially true for paediatric 
allergy where the trained specialist numbers are even lower [19, 114]. This heterogeneous 
spread of specialists can result in unequal access to care and treatment across the country. 




Training more nurses in allergy can improve pathways of care whilst keeping the costs down 
[8]. Indeed, the qualitative study discussed in Chapter 5 suggested that parents in WM region 
were happy for their child to be reviewed by specialist nurses in secondary care. The DCE 
confirms this while showing that parents are willing to wait longer to see a trained nurse or 
consultant. 
The second important finding was that improving NHS choices or reliable information 
websites was favoured strongly over the other two options in the questionnaire (provision of 
verbal or detailed written information). Better health education and improved communication 
with clinicians leads to more patient satisfaction as well as improved health and non-health 
outcomes [250, 251]. Whilst it is possible that there was a selection bias given that this was a 
web based survey of parents with young children, it cannot be denied that the internet is 
becoming an increasingly popular medium for the delivery of information per se [252]. 
Individuals use information technology in different ways, based perhaps on age, the 
underlying health condition and familiarity with web based tools [253]. For instance, about 
60% of young adults surveyed in a study in France used the internet as a source of health 
information instead of or before seeing a doctor [254]. Respondents in an Australian study of 
web users with chronic medical conditions used the internet to manage their health as well as 
to clarify the information given by their physician [255]. Literature suggests that unmet 
information needs in allergy can lead to increased consultations with doctors [256] and greater 
anxiety regarding management of the condition [257]. Thus, there are clear incentives to 
improving the availability of evidence based information regarding allergies to the public. The 
internet is a relatively easy route for the  delivery of such information, although many 
individuals are concerned about the reliability of most web based information outlets [253]. 
However, more effort should be made to improve the allergy data available on the NHS 
choices or similar reliable websites that are well respected by the UK public.  
Parents also preferred to have additional services (such as dietetic support, dermatology 
advice for eczema) in the allergy clinic. Allergy amongst UK (and WM) children, as shown 




through analysis of the THIN database (see Figure 3-17) is becoming increasingly complex. 
More children now present with a combination of allergic conditions such as food allergy, 
eczema and asthma. In order to provide these children with the care they require, it is 
important to have multi-disciplinary teams providing input into their management [6, 7]. A 
report from the Royal College of Physicians suggested that only trained specialists could 
provide such a holistic service and recommended that more multi-specialist centres for allergy 
be commissioned [6]. However, the investment needed to achieve this has not been 
forthcoming. Very few clinics in the WM are able to provide parents with dietetic input and 
referrals to dermatology services where necessary (see section 1.2). This study suggests that 
parents value these inputs.   
The waiting times to see allergy specialists throughout the WM region are very long. Most 
clinics have waiting periods of at least 18 weeks, some are even longer (personal 
communication with Dr Goddard, Consultant Immunologist, UHNM). Parents are, not 
surprisingly, averse to long waiting times. However, it is interesting to note that they are 
willing to wait up to 18 weeks to see a consultant trained in allergy rather than an untrained 
one. 
6.8.2 Strengths and limitations of the study 
This study provides data regarding parental preferences that are directly relevant to 
planning allergy services in the WM. It shares principles of shared decision making and is the 
first study that aimed to understand population preferences for allergy specialist services. The 
attributes for the study were derived from a qualitative study, which ensured that they were 
relevant and important to the local service pathways. Indeed, clogit analysis showed that all 
the attributes and levels included in the DCE were important predictors of choice (p<0.0001 
for all). 
There are some potential limitations of the study, however. The recruitment rates were 
very low (overall rate: 2.8%). It should be noted that in most surveys of this nature, response 
rates are not made explicit [258, 259]. However, the proportion of individuals who completed 




the survey once the email was opened was 56%, which is perhaps above average for an online 
survey [260]. This may, in part, be due to the offer of a post-survey incentive (a chance to win 
a £25 Amazon voucher if the survey were to be completed). It could be argued that the size of 
the sample is less important than its representativeness [261]. About 50% of those who 
completed the survey had a child with either allergy, asthma or eczema and about 20% had 
consulted a hospital specialist for this condition. This suggests that there may have been some 
self-selection bias with the responses, although these proportions are perhaps in keeping with 
the current prevalence figures for these conditions (see Chapter 3).  
Some DCEs rely on paid panel survey members to complete the questionnaires, which 
may result in higher response rates [262]. Panels offer incentives per completed response 
which may lead to problems with data integrity (e.g. false answers, answering too fast, 
choosing the same option repeatedly). The use of general public rather than professional panel 
responders was therefore preferred in this study [263]. 
In a DCE, it is assumed that the respondents understand all the options provided to them in 
order to trade-off rationally between them [202]. However, some respondents may be fixated 
on a single attribute and may be unwilling to trade [264]. Although a great deal of effort was 
put into the design of the DCE and the explanations provided to the respondents beforehand 
(see Appendix 6.G), it is possible that these were either not read completely or understood 
sufficiently. Even though the a priori assumptions of the DCE were met and most of the 
respondents felt that the survey was easy to understand and to complete, it cannot be 
guaranteed that all respondents were able to consider opportunity costs before making their 
choices.   
6.8.3 Strengths and limitations in relation to other studies 
There are no published DCEs looking at preferences for allergy pathways. There are, 
however, a few published choice experiments focused on patient or public preferences for 
health pathways. Examples include a study assessing preferences of pregnant women for 
home versus hospital delivery [265], understanding public preferences for out-of-hours 




primary care [266], ascertaining preferences of vascular surgery patients for locally based care 
packages [267]. These studies, similar to the one discussed in this chapter, can inform 
commissioners about the preferences of stake holders regarding health services. Another 
strength of the study is the way out of pocket costs were explained and laid out (see Appendix 
6.G). Unlike a few other studies where cost attributes resulted in 'protest voting' [236], the 
parents understood the concept of willingness to pay in the current study and traded off the 
costs estimates as was expected. 
6.8.4 Future research 
For a better understanding of local priorities, a preference elicitation exercise involving 
GPs and perhaps commissioners may be useful in service planning. 
6.9 CONCLUSIONS 
Parents in the WM prefer to consult secondary care clinicians who have received formal 
allergy training for their children. Consultants who are not formally trained in allergy were 
not favoured. Parents were willing to wait longer to see trained clinicians. Access to allergy 
related educational resources on reliable websites was the preferred option over verbal and 
written information; Additional support for children with allergy (such as dietetics and 
dermatology) was also favoured. 
 Discrete choice experiments have  the potential to inform patient/ public preferences for 
health pathways. When systematically planned and executed, they can provide useful data 
regarding preferences of various stakeholders within health services. They can play a key role 
in improving shared decision making and should be considered when new services or 
investments are being planned.  
The findings from the systematic review, database analyses, qualitative review and the 
DCE are summarised in the next chapter. Current pathways for WM paediatric allergy 
services are outlined and changes proposed to improve these services. 
  





This thesis presented an in-depth insight into the current state of paediatric allergy services 
in the West Midlands. Analysis of databases was carried out, end users were interviewed and 
opinions of parents were sought in order to propose a service redesign.  This chapter brings 
together the findings from the thesis. Implications of these findings for allergy pathways and 
clinical practice are discussed. The strength and weaknesses of the study are highlighted and 
areas needing further research are outlined. 
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7.1 SUMMARY OF FINDINGS 
This thesis evaluated paediatric allergy pathways in the WM. The principal findings from 
the research are summarised in relation to the objectives identified in Chapter 1 (see section 
1.3). 
7.1.1 Objective 1: To understand the modes of delivery of allergy services 
worldwide; to explore the challenges, success stories and the future directions 
for service delivery 
This objective was addressed by a systematic review described in Chapter 2. The review 
found that allergy services globally are not meeting the escalating demands due to increasing 
prevalence of allergies and related conditions [19]. The lack of specialists in allergy across the 
world and particularly the EU has been highlighted repeatedly in the literature. 
A majority of studies included in the systematic review were published in the UK [19]. It 
is somewhat surprising that despite the intense interest in the topic and the recognition that 
services need improvement, that very little progress has actually been achieved during this 
period. Indeed, there has been not been a notable increase either in the number of qualified 
specialists or in the number of trainee doctors in the specialty (see section 2.3.2). There has 
been no national drive to include structured allergy training in the curriculum. Given that an 
estimated 30% of all current UK adults and 40% of children will experience some allergic 
disorder during their lifetime [47], the training provided to doctors currently is woefully 
inadequate. 
The review also revealed that, the lack of training in allergy amongst General Practitioners 
is a particularly pertinent issue [19]. GPs are the gatekeepers to NHS specialist services and 
the review highlighted that their lack of confidence and, in some cases competence, in the 
management of allergies is a source of great distress to patients (section 2.3.1). This also 
creates inefficiencies in the care pathways for allergy since specialist resources, scarce as they 
are, are not particularly well utilised. Therefore, from Chapter 2, it was surmised that 
increasing the number of specialists alone without improving other aspects (such as GP 
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training in allergy, empowering patients for self management) cannot improve services 
(section 2.3.2).  
A hub and spoke model of service delivery was championed in most of the initial reports. 
However, the review in Chapter 2 identified  no evidence to suggest that this is a suitable 
model for NHS allergy services. Allergy is mostly managed in primary care with a small 
proportion of individuals referred for specialist management. In order to improve the overall 
service delivery, it is imperative that concerted efforts be made to improve knowledge and 
resources available to primary care practitioners for the diagnosis and management of their 
patients with allergy. Education of patients to improve self-management should also be 
prioritised. In Finland, this approach produced considerable improvement in patient outcomes 
for asthma over a 10 year period despite an overall increase in asthma prevalence in the 
country [59].  
7.1.2 Objective 2: To understand the current demands placed on NHS services due 
to paediatric allergy in a) the UK or England and b) the West Midlands (WM) 
Chapters 3 and 4 scrutinised and discussed the analysis of two large NHS databases (THIN 
and HES) to estimate the extent to which paediatric allergy and related conditions are 
reviewed in primary and secondary care. The data showed that while incidence rates for most 
GP diagnosed allergies and related conditions remain stable, allergy prevalence (based on GP 
data) amongst children is increasing in the UK as well as in the WM (see Figure 3-4 and 
Figure 3-8). The analysis showed that the overall burden and trends in prevalence of allergic 
disease across the UK are similar to those seen in children in the WM, except that allergic 
rhino conjunctivitis (ARC) is more commonly diagnosed in the WM (Figure 3-16). 
Nevertheless, the proportion of children who receive allergen specific immunotherapy  (which 
is a proven clinically effective and cost effective treatment for ARC [137]),  is much lower in 
the WM than that of the English average (Figure 4-6). 
The increasing allergy prevalence highlighted in chapter 3 directly impacts the demand for 
allergy services. Whereas asthma prevalence has remained more or less stable, the prevalence 
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of ARC and food allergy have more than doubled between 2000 and 2015 (see Table 3-3). 
Nut allergy rates have more than trebled, with a 275% increase during this period. Nearly one 
in 3 children in the UK is being diagnosed with eczema by their GP by the age of five and 
nearly one in four children has received a diagnosis of ARC by the age of 15 years (Table 
3-5). One in six children has been diagnosed with urticaria at least once by age 15. In 
addition, the proportion of children with complex allergies has increased considerably, both in 
the UK and in the WM (Table 3-4). 
Analysis of the Hospital Episodes Statistics (HES) database revealed that the number of 
children being admitted to NHS hospitals with allergy related diagnoses has increased during 
the period 2008-2014 (Figure 4-2) (Figure 4-5). As shown in previous publications using the 
HES database, it is clear that children aged 5 or under are more likely to present with 
anaphylaxis, about 60% of these have food related reactions [122].  
Chapter 4 showed that elective hospital admissions for allergy, specifically for allergen 
immunotherapy or desensitisation treatments, have increased steadily between 2008-2014 and 
this perhaps reflects the general willingness amongst secondary care practitioners to provide 
these disease modifying treatments for ARC, given that they are safe and effective. However, 
the number of children overall receiving these treatments is still substantially low suggesting 
that the paediatric allergy services in England and particularly the WM are poor (see section 
4.6.3).  
7.1.3 Objectives 3 and 4: To understand experiences and preferences of parents 
regarding paediatric allergy services in the WM 
In Chapters 5 and 6, a qualitative study of parents who had accessed secondary care 
allergy services for their children and a discrete choice experiment (DCE) of parents in the 
WM region were discussed respectively. 
The qualitative study revealed that parents face many barriers accessing primary and 
secondary care services. Although the narrative depended strongly on the underlying allergy, 
appointments with GPs were difficult to obtain for some parents and most experienced long 
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waiting lists before they could see the specialist. GPs were sometimes ill informed about 
allergy diagnosis and management, leading to considerable stress and anxiety for parents (see 
5.4.3). Lack of access to reliable information regarding allergies prior to seeing a specialist 
meant that parents were left with many weeks of being unable to manage their child's 
condition effectively. Websites such as NHS choices were deemed inadequate by parents and 
the credibility of other sources of information on the internet was suspected. The qualitative 
work also revealed that parents were often quite anxious about the management of their child 
and were particularly worried about delegating child care to other individuals who may or 
may not take their child's allergies seriously . Where the children had food allergies, parents 
found labelling of foods in supermarkets confusing leading to a considerable impact on 
household shopping and budget (section 5.4.4).  
A discrete choice experiment (Chapter 6) carried out with parents in the WM revealed that 
parents were willing to wait longer to see trained allergy practitioners in secondary care 
compared with consultants not formally trained in allergy. They also strongly preferred web 
based educational tools to written and verbal information and also preferred multi-disciplinary 
clinics (see 6.7.5).  
7.2 STRENGTHS AND LIMITATIONS OF THE STUDY 
The main strength of this study is its systematic approach to service pathway evaluation 
and evidence synthesis including a systematic literature review of allergy service pathways 
worldwide;  a structured analysis of primary and secondary databases to understand current 
demand on paediatric allergy services and to predict future trends of the pressures on the 
service; and a qualitative synthesis and DCE to understand the experiences of individuals 
currently accessing  these services in the WM and ascertaining the preferences of end users for 
specialist services for paediatric allergy. 
The study brings together various resources (e.g. large healthcare databases) and 
techniques (systematic review, qualitative techniques, discrete choice experiment) to 
comprehensively understand the strengths and weaknesses of current pathways for service 
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delivery in the WM. The techniques used in this study are generalisable for not just allergy 
service pathways across the UK but also for health pathway assessments in other areas.  
The systematic review appraised all published English literature regarding allergy 
pathways across the world. However, there were no eligible publications for this review from 
the Americas, Australia, large parts of Asia and Africa. Data from low and middle income 
countries were conspicuously missing. There were only three prospective studies and none 
had a control group.  Studies not reported in the English language were excluded. It was 
nevertheless, the first review to scrutinise allergy pathways, highlight their advantages and 
drawbacks and identify models that are most likely to be successful for service delivery. 
Analysis of the primary care database (The Health Improvement Network or THIN 
database) presented in Chapter 3 provided longitudinal data on over 1.5 million children over 
15 years (2000-2015). GP diagnosed allergy incidence and prevalence trends for children in 
the UK as well as the WM were estimated. The Hospital Episodes Statistics database (HES) 
analysis presented in Chapter 4 provided 87,000 finished admission episodes data over a 
period of 7 years (2008-2014). Estimates for trends in emergency and elective admissions into 
English (and WM) NHS hospitals were derived from this dataset.  
Both THIN and HES record diagnoses made by qualified medical practitioners. However, 
as with any other large database of routinely collected information, there can be issues with 
accuracy of the diagnosis, coding and also problems with missing data. Although the datasets 
reflect NHS related activity across UK and England respectively, there are no data assessing 
the accuracy and generalisability of regional estimates  of disease burden using these datasets 
(particularly THIN). In addition, most allergy in the UK is self-managed by patients in the 
community and analysis of these databases may not provide an accurate estimation of either 
the population burden of disease or the disease pathways.  
The qualitative study (Chapter 5) was the first to evaluate experiences of end users relating 
to primary and secondary care allergy services. The study interviewed 18 parents, mostly 
mothers, to understand the barriers to accessing paediatric allergy services in the WM region. 
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Experiences of parents with primary care for their child's allergy varied considerably across 
the region. Only two specialist centres, both with trained allergy specialists, were included in 
the study. This may partially explain the high levels of satisfaction expressed by parents in 
relation to secondary care. However, the study did highlight the considerable problems that 
parents in the WM face not only accessing allergy services but also with everyday care of 
their children.   
Data from the qualitative study were used to plan the discrete choice experiment (DCE) 
described in Chapter 6. This DCE is the first to elicit public preferences for regional 
paediatric allergy services. Although the response rates for this study were low, the 
respondents appeared to trade-off appropriately between the various attributes and levels and 
all the levels used were found to be significant predictors of choice (p<0.0001; see section 
6.7.5). The use of results from qualitative study to populate the DCE ensured that the 
attributes most relevant to the regional services could be chosen and therefore the results 
obtained can be directly applied to service planning. 
This thesis presents the first systematic evaluation of a regional health service pathway. 
However, some crucial gaps in evidence remain. This thesis does not provide data on attitudes 
of local commissioners regarding allergy services in the region. Nor does it explore the 
opinions of service providers (GPs and specialist physicians/ nurses) regarding allergy 
pathways or services. Pharmacists, who have an important role in enabling patient self-
management, were not included in this evaluation.  
Comparisons between this study and the published literature could not be made since no 
other studies which have assessed service pathways in this manner could be identified.   
7.3 INTERPRETING THE RESULTS OF THE RESEARCH  
This thesis provides an important insight into the current challenges facing paediatric 
allergy services in the WM. The focus on the regional services was deliberate since specialist 
availability varies widely across the UK and little was previously known about the regional 
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variations in allergic disease and service availability. However, the techniques used in the study 
are robust and are generalisable to other regions as well as other aspects of healthcare in the UK 
and elsewhere. 
7.3.1 Implications for clinical practice 
The work presented in this thesis has shown that the demands on paediatric allergy 
services across the country are increasing and that there is an upward trend in disease 
prevalence amongst children. In addition, the proportion of children with complex allergies is 
also increasing (Chapter 3). Patients with allergy are finding it difficult to access both primary 
and secondary care allergy services (Chapter 5). Access to reliable information regarding 
allergies was also difficult for the parents interviewed in this study (Chapter 5). Parents in the 
WM preferred access to web based education tools and were willing to wait longer to see a 
specialist who has formally been trained in allergy (Chapter 6).  
However, as discussed in chapter 2, there is a serious shortage in specialist availability in 
allergy and this shortage is likely to continue for the foreseeable future. Most specialist clinics 
have very long waiting times currently and this is bound to worsen if no specific interventions 
are put in place.  
Given these constraints, a pragmatic approach towards improving services is needed. Since 
the main aim of allergy pathways is to enable self-management, clear and effective 
educational material should be made easily accessible to allergy sufferers in the community. 
GPs should be provided with readily accessible and relevant educational material which can 
improve their diagnostic and management skills for allergies and related conditions (e.g. 
online continuing medical education modules in allergy aimed at primary care physicians).  
More efforts should be made to tackle inefficiencies in the current allergy care pathways. 
A large proportion of patients who are currently referred to specialists for allergies can be 
managed effectively in primary care [13] through patient education and improving GP 
knowledge of these conditions. Providing a specialist nurse (or consultant led) allergy 
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advisory service aimed at reducing referrals from GPs may be useful, although a similar 
scheme was not particularly successful in Ireland [40]. 
All specialists with an interest in providing allergy services should be required to have 
some formal training in the subject. This is vital for an overall improvement in service quality 
not only across the WM but in the UK as a whole. Formal assessments similar to the 
European examination in Allergology and Clinical Immunology [58] should be made 
mandatory for consultants expecting to look after allergy patients. In addition, collaborations 
could be set up between various medical Royal Colleges to develop a competency based 
training scheme for specialist trainees (or consultants) interested in providing allergy services. 
7.3.2 Implications for service pathways 
The data from this research (primarily presented in chapters 3 and 4)  suggest that there 
will be steadily increasing demand on paediatric allergy services across the country in the 
next few years. This research has shown that access to secondary care is poor in England, 
particularly in the WM region. 
In an era of unprecedented financial cuts within the NHS, the idea of a service overhaul is 
bound to be viewed with some scepticism and, perhaps, weariness. However, findings from 
this research suggest that considerable dividends can be obtained in the longer term by 
making some relatively inexpensive changes to service pathways. These include improving 
undergraduate medical student, pharmacist and nursing training in the management of 
common allergies, as well as improving training of GP trainees in allergy. Such initiatives are 
necessary since a third of all UK adults (and a higher proportion of children) are expected to 
be diagnosed with at least one allergy or related condition during their lifetime. The 
prevalence of allergy amongst UK adults is considerably higher than that  of diabetes (9%) 
[268] and heart disease (under 5%) [269]. Focussing some attention toward improving the 
undergraduate and GP curriculum with regards to allergy training deserves much 
consideration.  
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The other important issue highlighted in this thesis (Chapter 5)  is the lack of educational 
resources for patients. Allergy related information, especially those available on trusted 
websites such as NHS choices should be improved. More information regarding web based 
resources should be made accessible to GPs so that these can then be cascaded to patients as 
appropriate. The rapid ascendancy of the world wide web and its popularity with the younger 
generations -including young parents belonging to the so-called millennial generation, has not 
been harnessed adequately by the NHS. More should be done to use social media and well 
established and trusted web spaces to improve education and empower these individuals to 
manage their health conditions, including allergies, better.  
Other measures which are needed to improve services in the medium and longer term will 
require some initial investment. These include expanding specialist training in allergy to 
generalists (e.g. paediatricians) and interested specialists from other fields. Formal assessment 
for certification and regular CME activities should be mandated for all specialists practising 
allergy. Clinical allergists and immunologists could provide much needed oversight for 
clinical pathways for the region by managing complex patients, being part of multi-
disciplinary teams,  providing niche services (such as drug allergy tests or management of 
severe urticaria).  This would ensure that all practitioners are competent and that patients get 
the appropriately robust advice that they are entitled to when they are reviewed by a 
secondary care physician. In addition, targeted initiatives with financial incentives such as 
commissioning for quality and innovation (CQUIN) can be employed to improve allergy 
services. It is interesting to note that there have been no allergy related CQUINs to date which 
perhaps reflects the low priority that allergy services have hitherto received. Such initiatives 
would need a coordinated effort between the Royal colleges (of physicians as well as child 
health) with a leadership role from a national allergy society such as the BSACI.  
More specialist nurses should be trained to ease the burden on allergy services. 
Appropriately trained nurses were more preferable to consultants not formally trained in 
allergy to parents in the WM. Many of the UK reports discussed in the systematic review 
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(Chapter 2) have highlighted the underutilisation of nurses in the delivery of allergy services. 
Specialist nurses can provide a very competent service at a relatively lower cost to the NHS 
[270]. Most nurse led services will need consultant support, however, and this can be 
provided in person or remotely via regular case/ service discussions. 
Importantly, implementation of these initiatives should be done systematically, with a 
good deal of thought given to the ways in which the effects of such changes can be measured. 
Where possible, trials with suitable control groups should be planned to ensure that true 
effects of interventions can be measured. Clustered randomised trials or multicentre 
controlled trials can be planned for service evaluation where appropriate. Other models such 
as difference in difference studies [271] may also be suitable when regional pathways are 
modified. 
7.4 AREAS FOR FUTURE RESEARCH 
Although there is a lot of important work being done to understand the underlying causes 
of allergy, research into allergy clinical pathways and service delivery has been largely 
ignored in the past. More efforts should be made to identify and tackle inefficiencies in 
service pathways. Qualitative work involving primary and secondary care physicians aimed at 
identifying inefficiencies in the current care pathways will help identify areas that can be 
improved. Since there are many competing interests involved in the evolution and planning of 
service pathways, qualitative studies can be combined with Discrete Choice Experiments to 
understand the strength of preferences of different stakeholders for various aspects of allergy 
management. 
Decision analytical modelling can be used to better understand the inputs and the 
outcomes of various service pathways. Exploration of uncertainties within the model using 
probabilistic sensitivity analysis, cost effectiveness acceptability curves can provide much 
information regarding the relative efficiency of different pathways. Econometric analyses 
such as value of information analysis can help identify areas within the model that can 
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provide best value for research. Bayesian priors can also be used to understand the impact of 
service alterations on outcomes.  
Patient involvement should be actively sought in allergy research. A majority of allergies 
can be self-managed in the community and the need for patient input into the development of 
tools to enable this cannot be over-stated. A priority setting partnership such as those 
championed by the James Lind Alliance [272] involving patients and/ or carers, primary and 
secondary care practitioners can be very useful and informative in directing future research 
into allergies and service pathways.  
Conventional quality of life instruments such as EQ-5D and SF-6D aimed at measuring 
Quality Adjusted Life Years (QALYs) are not sensitive enough to measure the beneficial 
effects of such initiatives in allergy management. Symptoms associated with conditions such 
as hay fever, even if severe, are seasonal and therefore may not be adequately captured using 
QALY measures. This has a direct impact on the resource allocation decisions made for 
allergy management and therefore needs to be addressed in the future. Efforts should be made 
to develop newer and more relevant questionnaires such as the Juniper quality of life 
questionnaire for allergic rhinitis [273] and the 7 day Urticaria Activity Score (UAS7) [274]. 
Development of patient reported outcome measures (PROMs) has been gaining some 
momentum in allergy [275] and requires further investment. These instruments will help 
establish agreed goals for disease management. They will also help ensure a more consistent 
assessment of services which, in turn, can help reduce heterogeneity in service pathways. 
7.5 CONCLUSIONS 
Paediatric allergy services in the UK are disparate and are currently inadequate to meet 
the demands placed on them. With the rising prevalence of allergies, including complex 
allergies and life-threatening manifestations such as anaphylaxis, more needs to be done to 
improve services in the WM as well as across the UK. There was much focus on hub and 
spoke model of service delivery in the past, but this is unlikely to be a good model for the UK. 
Improving patient self management through developing effective shared learning pathways, 
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improving knowledge of GPs with regards to allergy diagnosis and management, ensuring all 
specialists offering secondary care services are adequately trained in the disease area will be 
important for the much needed upliftment of services. Patient involvement in planning allergy 
service is necessary. Ensuring that physicians and patients work in partnership with each other 
is vital for the success of allergy pathways anywhere.  
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Fig1.A: A map showing all the  NHS Trusts offering paediatric allergy services within the West 
Midlands region




2.A: PRISMA CHECKLIST FOR THE SYSTEMATIC REVIEW 
Section/topic  # Checklist item  Reported 
on page # 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key 
findings; systematic review registration number.  
2,3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, 
and study design (PICOS).  
NA 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration 
information including registration number.  
NA 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale.  
5,6 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) 
in the search and date last searched.  
5,6 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.  S2 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the 
meta-analysis).  
6 







From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA 









Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining 
and confirming data from investigators.  
6 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications 
made.  
NA 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used in any data synthesis.  
NA 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  NA 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for 
each meta-analysis.  
NA 








3. 1 or 2 
4. (care adj pathway*).mp. 
5. 3 and 4 
6. (servic* adj pathway*).mp. 
7. (allerg* adj service*).mp. 
8. 5 or 6 or 7 
9. conference abstract.pt. 
10. 8 not 9 
11. limit 10 to human 
12. limit 11 to english 
13. Remove duplicates from 12 
  
CINAHL SEARCH STRATEGY 
S1 TI allergy 
S2 TI service 
S3 TI care 
S4 S2 or S3 
S5 (MH “Health Care Delivery”) OR (MH “Health Resource Allocation”) OR (MH “Health 
Care Reform”) OR (MH “Health Services Purchasing”) OR  (MH “Managed Care 
Programs”) OR (MH “National Health Programs”) OR (MH “Primary Health Care”) OR 
(MH “Telehealth”) OR (MH “Health Care Delivery, Integrated”) OR (MH“Health Services 
Administration”)  
S6 (MH “Health Services Administration”) OR (MH “Patient Care”) OR (MH “Protocols”) OR 
(MH “Nursing Protocols”) OR (MH “Patient Care Plans”)  
S7 “design” 
S8 (MH “Community networks”) OR (MH “Hospitals, Community”) OR (MH “Community 
Assessment) OR (MH “Health Information Networks”) OR (MH “Community Role”) OR 
(MH “Community Health Centers”) 
S9 S5 OR S6 ORS7 OR S8 
S10 S4 AND S9 
S11 S1 AND S10 
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2.C: DATABASES USED IN THE SYSTEMATIC REVIEW 
DATABASE PUBLISHER TIME FRAME WHAT IS COVERED? 
EMBASE Elsevier 1947- present Biomedical and Pharmacological publications covering more than 90 countries; 
Especially strong in coverage of drug and pharmaceutical research. 
 




1946- present Updated daily; Access to over 5,600 biomedical and life sciences journals in nearly 
40 languages (60 languages for older journals). English abstracts are included in more 
than 80% of the records.  
Cumulative Index 




EBSCO host 1961- present Literature covers a wide range of topics including nursing, biomedicine, health 
sciences librarianship, alternative/complementary medicine, consumer health and 17 









1994- 2015 Includes  CRD assessed reviews and Cochrane reviews; Access to over 35,000 
quality assessed systematic reviews of health and social care interventions ; 












1994-2015 CRD assessed economic evaluations;  Over 17,000 economic evaluations of health 











1989- present The NIHR HTA database provides free access to bibliographic information about 
ongoing and published health technology assessments commissioned from around the 
world.  The database provides a comprehensive listing of over 15,000 in progress and 
published health technology assessments. 





2.D: DATA EXTRACTION TABLES: Summary of characteristics of the included publications (Arranged in chronological order)
 































3.A: SOME OF THE ROUTINELY COLLECTED HEALTH/ POPULATION DATASETS AVAILABLE IN THE UK 
 
  
NAME OF DATABASE DESCRIPTION LEVEL REGION 
The Health Improvement 
Network (THIN) 
Managed by IMS Real World Evidence; Anonymised longitudinal database of 
routine primary care visits; Vision software 
Primary care UK 
RCGP weekly returns service Weekly consultations for selected conditions from 100 GP practices Primary care England and 
Wales 
GP Research Database Run by the MHRA; Anonymised longitudinal database of 1
0
 care records; 
Vision software 
Primary care UK 
Doctors Independent Network 
(DIN) 
Direct download of normal working activity of about 1500 GPs from over 350 
General Practices 
Primary care UK 
Q-Research Run by Nottingham University; 655 general practices with 13 million 
registered patients; EMIS software 
Primary care UK 
Prescription cost Analysis 
(PCA) 
Based on data sent to the prescription pricing authority for payment; Only 
those dispensed in community (not hospital/ private) 
Secondary care England 
Hospital Episode Statistics 
(HES) 
Personal , medical and administrative details of all patients admitted to and 
treated in NHS hospitals 
Secondary care England 
Office of National Statistics 
(ONS) 
Key economic and social indicators; Data is free; Includes longitudinal study 
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FEATURE THIN  HES 
Type of data Primary care data; Produced 
when health care is demanded 
(i.e. when a person consults his/ 
her primary care physician) 
Secondary care data; Produced when health 
care is provided at secondary care level 
Data content About 6% of UK general 
population is represented in the 
THIN database. Data is 
longitudinally collected (see 
Fig.3.1) and has recently been 
linked to HES. 
NHS secondary care admission data from 
all of England is included. Data is 




All of UK; Currently over 500 
practices in UK and over 40 in 
W.Midlands contribute to the 
dataset  





Database started in January 
2003, although records are 
available from 1994. Data are 
updated throughout the year 
(usually once every 3 months). 
Database started in 1987; Admitted patient 




Read codes, Version 2.0 ICD-10 
Data 
managed by 
IMS Health Real World 
Evidence; Vision software 
installed in the participating GP 
surgeries and data regularly 
gathered. 
Managed by Secondary User Service (SUS) 
under the auspices of the Health and Social 
care Information centre (HSCIC). 
Deprivation 
index 
Townsend score Index of multiple deprivation (IMD) scores 
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3.C: CONDITIONS CONSIDERED IN THE THIN DATABASE ANALYSIS 
CONDITION DESCRIPTION 
Allergy An exaggerated, abnormal immune reaction to a normally harmless 
substance.  
Symptoms can range between mild rash, itchiness in mouth and throat, 
hives (urticaria) after ingestion of the allergen to a potentially life 
threatening reaction called anaphylaxis. 
Allergen A substance that induces an allergic reaction 
Allergic rhinitis (AR) Allergic rhinitis is an inflammation of the inside of the nose caused by an 
allergen, such as pollen, dust, mould or flakes of skin from certain animals. 
Symptoms include sneezing, runny and /or itchy nose, blocked nose. AR 
can present during certain times of the year (seasonal AR) or throughout 
the year (perennial AR) 
Allergic conjunctivitis Allergic conjunctivitis is a condition wherein an allergen that causes 
redness and inflammation of the thin layer of tissue that covers the front of 
the eye (the conjunctiva).  Symptoms include red, itchy, watery (or 
sometimes dry) eyes. It is usually associated with allergic rhinitis and may 
be seasonal or perennial 
Allergic rhinoconjunctivitis A combination of allergic rhinitis and conjunctivitis. This condition can be 
seasonal or perennial. 
Food Allergy The allergen in this case is a protein related to food. Food allergy is the 
commonest cause for anaphylaxis is childhood. 
Nut allergy Allergy to one or more nuts. Commonest nut allergen for children in the 
UK is peanut, although tree nut allergy (cashew, almonds, walnuts, 
macademia, brazil nuts etc) is also seen. Only 20% of children outgrow nut 
allergy by age 7. 
Egg allergy It is a common food allergy in young children.  However, about 80% 
outgrow egg allergy by age 5.  
Urticaria It is a raised, itchy rash that appears on the skin. It is usually described as 
hives, wheals, welts or nettle rash. It can occur in susceptible individuals as 
a result of an allergic reaction (e.g. food allergy), during infections, 
exposure to certain physical stimuli (e.g. heat/cold), or may occur without 
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an obvious cause 
Eczema/ Atopic dermatitis 
 
Atopic dermatitis is the most common type of eczema. It is a chronic 
condition seen in association with allergies in children (and also adults), 
although it is not usually a manifestation of allergy per se. Eczematous skin 
is usually red, itchy, dry and cracked.  The condition is characterised by 
periods of remission and flare-ups. 
Allergic asthma Asthma is a common long-term condition that can cause coughing, 
wheezing, chest tightness and breathlessness. In many cases, especially in 
children, asthma is caused due to allergies. Symptoms of allergic and non-
allergic asthma are the same.  
Complex allergies The diagnosis of more than one allergy (or related condition) in a given 
individual. For example, individuals who have been diagnosed with a 
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3.D: READ CODES USED IN THE ANALYSIS 
READCODE DESCRIPTION SUBGROUP 
All Asthma 
173A.00 Exercise induced asthma Asthma 
1781 Asthma trigger - pollen Asthma 
1787 Asthma trigger - seasonal Asthma 
1O2..00 Asthma confirmed Asthma 
H312000 Chronic asthmatic bronchitis Asthma 
H33..00 Asthma Asthma 
H33..11 Bronchial asthma Asthma 
H330.00 Extrinsic (atopic) asthma Asthma 
H330.11 Allergic asthma Asthma 
H330.12 Childhood asthma Asthma 
H330.13 Hay fever with asthma Asthma 
H330.14 Pollen asthma Asthma 
H330000 Extrinsic asthma without status asthmaticus Asthma 
H330011 Hay fever with asthma Asthma 
H330100 Extrinsic asthma with status asthmaticus Asthma 
H330111 Extrinsic asthma with asthma attack Asthma 
H330z00 Extrinsic asthma NOS Asthma 
H331.00 Intrinsic asthma Asthma 
H331.11 Late onset asthma Asthma 
H331000 Intrinsic asthma without status asthmaticus Asthma 
H331100 Intrinsic asthma with status asthmaticus Asthma 
H331111 Intrinsic asthma with asthma attack Asthma 
H331z00 Intrinsic asthma NOS Asthma 
H332.00 Mixed asthma Asthma 
H333.00 Acute exacerbation of asthma Asthma 
H334.00 Brittle asthma Asthma 
H335.00 Chronic asthma with fixed airflow obstruction Asthma 
H33z.00 Asthma unspecified Asthma 
H33z.11 Hyperreactive airways disease Asthma 
H33z000 Status asthmaticus NOS Asthma 
H33z011 Severe asthma attack Asthma 
H33z100 Asthma attack Asthma 
H33z111 Asthma attack NOS Asthma 
H33z200 Late-onset asthma Asthma 
H33zz00 Asthma NOS Asthma 
H33zz11 Exercise induced asthma Asthma 
H33zz12 Allergic asthma NEC Asthma 
H33zz13 Allergic bronchitis NEC Asthma 
H35y600 Sequoiosis (red-cedar asthma) Asthma 
H35y700 Wood asthma Asthma 
H47y000 Detergent asthma Asthma 
173c.00 Occupational asthma Asthma 
173d.00 Work aggravated asthma Asthma 
Allergic Rhinoconjunctivitis (ARC) 
F4A3100 Vernal conjunctivitis of limbus and cornea Allergic conjunctivitis 
F4C0600 Acute atopic conjunctivitis Allergic conjunctivitis 
F4C0611 Acute allergic conjunctivitis Allergic conjunctivitis 
F4C1300 Vernal conjunctivitis Allergic conjunctivitis 
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F4C1400 Other chronic allergic conjunctivitis Allergic conjunctivitis 
F4C1411 Allergic conjunctivitis Allergic conjunctivitis 
H17..00 Allergic rhinitis Allergic rhinitis 
H17..11 Perennial rhinitis Allergic rhinitis 
H17..12 Allergic rhinosinusitis Allergic rhinitis 
H171.00 Allergic rhinitis due to other allergens Allergic rhinitis 
H172.00 Allergic rhinitis due to unspecified allergen Allergic rhinitis 
H17z.00 Allergic rhinitis NOS Allergic rhinitis 
Hyu2100 [X]Other allergic rhinitis Allergic rhinitis 
H171.11 Cat allergy Allergic rhinitis 
H171.12 Dander (animal) allergy Allergic rhinitis 
H171.13 Feather allergy Allergic rhinitis 
H171000 Allergy to animal Allergic rhinitis 
H171100 Dog allergy Allergic rhinitis 
H171.15 House dust allergy Allergic rhinitis 
H171.16 House dust mite allergy Allergic rhinitis 
H170.00 Allergic rhinitis due to pollens Hay fever 
H170.11 Hay fever - pollens Hay fever 
H171.14 Hay fever - other allergen Hay fever 
H172.11 Hay fever - unspecified allergen Hay fever 
Hyu2000 [X]Other seasonal allergic rhinitis Hay fever 
SN5A.00 Oral allergy syndrome Hay fever 
Anaphylaxis 
SN50.00 Anaphylactic shock Anaphylaxis 
SN50000 Anaphylactic shock due to adverse food reaction Anaphylaxis 
SN50100 Anaphy shock due/adv efect/correct drug or med proprly admin Anaphylaxis 
SN51.00 Angioneurotic oedema Angioedema 
SN51.11 Angioedema Angioedema 
M102.00 Infectious eczematoid dermatitis Eczema-like 
M125.00 Contact dermatitis due to food in contact with skin Eczema-like 
M125z00 Contact dermatitis due to food NOS Eczema-like 
M128500 Allergic contact dermatitis due to food in contact with skin Eczema-like 
M183100 Neurodermatitis circumscripta Eczema-like 
SN52.00 Drug hypersensitivity NOS Drug allergy 
SN52.11 Adverse drug reaction NOS Drug allergy 
SN52.13 Drug idiosyncrasy NOS Drug allergy 
Eczema 
26C4.00 Nipple eczema Eczema 
F4D3000 Eczematous eyelid dermatitis Eczema 
F4D3112 Contact eczema - eyelids Eczema 
F502400 Acute eczematoid otitis externa Eczema 
F502411 Eczema of external ear Eczema 
M07y.11 Pustular eczema Eczema 
M102.11 Pustular eczema Eczema 
M11..00 Atopic dermatitis and related conditions Eczema 
M111.00 Atopic dermatitis/eczema Eczema 
M112.00 Infantile eczema Eczema 
M113.00 Flexural eczema Eczema 
M114.00 Allergic (intrinsic) eczema Eczema 
M119.00 Discoid eczema Eczema 
M11A.00 Asteatotic eczema Eczema 
M11z.00 Atopic dermatitis NOS Eczema 
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M12..00 Contact dermatitis and other eczemas Eczema 
M12..12 Contact eczema Eczema 
M12z100 Eczema NOS Eczema 
M12z111 Discoid eczema Eczema 
M12z200 Infected eczema Eczema 
M12z300 Hand eczema Eczema 
M12z400 Erythrodermic eczema Eczema 
Myu2.00 [X]Dermatitis and eczema Eczema 
Myu2200 [X]Exacerbation of eczema Eczema 
Eczema-like 
F4D3100 Contact or allergic eyelid dermatitis Dermatitis 
F4D3111 Allergic dermatitis - eyelid Dermatitis 
F4D4.00 Infective eyelid dermatitis of types resulting in deformity Dermatitis 
F4D5.00 Other eyelid infective dermatitis Dermatitis 
M070.11 Purulent dermatitis Dermatitis 
M07z.14 Infected dermatitis Dermatitis 
M1...11 Dermatitis/dermatoses Dermatitis 
M101.00 Seborrhoeic dermatitis Dermatitis 
M101.11 Seborrhoeic dermatitis capitis Dermatitis 
M101.12 Seborrhoeic eczema Dermatitis 
M110.00 Napkin dermatitis Dermatitis 
M110.11 Ammonia dermatitis Dermatitis 
M118.00 Infantile seborrhoeic dermatitis Dermatitis 
M118000 Infantile seborrhoeic dermatitis capitis Dermatitis 
M118z00 Infantile seborrhoeic dermatitis NOS Dermatitis 
M12..11 Contact dermatitis Dermatitis 
M12..13 Occupational dermatitis Dermatitis 
M120.00 Contact dermatitis due to detergents Dermatitis 
M121.00 Contact dermatitis due to oils and greases Dermatitis 
M121.11 Grease contact dermatitis Dermatitis 
M121.12 Oil contact dermatitis Dermatitis 
M122.00 Contact dermatitis due to solvents Dermatitis 
M122000 Contact dermatitis due to chlorocompound Dermatitis 
M122100 Contact dermatitis due to cyclohexane Dermatitis 
M122200 Contact dermatitis due to ester Dermatitis 
M122300 Contact dermatitis due to glycol Dermatitis 
M122400 Contact dermatitis due to hydrocarbon Dermatitis 
M122500 Contact dermatitis due to ketone Dermatitis 
M122z00 Contact dermatitis due to solvent NOS Dermatitis 
M123.00 Contact dermatitis due to drugs and medicaments Dermatitis 
M123000 Contact dermatitis due to arnica Dermatitis 
M123100 Contact dermatitis due to fungicides Dermatitis 
M123200 Contact dermatitis due to iodine Dermatitis 
M123300 Contact dermatitis due to keratolytics Dermatitis 
M123400 Contact dermatitis due to mercurials Dermatitis 
M123500 Contact dermatitis due to neomycin Dermatitis 
M123600 Contact dermatitis due to pediculocides Dermatitis 
M123700 Contact dermatitis due to phenols Dermatitis 
M123800 Contact dermatitis due to scabicides Dermatitis 
M123z00 Contact dermatitis due to medicament NOS Dermatitis 
M124.00 Contact dermatitis due to other chemical products Dermatitis 
M124000 Contact dermatitis due to acids Dermatitis 
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M124100 Contact dermatitis due to adhesive plaster Dermatitis 
M124111 Elastoplast contact dermatitis Dermatitis 
M124200 Contact dermatitis due to alkalis Dermatitis 
M124300 Contact dermatitis due to caustics Dermatitis 
M124400 Contact dermatitis due to dichromate Dermatitis 
M124500 Contact dermatitis due to insecticide Dermatitis 
M124600 Contact dermatitis due to nylon Dermatitis 
M124700 Contact dermatitis due to plastic Dermatitis 
M124800 Contact dermatitis due to rubber Dermatitis 
M124z00 Contact dermatitis: other chemicals NOS Dermatitis 
M125000 Contact dermatitis due to cereals Dermatitis 
M125100 Contact dermatitis due to fish Dermatitis 
M125200 Contact dermatitis due to flour Dermatitis 
M125300 Contact dermatitis due to fruit Dermatitis 
M125400 Contact dermatitis due to meat Dermatitis 
M125500 Contact dermatitis due to milk Dermatitis 
M125z11 Egg contact dermatitis Dermatitis 
M126.00 Contact dermatitis due to plants Dermatitis 
M126000 Contact dermatitis due to lacquer tree Dermatitis 
M126100 Contact dermatitis due to poison-ivy Dermatitis 
M126200 Contact dermatitis due to poison-oak Dermatitis 
M126300 Contact dermatitis due to poison-sumac Dermatitis 
M126400 Contact dermatitis due to poison-vine Dermatitis 
M126500 Contact dermatitis due to primrose Dermatitis 
M126600 Contact dermatitis due to ragweed Dermatitis 
M126z00 Contact dermatitis due to plants NOS Dermatitis 
M127.00 Contact dermatitis due to solar radiation Dermatitis 
M127000 Unspecified contact dermatitis due to solar radiation Dermatitis 
M127300 Photodermatitis Dermatitis 
M127800 Photocontact dermatitis [berloque dermatitis] Dermatitis 
M127z00 Contact dermatitis due to solar radn NOS Dermatitis 
M128.00 Allergic contact dermatitis Dermatitis 
M128000 Allergic contact dermatitis due to adhesives Dermatitis 
M128100 Allergic contact dermatitis due to cosmetics Dermatitis 
M128200 Allergic contact dermatitis due drugs in contact with skin Dermatitis 
M128300 Allergic contact dermatitis due to dyes Dermatitis 
M128400 Allergic contact dermatitis due to other chemical products Dermatitis 
M128600 Allergic contact dermatitis due to plants, except food Dermatitis 
M129.00 Irritant contact dermatitis Dermatitis 
M129000 Irritant contact dermatitis due to cosmetics Dermatitis 
M129100 Irritant contact dermatitis due drugs in contact with skin Dermatitis 
M129200 Irritant contact dermatitis due to other chemical products Dermatitis 
M129300 Irritant contact dermatitis due to food in contact with skin Dermatitis 
M129400 Irritant contact dermatitis due to plants, except food Dermatitis 
M129500 Incontinence-associated dermatitis Dermatitis 
M12C.00 Radiodermatitis Dermatitis 
M12C000 Acute radiodermatitis Dermatitis 
M12C100 Chronic radiodermatitis Dermatitis 
M12y.00 Contact dermatitis due to other specified agents Dermatitis 
M12y000 Contact dermatitis due to cosmetics Dermatitis 
M12y011 Lanolin contact dermatitis Dermatitis 
M12y012 Perfume contact dermatitis Dermatitis 
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M12y100 Contact dermatitis due to cold weather Dermatitis 
M12y200 Contact dermatitis due to dyes Dermatitis 
M12y300 Contact dermatitis due to furs Dermatitis 
M12y400 Contact dermatitis due to hot weather Dermatitis 
M12y500 Contact dermatitis due to infra-red rays Dermatitis 
M12y600 Contact dermatitis due to jewellery Dermatitis 
M12y700 Contact dermatitis due to light (excluding sunlight) Dermatitis 
M12y800 Contact dermatitis due to metals Dermatitis 
M12y900 Contact dermatitis due to preservatives Dermatitis 
M12yA00 Contact dermatitis due to radiation NOS Dermatitis 
M12yB00 Contact dermatitis due to ultra-violet rays (excluding sun) Dermatitis 
M12yC00 Contact dermatitis due to x-rays Dermatitis 
M12yD00 Contact dermatitis due to casting materials Dermatitis 
M12yz00 Contact dermatitis: specified agent NOS Dermatitis 
M12z.00 Contact dermatitis NOS Dermatitis 
M12z000 Dermatitis NOS Dermatitis 
M12zz00 Contact dermatitis NOS Dermatitis 
M13..00 Ingestion dermatitis Dermatitis 
M130.00 Ingestion dermatitis due to drugs Dermatitis 
M131.00 Ingestion dermatitis due to food Dermatitis 
M13y.00 Ingestion dermatitis due to other specified substance Dermatitis 
M13z.00 Ingestion dermatitis NOS Dermatitis 
M153500 Perioral dermatitis Dermatitis 
M153511 Circumoral dermatitis Dermatitis 
M153600 Periocular dermatitis Dermatitis 
M15y011 Dermatitis exfoliativa neonatorum Dermatitis 
M17y200 Infantile papular acrodermatitis Dermatitis 
M184.00 Dermatitis artefacta Dermatitis 
M184.11 Dermatitis factitia Dermatitis 
M1B..11 Juvenile plantar dermatitis Dermatitis 
M1y0.00 Nummular dermatitis Dermatitis 
M2y4811 Juvenile plantar dermatitis Dermatitis 
Myu2000 [X]Other seborrhoeic dermatitis Dermatitis 
Myu2100 [X]Allergic contact dermatitis due to oth chemical products Dermatitis 
Myu2300 [X]Allergic contact dermatitis due to other agents Dermatitis 
Myu2400 [X]Irritant contact dermatitis due to oth chemical products Dermatitis 
Myu2500 [X]Irritant contact dermatitis due to other agents Dermatitis 
Myu2600 [X]Unspcfd contact dermatitis due to other chemical products Dermatitis 
Myu2700 [X]Unspecified contact dermatitis due to other agents Dermatitis 
Myu2800 [X]Dermatitis due to other substances taken internally Dermatitis 
Myu2900 [X]Dermatitis due to unspecified substance taken internally Dermatitis 
Myu2C00 [X]Other specified dermatitis Dermatitis 
1N03.00 C/O: dry skin Dry skin 
2587.00 O/E - abd.skin dry-dehydration Dry skin 
2587.12 O/E - abdominal skin dry Dry skin 
2F13.00 O/E - dry skin Dry skin 
M116.00 Neurodermatitis - diffuse Dry skin 
M116.11 Brocq's neurodermatitis Dry skin 
M117.00 Neurodermatitis - atopic Dry skin 
Z1O1300 Drying skin creases Dry skin 
Food allergy 
13A7.00 Egg free diet - allergy Egg allergy 
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SN58000 Egg allergy Egg allergy 
SN58100 Egg protein allergy Egg allergy 
SN58200 Peanut allergy Nut allergy 
SN58300 Nut allergy Nut allergy 
ZC21L00 Advice to avoid nut intake Nut allergy 
13A6.00 Milk free diet - allergy Other food allergy 
8CA4S00 Dietary education for food allergy Other food allergy 
8CA4S11 Dietary advice for food allergy Other food allergy 
J154000 Allergic gastritis Other food allergy 
J432.00 Allergic gastroenteritis and colitis Other food allergy 
J432.11 Allergic diarrhoea Other food allergy 
J432.12 Cow's milk allergy Other food allergy 
J432000 Allergic gastroenteritis Other food allergy 
J432100 Allergic enteritis Other food allergy 
J432200 Allergic enterocolitis Other food allergy 
J432300 Allergic colitis Other food allergy 
J432z00 Allergic gastroenteritis NOS Other food allergy 
SN58.00 Food allergy Other food allergy 
SN58400 Wheat allergy Other food allergy 
SN58800 Mushroom allergy Other food allergy 
SN58900 Allergy to strawberries Other food allergy 
SN58911 Strawberry allergy Other food allergy 
SN58A00 Allergy to soya Other food allergy 
ZC2CF00 Dietary advice for food allergy Other food allergy 
SN58500 Fish allergy Seafood allergy 
SN58600 Seafood allergy Seafood allergy 
SN58700 Shellfish allergy Seafood allergy 
Other allergies 
SN53.11 Hypersensitivity NOS Other allegies 
SN52.12 Allergic drug reaction NOS Other allergies 
SN53.00 Allergy, unspecified Other allergies 
SN53000 Allergic reaction Other allergies 
SN53100 Latex allergy Other allergies 
SN53200 Allergic reaction to tattoo ink Other allergies 
D403300 Allergic eosinophilia Other allergies 
F510400 Acute allergic serous otitis media Other allergies 
F510500 Acute allergic mucoid otitis media Other allergies 
F510600 Acute allergic sanguinous otitis media Other allergies 
F513000 Chronic allergic otitis media Other allergies 
F514000 Allergic otitis media NOS Other allergies 
H025.00 Allergic pharyngitis Other allergies 
J072000 Allergic parotitis Other allergies 
N062.00 Allergic arthritis Other allergies 
N062000 Allergic arthritis of unspecified site Other allergies 
N062100 Allergic arthritis of the shoulder region Other allergies 
N062200 Allergic arthritis of the upper arm Other allergies 
N062300 Allergic arthritis of the forearm Other allergies 
N062400 Allergic arthritis of the hand Other allergies 
N062500 Allergic arthritis of the pelvic region and thigh Other allergies 
N062600 Allergic arthritis of the lower leg Other allergies 
N062700 Allergic arthritis of the ankle and foot Other allergies 
N062800 Allergic arthritis of other specified site Other allergies 
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N062900 Allergic arthritis of multiple sites Other allergies 
N062z00 Allergic arthritis NOS Other allergies 
SN59.00 Allergic reaction to venom Venom allergy 
SN59000 Allergic reaction to bee sting Venom allergy 
SN59100 Allergic reaction to insect bite Venom allergy 
SN59200 Allergic reaction to wasp sting Venom allergy 
SN59300 Anaphylactic shock due to bee sting Venom allergy 
SN59400 Anaphylactic shock due to wasp sting Venom allergy 
Referral 
ZLE6100 Discharge from clinical allergy service Referral allergy 
8HVK000 Private referral to allergy specialist Referral allergy 
8Hld.00 Referral to clinical allergy service Referral allergy 
8T0C.00 Referral to paediatric allergy service Referral allergy 
9NlX.00 Seen by clinical allergy - service Referral allergy 
ZL18200 Under care of clinical allergist Referral allergy 
ZL5A600 Referral to clinical allergist Referral allergy 
ZL9A200 Seen by clinical allergist Referral allergy 
ZLD3200 Discharge by clinical allergist Referral allergy 
8HTu.00 Referral to eczema clinic Referral eczema 
2126200 Asthma resolved Asthma resolved 
212G.00 Asthma resolved Asthma resolved 
Urticaria 
M28..00 Urticaria urticaria 
M280.00 Allergic urticaria urticaria 
M280.11 Drug induced urticaria urticaria 
M281.00 Idiopathic urticaria urticaria 
M282.00 Urticaria due to cold and heat urticaria 
M282000 Cold urticaria urticaria 
M282100 Thermal urticaria urticaria 
M282111 Heat urticaria urticaria 
M282z00 Urticaria due to cold and heat NOS urticaria 
M283.00 Dermatographic urticaria urticaria 
M283.11 Factitial urticaria urticaria 
M284.00 Vibratory urticaria urticaria 
M285.00 Cholinergic urticaria urticaria 
M286.00 Contact urticaria urticaria 
M287.00 Physical urticaria urticaria 
M28y.00 Other specified urticaria urticaria 
M28y.11 Nettle rash urticaria 
M28y000 Urticaria geographica urticaria 
M28y100 Menstrual urticaria urticaria 
M28y200 Urticaria persistans urticaria 
M28yz00 Other specified urticaria NOS urticaria 
M28z.00 Urticaria NOS urticaria 
M28z.11 Hives urticaria 
Myu4.00 [X]Urticaria and erythema urticaria 
Myu4000 [X]Other urticaria urticaria 
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READCODE DESCRIPTION SUBGROUP 
Prevalence 
14M4.00 H/O: cat allergy Allergic rhinitis 
14M5.00 H/O: anaphylactic shock Anaphylaxis 
ZV1B300 [V]Personal history of food induced anaphylaxis Anaphylaxis 
14B4.00 H/O: asthma Asthma 
178..00 Asthma trigger Asthma 
1780.00 Aspirin induced asthma Asthma 
1781.00 Asthma trigger - pollen Asthma 
1782.00 Asthma trigger - tobacco smoke Asthma 
1783.00 Asthma trigger - warm air Asthma 
1784.00 Asthma trigger - emotion Asthma 
1785.00 Asthma trigger - damp Asthma 
1786.00 Asthma trigger - animals Asthma 
1787.00 Asthma trigger - seasonal Asthma 
1788.00 Asthma trigger - cold air Asthma 
1789.00 Asthma trigger - respiratory infection Asthma 
178A.00 Asthma trigger - airborne dust Asthma 
178B.00 Asthma trigger - exercise Asthma 
661M100 Asthma self-management plan agreed Asthma 
661N100 Asthma self-management plan review Asthma 
663..11 Asthma monitoring Asthma 
663N.00 Asthma disturbing sleep Asthma 
663N000 Asthma causing night waking Asthma 
663N100 Asthma disturbs sleep weekly Asthma 
663N200 Asthma disturbs sleep frequently Asthma 
663O.00 Asthma not disturbing sleep Asthma 
663O000 Asthma never disturbs sleep Asthma 
663P.00 Asthma limiting activities Asthma 
663P000 Asthma limits activities 1 to 2 times per month Asthma 
663P100 Asthma limits activities 1 to 2 times per week Asthma 
663P200 Asthma limits activities most days Asthma 
663Q.00 Asthma not limiting activities Asthma 
663U.00 Asthma management plan given Asthma 
663V.00 Asthma severity Asthma 
663V000 Occasional asthma Asthma 
663V100 Mild asthma Asthma 
663V200 Moderate asthma Asthma 
663V300 Severe asthma Asthma 
663W.00 Asthma prophylactic medication used Asthma 
663d.00 Emergency asthma admission since last appointment Asthma 
663e.00 Asthma restricts exercise Asthma 
663e000 Asthma sometimes restricts exercise Asthma 
663e100 Asthma severely restricts exercise Asthma 
663f.00 Asthma never restricts exercise Asthma 
663h.00 Asthma - currently dormant Asthma 
663j.00 Asthma - currently active Asthma 
663m.00 Asthma accident and emergency attendance since last visit Asthma 
663n.00 Asthma treatment compliance satisfactory Asthma 
663p.00 Asthma treatment compliance unsatisfactory Asthma 
663q.00 Asthma daytime symptoms Asthma 
663r.00 Asthma causes night symptoms 1 to 2 times per month Asthma 
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663s.00 Asthma never causes daytime symptoms Asthma 
663t.00 Asthma causes daytime symptoms 1 to 2 times per month Asthma 
663u.00 Asthma causes daytime symptoms 1 to 2 times per week Asthma 
663v.00 Asthma causes daytime symptoms most days Asthma 
663w.00 Asthma limits walking up hills or stairs Asthma 
663x.00 Asthma limits walking on the flat Asthma 
663y.00 Number of asthma exacerbations in past year Asthma 
66Y5.00 Change in asthma management plan Asthma 
66Y9.00 Step up change in asthma management plan Asthma 
66YA.00 Step down change in asthma management plan Asthma 
66YC.00 Absent from work or school due to asthma Asthma 
66YE.00 Asthma monitoring due Asthma 
66YJ.00 Asthma annual review Asthma 
66YK.00 Asthma follow-up Asthma 
66YP.00 Asthma night-time symptoms Asthma 
66YQ.00 Asthma monitoring by nurse Asthma 
66YR.00 Asthma monitoring by doctor Asthma 
66YZ.00 Does not have asthma management plan Asthma 
66Yp.00 Asthma review using Roy Colleg of Physicians three questions Asthma 
66Yq.00 Asthma causes night time symptoms 1 to 2 times per week Asthma 
66Yr.00 Asthma causes symptoms most nights Asthma 
66Ys.00 Asthma never causes night symptoms Asthma 
66Yu.00 Number days absent from school due to asthma in past 6 month Asthma 
679J.00 Health education - asthma Asthma 
679J000 Health education - asthma self management Asthma 
679J100 Health education - structured asthma discussion Asthma 
679J200 Health education - structured patient focused asthma discuss Asthma 
68C3.00 Asthma screening Asthma 
8791.00 Further asthma - drug prevent. Asthma 
8793.00 Asthma control step 0 Asthma 
8794.00 Asthma control step 1 Asthma 
8795.00 Asthma control step 2 Asthma 
8796.00 Asthma control step 3 Asthma 
8797.00 Asthma control step 4 Asthma 
8798.00 Asthma control step 5 Asthma 
8B3j.00 Asthma medication review Asthma 
8CE2.00 Asthma leaflet given Asthma 
8CMA000 Patient has a written asthma personal action plan Asthma 
8CR0.00 Asthma clinical management plan Asthma 
8H2P.00 Emergency admission, asthma Asthma 
8HTT.00 Referral to asthma clinic Asthma 
9N1d.00 Seen in asthma clinic Asthma 
9N1d000 Seen in school asthma clinic Asthma 
9N4Q.00 DNA - Did not attend asthma clinic Asthma 
9NI8.00 Asthma outreach clinic Asthma 
9NNX.00 Under care of asthma specialist nurse Asthma 
9OJ..00 Asthma monitoring admin. Asthma 
9OJ..11 Asthma clinic administration Asthma 
9OJ1.00 Attends asthma monitoring Asthma 
9OJ2.00 Refuses asthma monitoring Asthma 
9OJ3.00 Asthma monitor offer default Asthma 
9OJ4.00 Asthma monitor 1st letter Asthma 
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9OJ5.00 Asthma monitor 2nd letter Asthma 
9OJ6.00 Asthma monitor 3rd letter Asthma 
9OJ7.00 Asthma monitor verbal invite Asthma 
9OJ8.00 Asthma monitor phone invite Asthma 
9OJ9.00 Asthma monitoring deleted Asthma 
9OJA.00 Asthma monitoring check done Asthma 
9OJA.11 Asthma monitored Asthma 
9OJZ.00 Asthma monitoring admin.NOS Asthma 
9hA..00 Exception reporting: asthma quality indicators Asthma 
9hA1.00 Excepted from asthma quality indicators: Patient unsuitable Asthma 
9hA2.00 Excepted from asthma quality indicators: Informed dissent Asthma 
14L..00 H/O: drug allergy Drug allergy 
14L1.00 H/O: penicillin allergy Drug allergy 
14L2.00 H/O: antibiotic allergy NOS Drug allergy 
14L3.00 H/O: anaesthetic allergy Drug allergy 
14L4.00 H/O: analgesic allergy Drug allergy 
14L5.00 H/O: vaccine allergy Drug allergy 
14L5000 H/O: rotavirus vaccine allergy Drug allergy 
14L6.00 H/O: serum allergy Drug allergy 
14L7.00 H/O: cephalosporin allergy Drug allergy 
14L8.00 H/O: tetracycline allergy Drug allergy 
14L9.00 H/O: gentamicin allergy Drug allergy 
14LA.00 H/O: erythromycin allergy Drug allergy 
14LB.00 H/O: neomycin allergy Drug allergy 
14LC.00 H/O: chloramphenicol allergy Drug allergy 
14LD.00 H/O: sulphonamide allergy Drug allergy 
14LE.00 H/O: trimethoprim allergy Drug allergy 
14LF.00 H/O: co-trimoxazole allergy Drug allergy 
14LG.00 H/O: metronidazole allergy Drug allergy 
14LH.00 H/O: nalidixic acid allergy Drug allergy 
14LI.00 H/O: nitrofurantoin allergy Drug allergy 
14LJ.00 H/O: influenza vaccine allergy Drug allergy 
14LK.00 H/O: aspirin allergy Drug allergy 
14LL.00 H/O: betablocker allergy Drug allergy 
14LM.00 H/O: angiotensin converting enzyme inhibitor allergy Drug allergy 
14LN.00 H/O: angiotensin II receptor antagonist allergy Drug allergy 
14LP.00 H/O: warfarin allergy Drug allergy 
14LQ.00 H/O: clopidogrel allergy Drug allergy 
14LR.00 H/O: pneumococcal vaccine allergy Drug allergy 
14LS.00 H/O: combined calcium and vitamin D3 preparation allergy Drug allergy 
14LT.00 H/O: bisphosphonate allergy Drug allergy 
14LT000 H/O ibandronic acid allergy Drug allergy 
14LT100 H/O zoledronic acid monohydrate allergy Drug allergy 
14LT200 H/O disodium etidronate allergy Drug allergy 
14LT300 H/O alendronic acid allergy Drug allergy 
14LT400 H/O risedronate sodium allergy Drug allergy 
14LV.00 H/O: selective oestrogen receptor modulator allergy Drug allergy 
14LW.00 H/O: strontium ranelate allergy Drug allergy 
14LX.00 H/O: dipyridamole allergy Drug allergy 
14LZ.00 H/O: drug allergy NOS Drug allergy 
14La.00 H/O: raloxifene allergy Drug allergy 
14Lb.00 H/O: teriparatide allergy Drug allergy 
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14Lc.00 H/O denosumab allergy Drug allergy 
14Ld.00 H/O calcitonin allergy Drug allergy 
ZV14.00 [V]Personal history of drug allergy Drug allergy 
ZV14100 [V]Personal history of other antibiotic allergy Drug allergy 
ZV14200 [V]Personal history of sulphonamide allergy Drug allergy 
ZV14300 [V]Personal history of other anti-infective agent allergy Drug allergy 
ZV14400 [V]Personal history of anaesthetic agent allergy Drug allergy 
ZV14500 [V]Personal history of narcotic agent allergy Drug allergy 
ZV14600 [V]Personal history of analgesic agent allergy Drug allergy 
ZV14700 [V]Personal history of serum or vaccine allergy Drug allergy 
ZV14800 [V]Personal history of aspirin allergy Drug allergy 
ZV14900 [V]Personal history of co-proxamol allergy Drug allergy 
ZV14A00 [V]Personal history of warfarin allergy Drug allergy 
ZV14B00 [V]Personal history of clopidogrel allergy Drug allergy 
ZV14C00 [V]Personal history of betablocker allergy Drug allergy 
ZV14D00 [V]PH angiotensin-converting-enzyme inhibitor allergy Drug allergy 
ZV14E00 [V]PH of angiotensin II receptor antagonist allergy Drug allergy 
ZV14F00 [V]Personal history of influenza vaccine allergy Drug allergy 
ZV14G00 [V]Personal history of pneumococcal vaccine allergy Drug allergy 
ZV14H00 [V]Personal history of strontium ranelate allergy Drug allergy 
ZV14J00 [V]PH of selective oestrogen receptor modulator allergy Drug allergy 
ZV14K00 [V]Personal history of bisphosphonate allergy Drug allergy 
ZV14L00 [V]Personal history of calcium allergy Drug allergy 
ZV14M00 [V]Personal history of vitamin D3 allergy Drug allergy 
ZV14y00 [V]Personal history of other specified drug allergy Drug allergy 
ZV14z00 [V]Personal history of unspecified drug allergy Drug allergy 
ZVu6M00 [X]Personal history of allergy to other antibiotic agents Drug allergy 
ZVu6N00 [X]Personal history/allergy to other anti-infective agents Drug allergy 
ZVu6P00 [X]Personal history/allergy/other drugs+biological substances Drug allergy 
ZVu6T00 [X]Personal history/allergy,other than/drugs+biological substance Drug allergy 
ZVu6i00 [X]Personal history of allergy to bisoprolol Drug allergy 
ZVu6o00 [X]Personal history of allergy to carvedilol Drug allergy 
ZVu6q00 [X]Personal history of allergy to nebivolol Drug allergy 
ZVu6r00 [X]Personal history of allergy to hair dye Drug allergy 
ZVu6s00 [X]Personal history of allergy to cosmetic products Drug allergy 
ZV14000 [V]Personal history of penicillin allergy Drug allergy 
14F1.00 H/O: eczema Eczema 
14M1.00 H/O: food allergy Food allergy 
ZV1B300 [V]Personal history of food induced anaphylaxis Food Allergy 
14B1.00 H/O: hay fever Hay fever 
14M..00 H/O: non-drug allergy Other allegies 
14M3.00 H/O: multiple allergies Other allergies 
14M2.00 H/O: plant allergy Other allergies 
ZV07100 [V]Desensitization to allergen Other allergies 
ZV15000 [V]Personal history of non-drug allergy Other allergies 
ZV58900 [V]Desensitization to allergens Other allergies 
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3.E: SCIENTIFIC RESEARCH COMMITTEE APPROVAL FOR STUDY USING 








3.F: TOTAL NUMBER OF CHILDREN AND GP PRACTICES WITHIN THE 
























 UK (THIN) 
practices 
WM (THIN)  
practices 
1995 0.28 0.06 16 1 
1996 4.45 0.44 69 9 
1997 17.97 1.87 114 13 
1998 39.36 4.29 157 20 
1999 65.05 7.29 231 23 
2000 99.57 10.95 300 26 
2001 144.38 15.13 407 37 
2002 198.29 19.97 461 42 
2003 254.40 25.49 486 48 
2004 311.61 31.40 529 51 
2005 371.35 37.56 547 53 
2006 428.60 43.92 572 53 
2007 485.93 50.14 608 54 
2008 543.13 56.15 626 54 
2009 593.50 61.13 628 54 
2010 627.29 64.94 623 54 
2011 673.11 69.47 628 54 
2012 714.48 74.32 615 53 
2013 722.15 75.00 603 53 
2014 617.51 58.96 494 37 
2015 594.05 49.11 494 37 
2016 176.89 11.86 400 24 
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3.G: CHANGES IN GENDER COMPOSITION OF CHILDREN WITHIN THIN 
DATASET OVER THE STUDY PERIOD 
 
Year Female(%) Male (%) 
2000 48.17 51.83 
2001 48.38 51.62 
2002 48.39 51.61 
2003 48.44 51.56 
2004 48.45 51.55 
2005 48.53 51.47 
2006 48.61 51.39 
2007 48.62 51.38 
2008 48.65 51.35 
2009 48.69 51.31 
2010 48.74 51.26 
2011 48.85 51.15 
2012 48.90 51.10 
2013 48.89 51.11 
2014 48.89 51.11 
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4.A: ICD-10 AND OPSC4 CODES USED IN THE ANALYSIS 
Group ICD10 Code Description 
Allergic rhinitis 
J301 Allergic rhinitis due to pollen 
J302 Other seasonal allergic rhinitis 
J303 Other allergic rhinitis 
J304 Allergic rhinitis, unspecified 
Anaphylactic 
reactions 
T780 Anaphylactic shock due to adverse food reaction 
T782 Anaphylactic shock, unspecified 
T805 Anaphylactic shock due to serum 
T886 
Anaphylactic shock due to adverse effect of 
correct drug or medicament properly 
administered 
Food allergies 
K522 Allergic and dietetic gastroenteritis and colitis 
T781 Other adverse food reactions, not elsewhere classified 
Angioedema T78.3 Angioneurotic edema 
Urticaria 
L50.0 Allergic urticaria 
L50.5 Cholinergic urticaria 
L50.6 Contact urticaria 
L50.3 Dermatographic urticaria 
L50.1 Idiopathic urticaria 
L50.8 Other urticaria 
L56.3 Solar urticaria 
L50 Urticaria 
L50.2 Urticaria due to cold and heat 
L50.9 Urticaria, unspecified 
L50.4 Vibratory urticaria 
Procedure codes 
(OPSC4) 
X962 allergen immunotherapy drugs (Band1) 
Z516 Desensitisation to allergens 
X385 Subcutaneous immunotherapy 
X392 


















 *figures may not add up to 100% due to rounding error 




REGION FREQ. PERCENT** 
North East 3,706 4.52 
North West 23,517 28.67 
Yorkshire and The Humber 4,622 5.64 
East Midlands 3,533 4.31 
West Midlands 6,788 8.28 
East 6,562 8 
London 15,797 19.26 
South East 12,147 14.81 
South West 4,994 6.09 
Wales 314 0.38 
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4.C: PROPORTION OF CHILDREN (0-17YRS) WITHIN DIFFERENT AGE 






















England census Proportion 
Year 0-5yr 6-10yr 11-17 yr 
2007 29.13 28.00 42.87 
2008 30.01 27.51 42.48 
2009 30.69 27.38 41.93 
2010 31.30 27.48 41.22 
2011 31.10 27.44 41.46 
2012 31.50 27.88 40.62 
2013 31.52 28.60 39.88 
2014 31.43 29.35 39.22 
 
   WM census Proportion 
Year 0-5yr 6-10yr 11-17 yr 
2007 28.36 28.39 43.25 
2008 29.11 27.78 43.11 
2009 29.70 27.51 42.79 
2010 30.10 27.53 42.37 
2011 30.38 27.64 41.99 
2012 30.77 28.07 41.16 
2013 30.85 28.71 40.43 
2014 30.80 29.42 39.78 




5.A: ETHICS APPROVAL FOR THE QUALITATIVE STUDY 
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5.B: PATIENT INFORMATION SHEET FOR QUALITATIVE STUDY 
Paediatric Allergy Treatment Pathways in the West  Midlands – 
Understanding   Parent Experiences and Preferences 
 You have been provided with this information leaflet because the specialist treating 
your child’s allergies felt that you may be a suitable candidate to take part in this study. 
 The chief investigator for this study is Dr Lavanya Diwakar. She is a researcher working 
at the Health Economics Unit at the University of Birmingham. This study will be a part of 
her PhD research. 
Before you decide whether or not you want to take part, we would like you to 
understand why the research is being done and what it would involve for you. Please take 
the time to read this information carefully. Thank you for reading this.  
 You can contact Lavanya if you do not understand some of the information on this 
form or if you have any questions. Contact details are at the end of the form. 
  
1. Purpose of the study 
 Allergy is a common problem in the UK.  A large international study has shown that 
the UK has amongst the highest rates in the world for childhood asthma, eczema and hay 
fever. Allergic disease can significantly affect the quality of life of not only those suffering 
with the condition, but also that of their family members.  
We want to find out from you, the parent of a child suffering with allergies, about 
problems, if any, that you may have experienced whilst availing NHS treatment for your 
child. We also want to know your opinion about the quality of services you have received.  
 Your answers are important to us as they will help us to understand the quality of 
care available in the West Midlands for children with allergies. We will share our results 
with those who make decisions about funding in the NHS in order to make a case for 
improving childhood allergy services locally. 
2. Why have I been chosen? 
 We are inviting parents of over 18 years of age who can converse in English to take 
part in the study if their children have been diagnosed with an allergy at the specialist 
clinic. 
We are trying to include parents of children with different allergies and age groups in 
order to get a broad understanding of the services in the West Midlands region. 
3. Do I have to take part? 
 It is up to you to decide. Deciding not to participate or withdrawing from the study 
will not affect your/ your child’s care in any way. 
You can take your time to consider whether or not you want to participate in this 
study. You do not need to respond immediately and can take the documents provided 
with you if you prefer. We have provided a self-addressed envelope which can be used to 
post the consent form and the baseline form at a later date if you do agree to take part. 
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Even after signing the consent form, you are free to withdraw from the study at any 
time without giving us any explanation. 
 4. What will happen if I take part? 
 You will be asked to complete a consent form and another baseline form so that we 
can obtain your contact details. This should take no longer than 5-10 minutes to 
complete.  
 The researcher will then contact you to arrange for either a face-to-face interview or a 
telephone interview at a time that suits you.  The face-to-face interviews can be carried 
out at the hospital, the University of Birmingham or at your home as per your 
convenience. The interview will take no longer than 45 minutes.  
In order to make sure that we remember the information that we collect from all the 
different interviews, the interviews will be audio taped with your consent.  
  5. What are the possible benefits of taking part? 
 The information that we get from this study will be used to help understand your 
views and     opinions on the current treatment pathways available for managing your 
child’s allergy. This will be shared with those involved with designing NHS services and 
can help improve allergy services for children locally.  
 6. Will my taking part in the study be kept confidential? 
 Yes. Answers will be completely anonymous. With your permission we will audio 
record the information so that we are able to capture all your views and opinions as well 
as around 20 other people’s views and opinions. 
We may send the recorded interviews to an external company so that they can be 
transcribed into writing form. This external company will not have access to your 
personal identification data and is also bound by an agreement to keep the data 
confidential. 
We will follow ethical and legal practice and all information will be kept confidential. 
We will not publish any information which could allow you to be identified.  
7. Who is organising and funding the study? 
The study is organised and sponsored by the University of Birmingham.  
It is also supported by the Heart of England NHS Foundation Trust as well as the 
Shrewsbury and Telford Hospitals NHS Trust. 
It is funded by the Wellcome Trust, which is a global charitable foundation that 
supports research worldwide   
 The Anaphylaxis campaign, a leading charity for individuals with serious allergies, 
also supports the study. 
 8. Who has reviewed the study? 
This study has been reviewed and given a favourable opinion by an independent ethics 
organisation- the Newcastle & North Tyneside Research Ethics Committee -to protect 
your safety, rights, wellbeing and dignity.  
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 Further approval has been obtained from the individual hospitals (i.e. Heartlands 
Hospital and Shrewsbury and Telford Hospitals) taking part in the study. 
 Researcher Contact Details: 
Dr Lavanya Diwakar 
Health Economics Unit 
University of Birmingham 
Edgbaston 
B15 2TT 
 Email:  
Tel:  
Fax   
 Independent Contact (Not related to this study): 
Shrewsbury Hospital: 
Patient Advise and Liaison 
Services (PALS) 
Level 2, Main Ward block 
Royal Shrewsbury Hospital  
Mytton Oak Road 
Shrewsbury, Shropshire, SY3 8XQ 
Tel:  
Heartlands Hospital: 
Patient Advise and Liaison 
Services (PALS) 
Heartlands Hospital NHS 
Foundation Trust 
Bordesley Green East 
Birmingham, B9 5SS 
Tel:   
 
Study Supervisors: 
Prof Tracy Roberts, Head of Health Economics Unit, University of Birmingham 
Dr Carole Cummins, Senior Lecturer in Public Health, Epidemiology and Population 
Sciences, University of Birmingham 
Prof Richard Lilford, Head of the Centre for    International Research, University of 
Warwick 
Clinical Collaborators: 
Dr Scott Hackett, Consultant Paediatrician, Heartlands Hospital NHS Foundation Trust 
Dr Martyn Rees, Consultant Paediatrician, Royal Shrewsbury Hospital NHS Trust 
Supported by:  
The anaphylaxis campaign; www.anaphylaxis.org.uk 
 CONSULTANT NAME:              CONSULTANT TEL:  
THANK YOU FOR TAKING THE TIME TO READ THIS INFORMATION SHEET.  
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Version 3.2  25.06.2014 
5.C: PARTICIPANT CONSENT FORM 
Paediatric Allergy Pathways in the West Midlands- Parent Experiences  
Participant Consent Form 
 
I confirm that I have read and understood the information sheet (Version 3.2,         
Date: 25.06.2014) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
I agree to my sample/data being shared with collaborating institutions, 
NHS Trusts, Universities and Commercial partners within and outside 
of the UK now and in the future.  
I understand that my sample/data will be completely anonymised and 
no identifiable information will be shared. 
I understand the data collected during the study may be looked at by 
regulatory authorities where relevant in this research.  I give permission 
for these individuals to have access to these data. 
I understand that my participation is voluntary and that I am free to withdraw at  
any time without giving any reason, without my medical care or legal rights being 
affected. 
 
I give permission for the study researchers to contact me by  
telephone to arrange an interview 
I give permission for the interviews to be tape-recorded. 
I understand that the information will be used for research only and that 
I will not be identified in any way in the analysis and the reporting of results. 
 
 
I understand what is involved and agree to take part in this study. 
 
   
Name of participant   Date  Signature 
      






Please  initial 
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 5.D: DEMOGRAPHIC DETAILS QUESTIONNAIRE 
 Interview study: Parent experiences with allergy services for children in the West 
Midlands 
Thank you for agreeing to take part in this study. We want to find out about your 
experiences with accessing allergy services for your child. Participation in this study does 
not affect the care provided to your child in any way and you are free to withdraw from it 
at any time without providing any explanation. 
Details regarding the study are provided in the information sheet which would have 
been given to you. Please feel free to contact the researcher (Dr Diwakar) if you have any 
further details that you may wish to clarify. 
Please complete this questionnaire after you have read the information sheet carefully 
and send it to the researcher using the self-addressed envelope provided. The researcher 
will be in touch with you within 7 days after that to confirm with you a date, time and 
place for a detailed interview. This initial call will take not more than 5 -10 minutes. 
The detailed interview can be carried out at the hospital, your home or on the 
telephone as per your preference. The interview will last between 45 and 60 minutes. 
1. Your name: 
2. Your age group (please circle as appropriate):  
<18 yrs;  19-25 yrs;  26-40 yrs;  41-55 yrs;  >55 yrs 
3. What allergies does your child have? ........................................................................ 
4. How old is your child?                    ............................. yrs 




(*We will call you on your mobile number unless you prefer that we call another 
number. Other details will only be used if we are unable to contact you for any reason. 
We will not share these details with anyone and this form will be destroyed once the 
main interview has been completed) 
6. When would it be suitable for us to contact you for the initial 5-10 min call? 
Day (circle one or more days that suit): Monday/ Tuesday/ Wednesday/ Thursday/ 
Friday   Time: ............................ 
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I give permission for Dr Diwakar to contact me regarding this study using the 
details provided  
Signature: 
Name (Print):                                                                             Date:  
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5.E: INTERVIEW TOPIC GUIDE 
Parent experiences of paediatric allergy pathways in the West Midlands 
 (Note – the points below will act as a guide to make sure all relevant topics are 
covered. The interview will be semi-structured and take form of a ‘guided conversation’, 
hence the points may not be covered in this specific order etc.) 
 Check that this is a good time? It won’t take long – about 45 minutes. 
 Thank you for agreeing to talk to me today. I just wanted to start off by talking to you again 
about the study – is that ok? 
 I’m Lavanya, a researcher at the University of Birmingham. We are carrying out research 
looking at parent’s experiences with getting health care for their children’s allergies. We are 
talking to around 20 parents who have accessed the allergy clinics for their children in order to 
find out what their experiences have been like. The findings of the research will be used to 
help improve services. 
 All the information we are collecting will be anonymous. Just to confirm that I am an 
independent researcher, employed by the University of Birmingham, and nothing you say will 
have any effect on your care at the hospital or GP surgery.  
 Most of the issues that we discuss should be straightforward but it is possible that you may 
feel uncomfortable talking about certain things.  If you feel you would rather not answer any of 
the questions you can tell me and we can skip to something else. If you want to finish our 
conversation at any time – that is absolutely fine. 
 The results of the study will be used for research, to understand people’s experiences of 
accessing allergy services. We will share some overall findings with the centre and publish our 
results in academic journals, but no information will be published which would allow individuals 
to be identified.  
 Are you happy to talk to me today to help with this study?  
 I would like to tape record the interview – this is so that I can concentrate on what you are 
saying and so that I can examine what people have said in more detail afterwards. Only 
people in the research team at the University of Birmingham will listen to the recordings. Is this 
ok? 
 If you want to withdraw from the study for any reason, you can do so within 2 weeks of this 
interview. We will ensure that the details relating to this interview are removed and destroyed. 
 Do you have any questions about the study? 





1. Warm up 
 Just to start off, can you tell me a bit about yourself? We don’t need to know any personal 
information, but it would be good to know whether you are working, not working, training, 
studying, looking after family etc.? 
 About your child- how old is he/ she? Is he/she in school? Siblings? 
 
2. Allergies 
 Tell me a little about your little ones allergies. 
(when diagnosed, by whom, how serious) 
 At the time that this reaction occurred, how did you feel? (in control or not?) 
 Any help with managing these? 
 Why did they feel the need for medical help? 
 
3. Primary care 
 How easy was it to see your GP? 
 How did your GP treat the condition? (were they understanding/ dismissive/ helpful) 
 Did you see anyone else at the surgery? (practice nurse/ dietician etc) 
 Was it useful to see the GP? (more control?/ better understanding?) 
 Did you feel satisfied with the appointment? 
 
4. Referral to secondary care 
 Did your GP offer to refer you on? 
 Why did you feel the need to go to secondary care? 
 How easy was it to get an appointment for the allergy clinic? 
 How long did you have to wait? 
 Was it easy to get to the clinic? 
 How far away is the clinic from your home? 
 Did you have any other problems? (parking?) 
 
5. Specialist clinic 
 Did you get seen on time? 
 What did you think about the clinic? Was it pleasant? Were the staff helpful? 
 Who saw you? (nurse/ doctor) 
 Did you feel that you had sufficient time with the specialist? 
 What was your appointment like? 
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 Did he/ she have any tests? 
 Was it useful? 
 Were you satisfied with the appointment? 
 
6. Advantages of seeing practitioners for allergy 
 Do you feel that you have gained anything from 
o The GP appointment 
o The specialist appointment 
 Could you have managed without seeing them? 
 Have you seen any other practitioners for your child’s allergy? 
o If yes, was it useful and how? 
 
7. General effects of the allergy 
 How has your child’s allergy affected life at home/ school/ play etc? 
 Have you told other family members about the child’s allergy? What is the reaction? 
 How do you see the future for your child in the context of his/ her allergies? 
 Does it worry you? 
 Cost of food/ allergen free products 
 Other costs to the household 
 
8. Services for allergy 
 How do you think services for allergy can be improved? (are the services ok the way they 
are now/ are you happy with them?) 
 Ask specifically about primary care 
 Do you think availability of better information will help? 
 What do you think of the current food labelling systems? 
 
9. Closing, thanking and signposting 
 Did you have anything else you wanted to tell me about? 
 It’s been so helpful talking to you today. Just to stress that all the information you have 
given us will be anonymous – we don’t have any personal information about you. All the 
information will be kept confidential and secure. We will share some general results with 
the centre and publish our findings to help improve services. But we won’t publish any 
information which could identify someone. 











6.A NGENE CODING AND OUTPUT FOR FINAL DCE 
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6.C: EFFECTS CODING VERSUS DUMMY CODING IN DCE 
Effects coding and dummy coding are two commonly used methods for categorical coding 
within a DCE. In both of these approaches, one level within each attribute is used as the 
reference point for estimating the utility values for the other levels[223]. 
In the example shown below (Table 6-), the nurse specialist level is the omitted variable 
(or the reference variable). In dummy coding, the reference variable is given a value of 0 as 
default. The other levels within the attribute are assigned a value of 1 when present within the 
choice set and 0 when a different level is present in the corresponding choice set. However, 
this type of coding can cause an issue with identification during analysis since it does not 
differentiate between the utilities of the reference variable and the omitted variables. Effects 
coding provides a way to resolve this problem by assigning  the reference variable a value of -
1[276] whist assigning values of 0 and 1 to the omitted and non-omitted variables 
respectively. 
Table 6-A: An example of dummy and effects coding within DCE  
 
Attribute Levels Dummy coding Effects coding 





0 0 -1 -1 
 Consultant- no 
allergy training 
1 0 1 0 
 Consultant 
Allergy trained 
0 1 0 1 
Both types of coding analysis yield the same information regarding the difference in utility 
estimates between the levels of the attribute. However, whereas effects coding estimates the 
coefficient relative to the mean attribute effect, dummy coding estimates the strength of 
preference of a given level relative to the omitted level[277]. Thus, in dummy coding (and not 
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in effects coding), the statistical tests for significance are a reflection of the difference in 
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 APPENDIX 6.F: DCE RESULTS ( SUBGROUP ANALYSIS)  
 
$ Child currently has either eczema, asthma or allergy; ^ Income of £43,000 or more; Respondents who did not provide an income level (14.3%) were excluded from the 
analysis.++ Child seen by consultant in the last 12 months for any condition; ***p<0.0001; **p<0.001; #p=0.01
Attribute Child with allergy$ High income^ Has consulted secondary care ++ 
Person    
Nurse specialist (allergy trained) (Baseline) (Baseline) (Baseline) 
Consultant-no allergy training -0.99*** -1.11*** -1.11*** 
Consultant - allergy trained 0.29*** 0.40*** 0.38*** 
Information    
Improved NHS choices website (Baseline) (Baseline) (Baseline) 
Verbal information -0.34*** -0.43*** -0.43*** 
Detailed written information -0.25*** -0.32*** -0.32*** 
Support    
No additional support (Baseline) (Baseline) (Baseline) 
Additional support available 0.11*** 0.14** 0.15*** 
Waiting time    
8 weeks (Baseline) (Baseline) (Baseline) 
12 weeks -0.39*** -0.52*** -0.51*** 
18 weeks -0.69*** -0.86*** -0.85*** 
Out of pocket costs    
£25 (Baseline) (Baseline) (Baseline) 
£50 -0.33*** -0.43*** -0.42*** 
£100 -0.42*** -0.54*** -0.52*** 
Constant 0.113# 0.72*** 0.71*** 
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APPENDIX 6.G: FINAL DCE QUESTIONNAIRE (.pdf attached) 
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 APPENDIX 7.A: SYSTEMATIC REVIEW PUBLICATION 
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 APPENDIX 7.B: ADRENALINE AUTOINJECTOR PUBLICATION  
 
